<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Environ Health Perspect</journal-id>
<journal-id journal-id-type="iso-abbrev">Environ. Health Perspect</journal-id>
<journal-id journal-id-type="publisher-id">EHP</journal-id>
<journal-title-group>
<journal-title>Environmental Health Perspectives</journal-title>
</journal-title-group>
<issn pub-type="ppub">0091-6765</issn>
<issn pub-type="epub">1552-9924</issn>
<publisher>
<publisher-name>Environmental Health Perspectives</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31985273</article-id>
<article-id pub-id-type="pmc">7015578</article-id>
<article-id pub-id-type="publisher-id">EHP5053</article-id>
<article-id pub-id-type="doi">10.1289/EHP5053</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Screening ToxCast™ for Chemicals That Affect Cholesterol Biosynthesis: Studies in Cell Culture and Human Induced Pluripotent Stem Cell–Derived Neuroprogenitors</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wages</surname>
<given-names>Phillip A.</given-names>
</name>
<xref ref-type="aff" rid="a1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Joshi</surname>
<given-names>Piyush</given-names>
</name>
<xref ref-type="aff" rid="a2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tallman</surname>
<given-names>Keri A.</given-names>
</name>
<xref ref-type="aff" rid="a1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hye-Young H.</given-names>
</name>
<xref ref-type="aff" rid="a1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bowman</surname>
<given-names>Aaron B.</given-names>
</name>
<xref ref-type="aff" rid="a2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="a3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Porter</surname>
<given-names>Ned A.</given-names>
</name>
<xref ref-type="aff" rid="a1">
<sup>1</sup>
</xref>
</contrib>
<aff id="a1"><label>1</label>Department of Chemistry and Vanderbilt Institute of Chemical Biology, <institution>Vanderbilt University</institution>, Nashville, Tennessee, <country>USA</country></aff>
<aff id="a2"><label>2</label>Departments of Pediatrics, Neurology and Biochemistry, <institution>Vanderbilt University Medical Center</institution>, Nashville, Tennessee, <country>USA</country></aff>
<aff id="a3"><label>3</label>School of Health Sciences, <institution>Purdue University</institution>, West Lafayette, Indiana, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address correspondence to Ned A. Porter, Department of Chemistry, 7300 Stevenson Center, Vanderbilt University, Nashville, TN 37235 USA. Telephone: (615) 343-2693, Fax: (615) 343-1234. Email: <email>n.porter@vanderbilt.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>1</month>
<year>2020</year>
</pub-date>
<volume>128</volume>
<issue>1</issue>
<elocation-id>017014</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>11</month>
<year>2019</year>
</date>
</history>
<permissions>
<license license-type="open-access">
<license-p><italic>EHP</italic> is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="ehp-128-017014.pdf"></self-uri>
<abstract>
<sec>
<title>Background:</title>
<p>Changes in cholesterol metabolism are common hallmarks of neurodevelopmental pathologies. A diverse array of genetic disorders of cholesterol metabolism support this claim as do multiple lines of research that demonstrate chemical inhibition of cholesterol biosynthesis compromises neurodevelopment. Recent work has revealed that a number of commonly used pharmaceuticals induce changes in cholesterol metabolism that are similar to changes induced by genetic disorders with devastating neurodevelopmental deficiencies.</p>
</sec>
<sec>
<title>Objectives:</title>
<p>We tested the hypothesis that common environmental toxicants may also impair cholesterol metabolism and thereby possibly contribute to neurodevelopmental toxicity.</p>
</sec>
<sec>
<title>Methods:</title>
<p>Using high-throughput screening with a targeted lipidomic analysis and the mouse neuroblastoma cell line, Neuro-2a, the ToxCast™ chemical library was screened for compounds that impact sterol metabolism. Validation of chemical effects was conducted by assessing cholesterol biosynthesis in human induced pluripotent stem cell (hiPSC)–derived neuroprogenitors using an isotopically labeled cholesterol precursor and by monitoring product formation with UPLC-MS/MS.</p>
</sec>
<sec>
<title>Results:</title>
<p>Twenty-nine compounds were identified as validated lead-hits, and four were prioritized for further study (endosulfan sulfate, tributyltin chloride, fenpropimorph, and spiroxamine). All four compounds were validated to cause hypocholesterolemia in Neuro-2a cells. The morpholine-like fungicides, fenpropimorph and spiroxamine, mirrored their Neuro-2a activity in four immortalized human cell lines and in a human neuroprogenitor model derived from hiPSCs, but endosulfan sulfate and tributyltin chloride did not.</p>
</sec>
<sec>
<title>Conclusions:</title>
<p>These data reveal the existence of environmental compounds that interrupt cholesterol biosynthesis and that methodologically hiPSC neuroprogenitor cells provide a particularly sensitive system to monitor the effect of small molecules on <italic>de novo</italic> cholesterol formation. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1289/EHP5053">https://doi.org/10.1289/EHP5053</ext-link></p>
</sec>
</abstract>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Human exposure studies with organic solvents, metal exposures, and air pollutants have revealed the existence of developmental neurotoxicants (<xref ref-type="bibr" rid="c9">Costa et al. 2014</xref>; <xref ref-type="bibr" rid="c18">Grandjean and Landrigan 2006</xref>, <xref ref-type="bibr" rid="c19">2014</xref>). To proactively address the potential for environmental contributors to neurological disease, protocols were proposed in the late 1980s to identify and screen for neurodevelopmental toxicants (<xref ref-type="bibr" rid="c75">Wier et al. 1989</xref>). Yet, the difficulty of translating the identification of potential neurodevelopmental toxicants into human health risk assessments has been apparent, given the need for anthropomorphized animal behavior experiments in addition to human epidemiological studies to support the adverse outcome of this class of toxicants (<xref ref-type="bibr" rid="c71">Vrijheid et al. 2014</xref>). An alternative method to study neurodevelopmental toxicants is through the use of developing neural tissue—most commonly from human stem cell or induced pluripotent stem cell (hiPSC) sources (<xref ref-type="bibr" rid="c2">Bal-Price et al. 2010</xref>; <xref ref-type="bibr" rid="c14">Fritsche et al. 2018a</xref>, <xref ref-type="bibr" rid="c15">2018b</xref>; <xref ref-type="bibr" rid="c34">Kumar et al. 2012</xref>). Further, these model systems can be used to screen for developmental neurotoxicants by prioritizing chemicals that result in metabolic phenotypes of neurological disorders (<xref ref-type="bibr" rid="c29">Kleinstreuer et al. 2011</xref>).</p>
<p>Hypocholesterolemia is a common metabolic feature of many neurodevelopmental disorders (<xref ref-type="bibr" rid="c49">Porter and Herman 2011</xref>) and neurodegenerative diseases, including Huntington’s disease and Alzheimer’s disease (<xref ref-type="bibr" rid="c36">Leoni and Caccia 2014</xref>; <xref ref-type="bibr" rid="c41">Martín et al. 2014</xref>; <xref ref-type="bibr" rid="c70">Vance 2012</xref>). Cholesterol is an indispensable lipid in the central nervous system, with more than 25% of the total cholesterol content of a human body residing in the brain (<xref ref-type="bibr" rid="c4">Björkhem and Meaney 2004</xref>). In addition to cholesterol serving as an important structural component for cellular membranes and myelin sheathes, a number of cholesterol metabolites, including neurosteroids, serve as critical signaling molecules (<xref ref-type="bibr" rid="c57">Schroepfer 2000</xref>, <xref ref-type="bibr" rid="c77">Zhang and Liu 2015</xref>). To maintain this indispensable pool of cholesterol, the anatomy of the central nervous system requires an active yet independent cholesterol biosynthetic pathway (<xref ref-type="fig" rid="f1">Figure 1</xref>). This requirement is because plasma cholesterol from either diet or hepato-synthesis does not freely cross the blood–brain barrier (<xref ref-type="bibr" rid="c11">Dietschy 2009</xref>). The most convincing evidence for the necessity of cholesterol in neural biology are in rare genetic syndromic disorders intimately tied to mutations in the enzymes of cholesterol biosynthesis (<xref ref-type="bibr" rid="c49">Porter and Herman 2011</xref>). One such disorder is Smith-Lemli-Opitz Syndrome (SLOS). SLOS is the result of genetic defects in the enzyme 7-dehydrocholesterol reductase (DHCR7) which compromises the cell’s ability to convert 7-dehydrocholesterol (7-DHC) to cholesterol. Research has found numerous connections of SLOS with neurological deficiencies (<xref ref-type="table" rid="t1">Table 1</xref>). One of the more compelling connections between the enzyme DHCR7 and neurobehavior is the number of independent diagnoses of autism spectrum disorder (ASD) in the SLOS patient population (<xref ref-type="bibr" rid="c58">Sikora et al. 2006</xref>). Reports have suggested that as many as 20% of individuals on the autism spectrum have mild hypocholesterolemia likely due to defects in cholesterol metabolism (<xref ref-type="bibr" rid="c35">Lee and Tierney 2011</xref>; <xref ref-type="bibr" rid="c65">Tierney et al. 2006</xref>).</p>
<fig id="f1" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Schematic of cholesterol biosynthesis. Note: Selected enzymes involved in cholesterol biosynthesis are shown in dashed boxes.</p>
</caption>
<alt-text>Figure 1 is a schematic diagram of the following chemical compounds: (1) lanosterol, (2) 7-dehydrodesmosterol, (3) desmosterol, (4) dihydrolanosterol, (5) 7-dehydrocholesterol, (6) cholesterol, (7) 8-dehydrocholesterol, and (8) cholecalciferol (Vitamin D3). Compound 1 synthesises to compound 2 through CYP51 and SC5D. Compound 2 synthesises to compound 3 through DHCR7. Compounds 1, 2, and 3 also synthesize to compounds 4, 5 (through DHCR24), and 6 (through DHCR24), respectively. Compound 4 synthesises to compound 5 through CYP51 and SC5D. Compound 5 synthesises to compound 6 through DHCR7. Compound 5 also synthesizes to compound 7 through EBP and compound 8 through UV light. Compound 7 can synthesise to compound 5 through EBP.</alt-text>
<graphic xlink:href="ehp-128-017014-g001"></graphic>
</fig>
<table-wrap id="t1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<p>Smith-Lemli-Opitz syndrome (SLOS) patient characteristics and associated severity scores observed clinically [adapted from Kelley and Hennekam (<xref ref-type="bibr" rid="c26">2000</xref>) and Porter (<xref ref-type="bibr" rid="c48">2008</xref>)].</p>
</caption>
<alt-text>Table 1 has three columns, namely, classification (score), biochemical features super a, and physical and behavioral symptoms super b.</alt-text>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" id="t1c1" rowspan="1" scope="col">Classification (score)</th>
<th align="center" colspan="1" id="t1c2" rowspan="1" scope="col">Biochemical features<xref ref-type="table-fn" rid="TF1"><sup><italic>a</italic></sup></xref></th>
<th align="center" colspan="1" id="t1c3" rowspan="1" scope="col">Physical and behavioral symptoms<xref ref-type="table-fn" rid="TF2"><sup><italic>b</italic></sup></xref><sup>,</sup><italic><sup>c</sup></italic></th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" headers="t1c1" id="t1c4" rowspan="1" scope="row">Mild (<inline-formula><mml:math id="m1"><mml:mrow><mml:mo>&lt;</mml:mo><mml:mn>20</mml:mn></mml:mrow></mml:math></inline-formula>)</td>
<td align="left" colspan="1" headers="t1c2 t1c4" rowspan="1"><inline-formula><mml:math id="m2"><mml:mrow><mml:mo>∼</mml:mo><mml:mn>90</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> of normal plasma cholesterol levels <break></break>7-DHC levels <inline-formula><mml:math id="m3"><mml:mrow><mml:mo>&gt;</mml:mo><mml:mn>2.7</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula></td>
<td align="left" colspan="1" headers="t1c3 t1c4" rowspan="1">
<list list-type="bullet"><list-item><p>Minimal toe syndactyl</p></list-item></list></td>
</tr>
<tr>
<td align="left" colspan="1" headers="t1c1" id="t1c5" rowspan="1" scope="row">Classical (20–50)</td>
<td align="left" colspan="1" headers="t1c2 t1c5" rowspan="1"><inline-formula><mml:math id="m4"><mml:mrow><mml:mo>∼</mml:mo><mml:mn>60</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> of normal plasma cholesterol levels</td>
<td align="left" colspan="1" headers="t1c3 t1c5" rowspan="1">
<list list-type="bullet"><list-item><p>Qualitative brain abnormality via MRI</p></list-item><list-item><p>Extremity syndactyl (1 instance)</p></list-item></list></td>
</tr>
<tr>
<td align="left" colspan="1" headers="t1c1" id="t1c6" rowspan="1" scope="row">Severe (<inline-formula><mml:math id="m5"><mml:mrow><mml:mo>&gt;</mml:mo><mml:mn>50</mml:mn></mml:mrow></mml:math></inline-formula>)</td>
<td align="left" colspan="1" headers="t1c2 t1c6" rowspan="1"><inline-formula><mml:math id="m6"><mml:mrow><mml:mo>∼</mml:mo><mml:mn>30</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:math></inline-formula> of normal plasma cholesterol levels <break></break>7-DHC levels <inline-formula><mml:math id="m7"><mml:mrow><mml:mo>&gt;</mml:mo><mml:mn>100</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">g</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula></td>
<td align="left" colspan="1" headers="t1c3 t1c6" rowspan="1">
<list list-type="bullet"><list-item><p>Major CNS malformations</p></list-item><list-item><p>Extremity syndactyl (<inline-formula><mml:math id="m8"><mml:mrow><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:mrow></mml:math></inline-formula> instances)</p></list-item></list></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF1">
<label>a</label>
<p>Biochemical values are typically graded across a spectrum of severity; shown are averaged values from multiple sources.</p>
</fn>
<fn id="TF2">
<label>b</label>
<p>Craniofacial defects are characteristic of SLOS patients with anteverted nares, microcephaly, and cleft palate all common.</p>
</fn>
<fn id="TF3">
<label>c</label>
<p>Dehydrocholesterol (7-DHC and 8-DHC) levels correlate with loss of cognitive function and adaptive functioning (<xref ref-type="bibr" rid="c62">Thurm et al. 2016</xref>) and score is correlated with increased aggression.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In addition to genetic-based evidence for the inhibition of cholesterol biosynthesis as a relevant metabolic feature for neurotoxicity, there is also chemical support for this suggestion. During the 1960s’ drug-discovery efforts to develop efficacious cholesterol-lowering pharmaceuticals, numerous lead-hit compounds failed in commercial development due to toxicity. For instance, AY-9944 was designed to inhibit DHCR7, but the compound never passed preclinical phases due to its potent teratogenicity (<xref ref-type="bibr" rid="c12">Dvornik and Hill 1968</xref>; <xref ref-type="bibr" rid="c55">Roux et al. 2000</xref>). A few decades later, AY-9944 was used to develop a rodent model of SLOS that had links to behavioral deficits found in the disorder (<xref ref-type="bibr" rid="c25">Jung et al. 2013</xref>; <xref ref-type="bibr" rid="c30">Kolf-Clauw et al. 1996</xref>). Given the history with the small molecule AY-9944, the question arises: are there environmental chemicals that affect human neural development by disrupting cholesterol metabolism?</p>
<p>Some environmental sterol biosynthesis disruptors have already been identified by cell culture experiments and the use of <italic>in silico</italic> predictive modeling. Namely, the widely used antiseptic benzalkonium chlorides were shown to inhibit DHCR7 (<xref ref-type="bibr" rid="c21">Herron et al. 2016</xref>). Another class of environmental sterol metabolism disruptors are the conazole fungicides. These agricultural pesticides are known to inhibit CYP51 by coordinating with the heme group, which halts substrate binding with a resulting increase of lanosterol (<xref ref-type="fig" rid="f1">Figure 1</xref>) in cell culture (<xref ref-type="bibr" rid="c37">Lepesheva et al. 2008</xref>). These compounds can also disrupt normal reproductive cell function in both murine and human cell models (<xref ref-type="bibr" rid="c53">Roelofs et al. 2014</xref>). Indeed, screening of a library of pharmacologically active molecules identified a number of hypocholesterolemic compounds when tested in mouse neuroblastoma cells (<xref ref-type="bibr" rid="c28">Kim et al. 2016</xref>; <xref ref-type="bibr" rid="c32">Korade et al. 2016</xref>) and human fibroblasts (<xref ref-type="bibr" rid="c32">Korade et al. 2016</xref>); in support of this, a screen of an independent pharmacopeia-based library identified about 1 in 4 drugs as hypocholesterolemic compounds, more than 20% of which targeted DHCR7 (<xref ref-type="bibr" rid="c72">Wages et al. 2018</xref>). The most common drug class to treat hypercholesterolemia, statins, is contraindicated for pregnancy due to an increased risk of spontaneous pregnancy loss (<xref ref-type="bibr" rid="c42">McGrogan et al. 2017</xref>), yet it is controversial whether this loss is due to teratogenicity (<xref ref-type="bibr" rid="c27">Karalis et al. 2016</xref>). Regarding chemical-induced hypocholesterolemia, it was shown in mice that the presence of aripiprazole, a commonly prescribed antipsychotic and known DHCR7 inhibitor, <italic>in utero</italic> impaired embryonic neurodevelopment (<xref ref-type="bibr" rid="c16">Genaro-Mattos et al. 2019</xref>).</p>
<p>The knowledge that numerous pharmaceutical agents inhibit <italic>DHCR7</italic>, a gene associated with a number of fetal anomalies as well as ASD, raised the possibility of the existence of environmental xenobiotics that inhibit DHCR7. We report here the results of a study that sought to address two potential public health issues: <italic>a</italic>) to identify and characterize environmental cholesterol biosynthesis disruptors and <italic>b</italic>) to characterize whether those identified compounds have the potential to inhibit cholesterol biosynthesis in developing human neurons.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2.1">
<title>Materials</title>
<p>Unless otherwise noted, all chemicals were purchased from Sigma-Aldrich. HPLC grade solvents were purchased from Thermo Fisher Scientific Inc. All cell culture reagents were from Mediatech, Life Technologies, and Greiner Bio-One. All sterol standards, natural and isotopically labeled, used in this study are available from Kerafast, Inc. The CytoTox 96® NonRadioactive Cytotoxicity Assay was obtained from Promega (G1780) to assess cytotoxicity.</p>
</sec>
<sec id="s2.2">
<title>Immortalized Cell Lines</title>
<p>The neuroblastoma cell lines Neuro-2a, SK-N-SH and IMR-32 were purchased from American Type Culture Collection. The hepatocyte carcinoma cell line HepG2 and lung carcinoma cell line A549 were purchased from the European Collection of Authenticated Cell Cultures (via Sigma-Aldrich). All cell lines were maintained as recommended by distributors, subcultured every 4–5 d up to 10 passages, and culture medium was changed every 2 days. All media components were purchased from Thermo Fisher Scientific Inc., including minimum essential medium eagle with glutamine (MEM, MT100010CV), Dulbecco’s modified eagle medium with <inline-formula><mml:math id="m9"><mml:mrow><mml:mn>4.5</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula> glucose and sodium pyruvate without glutamine (DMEM, MT15013CV), L-glutamine (25-030-081), penicillin-streptomycin solution (P/S, MT30002CI) and N-2 Supplement (17-502-048). Premium grade fetal bovine serum (FBS) was obtained from VWR/Seradigm (97068-085). Delipidated FBS (dFBS) was prepared by stirring <inline-formula><mml:math id="m10"><mml:mrow><mml:mn>20</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula> of silica (S5130, Sigma-Aldrich) into <inline-formula><mml:math id="m11"><mml:mrow><mml:mn>500</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> of FBS for 24 h at 4°C followed by centrifugation for 1 h at <inline-formula><mml:math id="m12"><mml:mrow><mml:mn>15,000</mml:mn><mml:mo>×</mml:mo><mml:mi>g</mml:mi></mml:mrow></mml:math></inline-formula> at 4°C in a Thermo Scientific Sorvall RC-6 Plus superspeed centrifuge. Supernatant was collected and validated for delipidation of cholesterol using UPLC-MS/MS derivatization with 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD).</p>
</sec>
<sec id="s2.3">
<title>Cortical Neuroprogenitors Derived from Human Induced Pluripotent Stem Cells (hiPSCs)</title>
<p>hiPSCs lines [(CC-3 and CD2 by Aaron Bowman’s laboratory at Vanderbilt University Medical Center, Nashville, TN) and (CX-3 by Kevin Ess’s laboratory also at Vanderbilt University Medical Center)] were reprogrammed and validated from human dermal fibroblasts that were isolated from skin biopsy of healthy human subjects after patient consent and assent under guidelines of an approved IRB protocol (Vanderbilt No. 080369, Kevin C. Ess PI) as previously reported (<xref ref-type="bibr" rid="c64">Tidball et al. 2016</xref>; <xref ref-type="bibr" rid="c1">Armstrong et al. 2017</xref>). Briefly, fibroblasts were reprogrammed into hiPSCs by electroporation with CXLE-hOCT3/4-shp53-F, pCXLE-hSK, and pCXLE-hUL (Addgene plasmid #27077, #27078, and #27079, respectively) plasmid vectors using Neon® transfection system (Life Technologies) described in Okita et al. (<xref ref-type="bibr" rid="c47">2011</xref>). The hiPSCs were cultured and passaged in mTeSR1 media (StemCell Technologies) on Matrigel (BD Biosciences)-coated six-well plates. hiPSCs were replated at <inline-formula><mml:math id="m13"><mml:mrow><mml:mn>100,000</mml:mn><mml:mtext>  cells</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, and differentiation was initiated when cells were 100% confluent. Cortical neural induction was performed following the dual SMAD protocol published by Chambers et al. (<xref ref-type="bibr" rid="c7">2009</xref>), except that LDN (Stemgent Cat. No. 04-0074) at <inline-formula><mml:math id="m14"><mml:mrow><mml:mn>0.4</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula> was used instead of noggin. SB431542 (<inline-formula><mml:math id="m15"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula>) was purchased from (Stemgent Cat. No. 04-0010). Additional details and validation of this differentiation method have been previously reported (<xref ref-type="bibr" rid="c7">Chambers et al. 2009</xref>; <xref ref-type="bibr" rid="c45">Neely et al. 2012</xref>; <xref ref-type="bibr" rid="c63">Tidball et al. 2015</xref>). Briefly, neuralization medium consists of <inline-formula><mml:math id="m16"><mml:mrow><mml:mn>410</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> Knockout DMEM/F12 (Invitrogen #12660), <inline-formula><mml:math id="m17"><mml:mrow><mml:mn>75</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> Knockout Serum (Invitrogen #10828), <inline-formula><mml:math id="m18"><mml:mrow><mml:mn>5</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> glutamax (<inline-formula><mml:math id="m19"><mml:mrow><mml:mn>100</mml:mn><mml:mo>×</mml:mo><mml:mtext>stock</mml:mtext></mml:mrow></mml:math></inline-formula>; Invitrogen #35050-061), <inline-formula><mml:math id="m20"><mml:mrow><mml:mn>5</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> Pen/Strep (<inline-formula><mml:math id="m21"><mml:mrow><mml:mn>100</mml:mn><mml:mo>×</mml:mo><mml:mtext>stock</mml:mtext></mml:mrow></mml:math></inline-formula>; Mediatech #30-002-Cl), <inline-formula><mml:math id="m22"><mml:mrow><mml:mn>5</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> nonessential amino acids (<inline-formula><mml:math id="m23"><mml:mrow><mml:mn>100</mml:mn><mml:mo>×</mml:mo><mml:mtext>stock</mml:mtext></mml:mrow></mml:math></inline-formula>, Invitrogen #M7145), and <inline-formula><mml:math id="m24"><mml:mrow><mml:mn>1.93</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m25"><mml:mrow><mml:mi mathvariant="normal">β</mml:mi><mml:mtext>-mercaptoethanol</mml:mtext></mml:mrow></mml:math></inline-formula> (Sigma #M3148) and N2 medium, which consists of <inline-formula><mml:math id="m26"><mml:mrow><mml:mn>500</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> DMEM/F12 (Invitrogen #10,565-018, <inline-formula><mml:math id="m27"><mml:mrow><mml:mo>+</mml:mo><mml:mtext>glutamax</mml:mtext></mml:mrow></mml:math></inline-formula>), <inline-formula><mml:math id="m28"><mml:mrow><mml:mn>0.775</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula> D-Glucose, and <inline-formula><mml:math id="m29"><mml:mrow><mml:mn>5</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> N2 supplement (Thermo Fisher Scientific #17502048). Cortical neuroprogenitors were replated at <inline-formula><mml:math id="m30"><mml:mrow><mml:mn>300,000</mml:mn><mml:mtext>  cells</mml:mtext><mml:mo>/</mml:mo><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> on day 8 into 96-well plates for exposures that were conducted on day 10.</p>
</sec>
<sec id="s2.4">
<title>Chemical Screening and LC-MS Analysis</title>
<p>The 1,851 chemicals that comprise the ToxCast™ chemical library were obtained through Ann Richard [U.S. Environmental Protection Agency (U.S. EPA)]. The chemicals were supplied blinded in 384-well plates with one chemical per well at a target concentration of <inline-formula><mml:math id="m31"><mml:mrow><mml:mn>20</mml:mn><mml:mtext>  mM</mml:mtext></mml:mrow></mml:math></inline-formula> in DMSO. Chemical plates were shipped, registered, and stored in the Vanderbilt University High-Throughput Screening and Compound Management Facility. All screening experiments were conducted in the Vanderbilt University High-Throughput Screening Facility as previously described (<xref ref-type="bibr" rid="c72">Wages et al. 2018</xref>). Briefly, <inline-formula><mml:math id="m32"><mml:mrow><mml:mn>2.5</mml:mn><mml:mtext>  nL</mml:mtext></mml:mrow></mml:math></inline-formula> of each compound (at <inline-formula><mml:math id="m33"><mml:mrow><mml:mn>10</mml:mn><mml:mtext>  mM</mml:mtext></mml:mrow></mml:math></inline-formula>) from the ToxCast™ Chemical Library were deposited into a separate well of a black 384-well cell culture plate (Grenier Bio-One) using a Labcyte Echo 550/555. Neuro-2a cells were trypsinized, counted by hemocytometer, resuspended in DMEM with reduced serum (0.5% FBS, <inline-formula><mml:math id="m34"><mml:mrow><mml:mn>2</mml:mn><mml:mtext>  mM</mml:mtext></mml:mrow></mml:math></inline-formula> L-glutamine, <inline-formula><mml:math id="m35"><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo></mml:mrow></mml:math></inline-formula> P/S), and <inline-formula><mml:math id="m36"><mml:mrow><mml:mn>25</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula> of cell suspension was dispensed to 384-well plates (on top of predeposited compounds) using Multidrop Combi (Thermo Scientific) at a final plating density of <inline-formula><mml:math id="m37"><mml:mrow><mml:mn>1.00</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> Neuro-2a cells per well. In addition to the test compounds, four positive control compounds identified and validated from previous studies (<xref ref-type="bibr" rid="c32">Korade et al. 2016</xref>; <xref ref-type="bibr" rid="c28">Kim et al. 2016</xref>) were included on each plate to probe the cholesterol biosynthetic pathway. These four compounds included simvastatin, which inhibits HMG-CoA Reductase (lowers all sterols analyzed); econazole, which inhibits CYP51 (increases lanosterol levels); aripiprazole, which inhibits DHCR7 (increases 7-DHC); and clomiphene, which inhibits DHCR24 (increases desmosterol). After 24 h of incubation at 37°C and 5% <inline-formula><mml:math id="m38"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">CO</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, Hoechst dye (Molecular Probes) was added using Agilent Velocity 11 Bravo and incubated at room temperature for 30 min in the dark. Cells were imaged and counted based on nuclear staining using ImageXpress Micro XL (Molecular Devices) with a <inline-formula><mml:math id="m39"><mml:mrow><mml:mn>4</mml:mn><mml:mo>×</mml:mo></mml:mrow></mml:math></inline-formula> objective. For analysis of sterols, MeOH containing internal standards (<inline-formula><mml:math id="m40"><mml:mrow><mml:mn>0.0166</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="m41"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m42"><mml:mrow><mml:mn>0.125</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="m43"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Des</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m44"><mml:mrow><mml:mn>0.115</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="m45"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-lanosterol</mml:mtext></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="m46"><mml:mrow><mml:mn>0.0434</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="m47"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-Chol</mml:mtext><mml:mo>/</mml:mo><mml:mtext>well</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to each well after removing the medium to extract all endogenous lipids. Plates were centrifuged, and supernatant was transferred by an automated liquid handler Agilent Velocity 11 Bravo to a plate (Waters #186002631, <inline-formula><mml:math id="m48"><mml:mrow><mml:mn>100</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula> flat bottomed) with <inline-formula><mml:math id="m49"><mml:mrow><mml:mn>50</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula> of 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) predeposited in each well. The plates were immediately sealed with Easy Pierce Heat Sealing Foil (ThermoScientific AB-1720), followed by 20 min of agitation at room temperature and then centrifuged for 10 min using a Sorvall swing rotor. Similar sample preparation via PTAD-derivatization was described previously (<xref ref-type="bibr" rid="c32">Korade et al. 2016</xref>; <xref ref-type="bibr" rid="c38">Liu et al. 2014</xref>) for UPLC-MS/MS analysis. Samples were analyzed on an Acquity UPLC system equipped with ANSI-compliant well plate holder. The sterols (<inline-formula><mml:math id="m50"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula> injection) were analyzed on an UPLC C18 column (Acquity UPLC BEH C18, <inline-formula><mml:math id="m51"><mml:mrow><mml:mn>1.7</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m52"><mml:mrow><mml:mn>2.1</mml:mn><mml:mo>×</mml:mo><mml:mn>50</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mm</mml:mi></mml:mrow></mml:math></inline-formula>) with 100% MeOH (0.1% v/v acetic acid) mobile phase at a flow rate of <inline-formula><mml:math id="m53"><mml:mrow><mml:mn>500</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mo>/</mml:mo><mml:mtext>min</mml:mtext></mml:mrow></mml:math></inline-formula> and runtime of 1.2 min. A TSQ Quantum Ultra tandem mass spectrometer (ThermoFisher) was used for MS detections, and data were acquired with a Finnigan Xcalibur software package (version 2.2 SP1.48; Thermo Xcalibur). Selected reaction monitoring (SRM) of the PTAD derivatives was acquired in the positive ion mode using atmospheric pressure chemical ionization (APCI). The monitored transitions included: Chol <inline-formula><mml:math id="m54"><mml:mrow><mml:mn>369</mml:mn><mml:mo>→</mml:mo><mml:mn>369</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m55"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-Chol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m56"><mml:mrow><mml:mn>376</mml:mn><mml:mo>→</mml:mo><mml:mn>376</mml:mn></mml:mrow></mml:math></inline-formula>, 7-DHC <inline-formula><mml:math id="m57"><mml:mrow><mml:mn>560</mml:mn><mml:mo>→</mml:mo><mml:mn>365</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m58"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m59"><mml:mrow><mml:mn>567</mml:mn><mml:mo>→</mml:mo><mml:mn>372</mml:mn></mml:mrow></mml:math></inline-formula>, Des <inline-formula><mml:math id="m60"><mml:mrow><mml:mn>592</mml:mn><mml:mo>→</mml:mo><mml:mn>365</mml:mn></mml:mrow></mml:math></inline-formula>, Lan <inline-formula><mml:math id="m61"><mml:mrow><mml:mn>634</mml:mn><mml:mo>→</mml:mo><mml:mn>602</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m62"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Des</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m63"><mml:mrow><mml:mn>595</mml:mn><mml:mo>→</mml:mo><mml:mn>368</mml:mn></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="m64"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Lan</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m65"><mml:mrow><mml:mn>637</mml:mn><mml:mo>→</mml:mo><mml:mn>605</mml:mn></mml:mrow></mml:math></inline-formula>. MS parameters were optimized for the 7-DHC-PTAD adduct and were as follows: auxiliary nitrogen gas pressure at <inline-formula><mml:math id="m66"><mml:mrow><mml:mn>55</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>psi</mml:mtext></mml:mrow></mml:math></inline-formula> and sheath gas pressure at <inline-formula><mml:math id="m67"><mml:mrow><mml:mn>60</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>psi</mml:mtext></mml:mrow></mml:math></inline-formula>; discharge current at <inline-formula><mml:math id="m68"><mml:mrow><mml:mn>22</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">A</mml:mi></mml:mrow></mml:math></inline-formula> and vaporizer temperature at 342°C. Collision-induced dissociation (CID) was optimized at <inline-formula><mml:math id="m69"><mml:mrow><mml:mn>12</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>eV</mml:mtext></mml:mrow></mml:math></inline-formula> under <inline-formula><mml:math id="m70"><mml:mrow><mml:mn>1.0</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>mTorr</mml:mtext></mml:mrow></mml:math></inline-formula> of argon. Endogenous sterol levels were quantified based on the known internal standard amount and then normalized to nuclear cell count, reported as nmol/million cells.</p>
</sec>
<sec id="s2.5">
<title>Lead-Hit Validation and <italic>in Vitro</italic> Dosing</title>
<p>Determination of lead-hit compounds from screening involved the calculation of screening window coefficients “<italic>Z</italic>” and “<italic>z</italic>-score” (<xref ref-type="bibr" rid="c76">Zhang et al. 1999</xref>); <italic>z</italic>-Scores are calculated from the following equation:
<disp-formula id="e1"><alternatives><graphic orientation="portrait" position="float" xlink:href="ehp-128-017014-e001.jpg"></graphic><mml:math id="m71"><mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mtext>compound</mml:mtext></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mrow><mml:mtext>vehicle</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>/</mml:mo><mml:msub><mml:mi mathvariant="normal">σ</mml:mi><mml:mrow><mml:mtext>vehicle</mml:mtext></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>where <inline-formula><mml:math id="m72"><mml:mi>x</mml:mi></mml:math></inline-formula> is lead-hit screened sterol level, <inline-formula><mml:math id="m73"><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:math></inline-formula> is averaged vehicle (0.1% DMSO) sterol level, and <inline-formula><mml:math id="m74"><mml:mi mathvariant="normal">σ</mml:mi></mml:math></inline-formula> is standard deviation of vehicle sterol level (compound: <inline-formula><mml:math id="m75"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>, vehicle: <inline-formula><mml:math id="m76"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>72</mml:mn></mml:mrow></mml:math></inline-formula>). Compounds with a <inline-formula><mml:math id="m77"><mml:mrow><mml:mi>z</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></inline-formula> were selected as lead-hits and effects validated in Neuro-2a cells in 96-well plates (Grenier Bio-One). Additionally, any chemicals that resulted in significant cell loss were selected as lead-hit compounds as well, specifically to be tested at lower doses: 0.01, 0.1, and <inline-formula><mml:math id="m78"><mml:mrow><mml:mn>0.4</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula>. Neuro-2a cells were seeded at <inline-formula><mml:math id="m79"><mml:mrow><mml:mn>0.75</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> Neuro-2a cells/well in DMEM with 10% FBS, <inline-formula><mml:math id="m80"><mml:mrow><mml:mn>2</mml:mn><mml:mtext>  mM</mml:mtext></mml:mrow></mml:math></inline-formula> L-glutamine, <inline-formula><mml:math id="m81"><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo></mml:mrow></mml:math></inline-formula> P/S. After 24 h, media was aspirated by pipette and replaced with DMEM exposure media (<inline-formula><mml:math id="m82"><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo></mml:mrow></mml:math></inline-formula> N-2 supplement, <inline-formula><mml:math id="m83"><mml:mrow><mml:mn>2</mml:mn><mml:mtext>  mM</mml:mtext></mml:mrow></mml:math></inline-formula> L-glutamine, <inline-formula><mml:math id="m84"><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo></mml:mrow></mml:math></inline-formula> P/S) containing <inline-formula><mml:math id="m85"><mml:mrow><mml:mn>1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula> lead-hit compound (0.05% DMSO) for 24 h. Neuro-2a cells were then prepped for the targeted lipidomic mass spectrometric analysis as with 384-well plates, but to each well in the 96-well plate was added the internal standards (<inline-formula><mml:math id="m86"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula> of stock solution in MeOH: <inline-formula><mml:math id="m87"><mml:mrow><mml:mn>0.087</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nmol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m88"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-Chol</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m89"><mml:mrow><mml:mn>0.033</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nmol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m90"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m91"><mml:mrow><mml:mn>0.25</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nmol</mml:mtext></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="m92"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Des</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m93"><mml:mrow><mml:mn>0.23</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nmol</mml:mtext></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="m94"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-lanosterol</mml:mtext></mml:mrow></mml:math></inline-formula>) and MeOH (<inline-formula><mml:math id="m95"><mml:mrow><mml:mn>100</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula>). All verified lead-hits were then exposed to Neuro-2a cells at 4 doses for 24 h in DMEM exposure media: 0.1, 0.4, 1, and <inline-formula><mml:math id="m96"><mml:mrow><mml:mn>4</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula>.</p>
<p>Using selection criteria (Table S1 and Figure S1) remaining lead-hits were tested in four human immortalized cell lines. All cell lines were cultured and maintained in MEM with 10% FBS, <inline-formula><mml:math id="m97"><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo></mml:mrow></mml:math></inline-formula> P/S. For dosing experiments, cells were seeded into 96-well plates (<inline-formula><mml:math id="m98"><mml:mrow><mml:mn>0.8</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> SK-N-SH cells/well, <inline-formula><mml:math id="m99"><mml:mrow><mml:mn>0.8</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> IMR-32 cells/well, <inline-formula><mml:math id="m100"><mml:mrow><mml:mn>0.6</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> A549 cells/well, <inline-formula><mml:math id="m101"><mml:mrow><mml:mn>1.0</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>4</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> HepG2 cells/well). After 24 h, media was aspirated by pipette and replaced with MEM exposure media (10% dFBS, <inline-formula><mml:math id="m102"><mml:mrow><mml:mn>1</mml:mn><mml:mo>×</mml:mo></mml:mrow></mml:math></inline-formula> P/S) containing compound at three doses for 24 h: 0.01, 0.1, and <inline-formula><mml:math id="m103"><mml:mrow><mml:mn>1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula> (0.05% DMSO). Each dosing experiment was conducted so that no two cell lines were cultured onto the same 96-well plate. After exposure, cells were then prepped for mass spectrometric analysis as with 384-well plates, but to each well of the black 96-well plates (Grenier Bio-One) was added the internal standards (<inline-formula><mml:math id="m104"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula> of stock solution in MeOH: <inline-formula><mml:math id="m105"><mml:mrow><mml:mn>0.087</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m106"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-Chol</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m107"><mml:mrow><mml:mn>0.033</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m108"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m109"><mml:mrow><mml:mn>0.066</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m110"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>8</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m111"><mml:mrow><mml:mn>0.25</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m112"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Des</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m113"><mml:mrow><mml:mn>0.23</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="m114"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-lanosterol</mml:mtext></mml:mrow></mml:math></inline-formula>), and MeOH (<inline-formula><mml:math id="m115"><mml:mrow><mml:mn>100</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula>). Updated monitored transitions for UPLC-MS/MS included Chol <inline-formula><mml:math id="m116"><mml:mrow><mml:mn>369</mml:mn><mml:mo>→</mml:mo><mml:mn>369</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m117"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-Chol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m118"><mml:mrow><mml:mn>376</mml:mn><mml:mo>→</mml:mo><mml:mn>376</mml:mn></mml:mrow></mml:math></inline-formula>, 7-DHC <inline-formula><mml:math id="m119"><mml:mrow><mml:mn>560</mml:mn><mml:mo>→</mml:mo><mml:mn>365</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m120"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m121"><mml:mrow><mml:mn>567</mml:mn><mml:mo>→</mml:mo><mml:mn>372</mml:mn></mml:mrow></mml:math></inline-formula>, 8-DHC <inline-formula><mml:math id="m122"><mml:mrow><mml:mn>558</mml:mn><mml:mo>→</mml:mo><mml:mn>363</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m123"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>8</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m124"><mml:mrow><mml:mn>565</mml:mn><mml:mo>→</mml:mo><mml:mn>370</mml:mn></mml:mrow></mml:math></inline-formula>, Des <inline-formula><mml:math id="m125"><mml:mrow><mml:mn>592</mml:mn><mml:mo>→</mml:mo><mml:mn>365</mml:mn></mml:mrow></mml:math></inline-formula>, Lan <inline-formula><mml:math id="m126"><mml:mrow><mml:mn>634</mml:mn><mml:mo>→</mml:mo><mml:mn>602</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m127"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Des</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m128"><mml:mrow><mml:mn>595</mml:mn><mml:mo>→</mml:mo><mml:mn>368</mml:mn></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="m129"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Lan</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m130"><mml:mrow><mml:mn>637</mml:mn><mml:mo>→</mml:mo><mml:mn>605</mml:mn></mml:mrow></mml:math></inline-formula>. The baseline sterol profile for each cell line was determined by assaying cells treated only with media in parallel to exposed cells.</p>
<p>For hiPSC experiments, neuroprogenitor cells were exposed to lead-hit compounds (fenpropimorph, spiroxamine) and positive control compound (haloperidol) at day 10 of differentiation. The hiPSC neuroprogenitor cells were exposed to chemicals at two doses (0.01 and <inline-formula><mml:math id="m131"><mml:mrow><mml:mn>1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula>, 0.05% DMSO) for four different durations of time (4, 8, 12, and 24 h) with and without <inline-formula><mml:math id="m132"><mml:mrow><mml:mn>500</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m133"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-lanosterol</mml:mtext></mml:mrow></mml:math></inline-formula> to measure <italic>de novo</italic> cholesterol synthesis as previously reported (<xref ref-type="bibr" rid="c31">Korade et al. 2017a</xref>). Briefly, <inline-formula><mml:math id="m134"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-lanosterol</mml:mtext></mml:mrow></mml:math></inline-formula> was added to the media (defined in section above) at 0.01% ethanol in order to trace the synthesis of <inline-formula><mml:math id="m135"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-lanosterol</mml:mtext></mml:mrow></mml:math></inline-formula> to <inline-formula><mml:math id="m136"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-dehydrocholesterol</mml:mtext></mml:mrow></mml:math></inline-formula> to <inline-formula><mml:math id="m137"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-cholesterol</mml:mtext></mml:mrow></mml:math></inline-formula> using the PTAD-UPLC-MS/MS analysis method. To evaluate <italic>de novo</italic> cholesterol synthesis a residual cholesterol synthesis (RCS) was calculated as described previously (<xref ref-type="bibr" rid="c17">Genaro-Mattos et al. 2018</xref>; <xref ref-type="bibr" rid="c22">Honda et al. 1995</xref>; <xref ref-type="bibr" rid="c74">Wassif et al. 2005</xref>) by the following equation: [<inline-formula><mml:math id="m138"><mml:mrow><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-cholesterol</mml:mtext><mml:mo>/</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext><mml:mo>+</mml:mo></mml:mrow><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-cholesterol</mml:mtext></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>]. After exposure of compound in the presence of <inline-formula><mml:math id="m139"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-lanosterol</mml:mtext></mml:mrow></mml:math></inline-formula>, hiPSC neuroprogenitors were then prepped for mass spectrometric analysis as with 384-well plates, but to each well in the 96-well plate was added the internal standards (<inline-formula><mml:math id="m140"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula> of stock solution in MeOH: <inline-formula><mml:math id="m141"><mml:mrow><mml:mn>0.087</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m142"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-Chol</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m143"><mml:mrow><mml:mn>0.033</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m144"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m145"><mml:mrow><mml:mn>0.066</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m146"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>8</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m147"><mml:mrow><mml:mn>0.25</mml:mn><mml:mtext>  nmol</mml:mtext></mml:mrow></mml:math></inline-formula>), and MeOH (<inline-formula><mml:math id="m148"><mml:mrow><mml:mn>100</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula>). Updated monitored transitions for UPLC-MS/MS included Chol <inline-formula><mml:math id="m149"><mml:mrow><mml:mn>369</mml:mn><mml:mo>→</mml:mo><mml:mn>369</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m150"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-Chol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m151"><mml:mrow><mml:mn>376</mml:mn><mml:mo>→</mml:mo><mml:mn>376</mml:mn></mml:mrow></mml:math></inline-formula>, 7-DHC <inline-formula><mml:math id="m152"><mml:mrow><mml:mn>560</mml:mn><mml:mo>→</mml:mo><mml:mn>365</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m153"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m154"><mml:mrow><mml:mn>567</mml:mn><mml:mo>→</mml:mo><mml:mn>372</mml:mn></mml:mrow></mml:math></inline-formula>, 8-DHC <inline-formula><mml:math id="m155"><mml:mrow><mml:mn>558</mml:mn><mml:mo>→</mml:mo><mml:mn>363</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m156"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>8</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m157"><mml:mrow><mml:mn>565</mml:mn><mml:mo>→</mml:mo><mml:mn>370</mml:mn></mml:mrow></mml:math></inline-formula>, Des <inline-formula><mml:math id="m158"><mml:mrow><mml:mn>592</mml:mn><mml:mo>→</mml:mo><mml:mn>365</mml:mn></mml:mrow></mml:math></inline-formula>, Lan <inline-formula><mml:math id="m159"><mml:mrow><mml:mn>634</mml:mn><mml:mo>→</mml:mo><mml:mn>602</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m160"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Des</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m161"><mml:mrow><mml:mn>595</mml:mn><mml:mo>→</mml:mo><mml:mn>368</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m162"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Lan</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m163"><mml:mrow><mml:mn>637</mml:mn><mml:mo>→</mml:mo><mml:mn>605</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m164"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Chol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m165"><mml:mrow><mml:mn>372</mml:mn><mml:mo>→</mml:mo><mml:mn>372</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m166"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m167"><mml:mrow><mml:mn>563</mml:mn><mml:mo>→</mml:mo><mml:mn>368</mml:mn></mml:mrow></mml:math></inline-formula>, and <inline-formula><mml:math id="m168"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-</mml:mtext><mml:mn>8</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m169"><mml:mrow><mml:mn>561</mml:mn><mml:mo>→</mml:mo><mml:mn>366</mml:mn></mml:mrow></mml:math></inline-formula>. Traceable isotopically labeled sterol levels were quantified based on the known internal standard amount or determined response factor to <inline-formula><mml:math id="m170"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-Chol</mml:mtext></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="m171"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Des</mml:mtext></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="m172"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Lan</mml:mtext></mml:mrow></mml:math></inline-formula>. Values were then normalized to nuclear cell count, reported as nmol/million cells.</p>
<p>Detailed <italic>in vitro</italic> dosing information for all experiments is referenced in Table S2.</p>
</sec>
<sec id="s2.6">
<title>Chemical Synthesis and Characterization of 8-Dehydrocholesterol</title>
<sec id="s2.6.1">
<title>Isolation of 8-DHC-PTAD adducts.</title>
<p>PTAD (<inline-formula><mml:math id="m173"><mml:mrow><mml:mn>50</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m174"><mml:mrow><mml:mn>0.29</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of 8-DHC (<inline-formula><mml:math id="m175"><mml:mrow><mml:mn>20</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m176"><mml:mrow><mml:mn>0.052</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in MeOH (<inline-formula><mml:math id="m177"><mml:mrow><mml:mn>1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) and benzene (<inline-formula><mml:math id="m178"><mml:mrow><mml:mn>0.1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> for solubility). After 1 h, the reaction mixture was concentrated and purified on a Si SPE cartridge (hexanes:EtOAc, 1:1) to remove most of the PTAD. The reaction mixture was further purified by semipreparative HPLC (C18, MeOH) to isolate the ene; 5,7,9-PTAD; and 5,9,14-MeOH adducts. The NMR data for the isolated products matched the independently synthesized adducts, which is described below. The ene adduct could not be isolated pure, likely due to the presence of minor amounts of the other ene adducts, as well as its instability. Only the diagnostic NMR signals are reported for the ene: <inline-formula><mml:math id="m179"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m180"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m181"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 7.59-7.35 (m, 4H), 7.38-7.35 (m, 1H), 5.35 (d, 1H, <inline-formula><mml:math id="m182"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>2.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.13 (s, 1H), 3.59-3.50 (m, 1H), 2.39 (d, 2H, <inline-formula><mml:math id="m183"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>5.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 1.21 (s, 3H), 0.93 (d, 3H, <inline-formula><mml:math id="m184"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>4.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.86 (br s, 3H), 0.85 (br s, 3H), 0.67 (s, 3H); <inline-formula><mml:math id="m185"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m186"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m187"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 151.5, 150.4, 145.8, 142.1, 131.4, 129.3, 128.2, 126.0, 125.7, 122.5, 116.4, 72.2, 54.4, 53.1, 49.8, 42.9, 42.1, 39.5, 38.7, 36.11, 36.08, 36.0, 35.4, 151.5, 150.4, 145.8, 142.1, 131.4, 129.3, 128.2, 126.0, 125.7, 122.5, 116.4, 72.2, 54.4, 53.1, 49.8, 42.9, 42.1, 39.5, 38.7, 36.11, 36.08, 36.0, 35.4, 31.9, 30.0, 29.4, 28.7, 28.0, 23.6, 23.3, 23.1, 22.8, 22.7, 22.6, 18.8, 11.6.</p>
</sec>
<sec id="s2.6.2">
<title>Synthesis of Ac-7-DHC 1.</title>
<p>Acetyl chloride (<inline-formula><mml:math id="m188"><mml:mrow><mml:mn>1.0</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m189"><mml:mrow><mml:mn>14</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of 7-DHC (<inline-formula><mml:math id="m190"><mml:mrow><mml:mn>3.2</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m191"><mml:mrow><mml:mn>8.4</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>mmol</mml:mtext></mml:mrow></mml:math></inline-formula>), DMAP (<inline-formula><mml:math id="m192"><mml:mrow><mml:mn>1.5</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m193"><mml:mrow><mml:mn>12</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>mmol</mml:mtext></mml:mrow></mml:math></inline-formula>), and <inline-formula><mml:math id="m194"><mml:mrow><mml:msub><mml:mrow><mml:mtext>Et</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mi mathvariant="normal">N</mml:mi></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m195"><mml:mrow><mml:mn>1.7</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m196"><mml:mrow><mml:mn>12</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in <inline-formula><mml:math id="m197"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CH</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m198"><mml:mrow><mml:mn>40</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>). After 1 h, the reaction mixture was washed with <inline-formula><mml:math id="m199"><mml:mrow><mml:msub><mml:mi mathvariant="normal">H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:math></inline-formula> and then with brine and then dried over <inline-formula><mml:math id="m200"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. The product was purified by column chromatography (hexanes:EtOAc, 9:1) and isolated as a white powder (<inline-formula><mml:math id="m201"><mml:mrow><mml:mn>3.0</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 83%). <inline-formula><mml:math id="m202"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m203"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m204"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.53 (dd, 1H, <inline-formula><mml:math id="m205"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>2.0</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m206"><mml:mrow><mml:mn>5.6</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.36–5.34 (m, 1H), 4.72–4.62 (m, 1H), 2.47 (ddd, 1H, <inline-formula><mml:math id="m207"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.0</mml:mn></mml:mrow></mml:math></inline-formula>, 4.9, <inline-formula><mml:math id="m208"><mml:mrow><mml:mn>14.5</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.33 (t, 1H, <inline-formula><mml:math id="m209"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>13.6</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.11–2.00 (m, 1H), 2.01 (s, 3H), 1.95–1.83 (m, 5H), 1.70–1.47 (m, 5H), 1.36–1.10 (m, 12H), 0.92 (s, 3H), 0.91 (d, 3H, <inline-formula><mml:math id="m210"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>5.8</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.85 (s, 3H), 0.83 (s, 3H), 0.59 (s, 3H); <inline-formula><mml:math id="m211"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m212"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m213"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 170.4, 141.5, 138.4, 120.2, 116.2, 72.7, 55.8, 54.4, 46.0, 42.8, 39.5, 39.1, 37.9, 37.0, 36.6, 36.1, 36.0, 28.1, 28.0, 23.8, 23.0, 22.8, 22.5, 21.4, 21.0, 18.8, 16.1, 11.8.</p>
</sec>
<sec id="s2.6.3">
<title>Synthesis of 2.</title>
<p>A solution of Ac-7-DHC (<inline-formula><mml:math id="m214"><mml:mrow><mml:mn>0.32</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m215"><mml:mrow><mml:mn>0.75</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in <inline-formula><mml:math id="m216"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CHCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m217"><mml:mrow><mml:mn>7</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) was added to a solution of <inline-formula><mml:math id="m218"><mml:mrow><mml:mi mathvariant="normal">Hg</mml:mi><mml:msub><mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtext>OAc</mml:mtext></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m219"><mml:mrow><mml:mn>1.0</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m220"><mml:mrow><mml:mn>3.1</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in HOAc (<inline-formula><mml:math id="m221"><mml:mrow><mml:mn>15</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>). After 30 min, a white precipitate formed and eventually turned yellow. After allowing the reaction to stir overnight, it was diluted with ether and filtered through a pad of silica. The filtrate was concentrated. The product was purified by column chromatography (hexanes:EtOAc, 9:1) and isolated as a yellow powder (<inline-formula><mml:math id="m222"><mml:mrow><mml:mn>0.16</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 50%). <inline-formula><mml:math id="m223"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m224"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m225"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.67 (dd, 1H, <inline-formula><mml:math id="m226"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.3</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m227"><mml:mrow><mml:mn>5.9</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.48 (d, 1H, <inline-formula><mml:math id="m228"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.37 (d, 1H, <inline-formula><mml:math id="m229"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>4.8</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 4.69–4.58 (m, 1H), 2.51 (t, 1H, <inline-formula><mml:math id="m230"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>12.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.42–2.31 (m, 2H), 2.22–209 (m, 2H), 2.01 (br s, 2H), 1.96–1.91 (m, 2H), 1.76–1.67 (m, 4H), 1.59–1.50 (m, 4H), 1.40–1.28 (m, 6H), 1.23 (s, 3H), 1.16-0.99 (m, 2H), 0.90 (d, 3H, <inline-formula><mml:math id="m231"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.85 (d, 3H, <inline-formula><mml:math id="m232"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.1</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.83 (d, 3H, <inline-formula><mml:math id="m233"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.54 (s, 3H); <inline-formula><mml:math id="m234"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m235"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m236"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 170.3, 143.9, 139.9, 135.6, 122.5, 119.0, 115.5, 74.0, 56.3, 50.8, 43.0, 42.2, 39.4, 39.3, 38.0, 37.4, 36.0, 35.9, 31.6, 30.2, 28.5, 28.3, 28.0, 23.9, 22.8, 22.5, 21.3, 18.3, 11.3.</p>
</sec>
<sec id="s2.6.4">
<title>Synthesis of 5,7,9-triene.</title>
<p>NaOH (<inline-formula><mml:math id="m237"><mml:mrow><mml:mn>50</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m238"><mml:mrow><mml:mn>1.3</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to solution of 2 (<inline-formula><mml:math id="m239"><mml:mrow><mml:mn>0.16</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m240"><mml:mrow><mml:mn>0.38</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in MeOH (<inline-formula><mml:math id="m241"><mml:mrow><mml:mn>2</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) and <inline-formula><mml:math id="m242"><mml:mrow><mml:msub><mml:mi mathvariant="normal">H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m243"><mml:mrow><mml:mn>1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) and then heated to 80°C. After 1.5 h, the reaction mixture was cooled and diluted with EtOAc. The organics were washed with <inline-formula><mml:math id="m244"><mml:mrow><mml:msub><mml:mi mathvariant="normal">H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:math></inline-formula>, and then with brine, and dried over <inline-formula><mml:math id="m245"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. Purification by column chromatography (hexanes:EtOAc, 4:1) yielded the product as a white powder (<inline-formula><mml:math id="m246"><mml:mrow><mml:mn>0.11</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 75%). <inline-formula><mml:math id="m247"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m248"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m249"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.65 (dd, 1H, <inline-formula><mml:math id="m250"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.5</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.49 (d, 1H, <inline-formula><mml:math id="m251"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.38 (d, 1H, <inline-formula><mml:math id="m252"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>5.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.62–3.54 (m, 1H), 2.45 (t, 1H, <inline-formula><mml:math id="m253"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>12.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.38–2.32 (m, 2H), 2.21–2.11 (m, 2H), 1.98-1.88 (m, 2H), 1.79–1.63 (m, 4H), 1.53–1.47 (m, 2H), 1.39–1.33 (m, 4H), 1.22 (s, 3H), 1.16–0.97 (m, 6H), 0.90 (d, 3H, <inline-formula><mml:math id="m254"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.85 (d, 3H, <inline-formula><mml:math id="m255"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.8</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.84 (d, 3H, <inline-formula><mml:math id="m256"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.8</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.54 (s, 3H); <inline-formula><mml:math id="m257"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m258"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m259"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 144.1, 141.2, 135.4, 122.5, 118.2, 115.5, 72.1, 56.3, 50.9, 43.0, 42.2, 41.5, 39.4, 39.2, 38.2, 36.0, 35.9, 32.2, 30.4, 28.4, 27.9, 23.8, 22.8, 22.5, 18.3, 11.3.</p>
</sec>
<sec id="s2.6.5">
<title>Synthesis of 5,7,9-PTAD.</title>
<p>PTAD (<inline-formula><mml:math id="m260"><mml:mrow><mml:mn>50</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m261"><mml:mrow><mml:mn>0.29</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of the 5,7,9-triene (<inline-formula><mml:math id="m262"><mml:mrow><mml:mn>20</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m263"><mml:mrow><mml:mn>0.052</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in MeOH (<inline-formula><mml:math id="m264"><mml:mrow><mml:mn>1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) and benzene (<inline-formula><mml:math id="m265"><mml:mrow><mml:mn>0.1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula> for solubility). After 1 h, the reaction was concentrated and purified by column chromatography (hexanes:EtOAc, 1:1). <inline-formula><mml:math id="m266"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m267"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m268"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 7.42–7.37 (m, 4H), 7.32–7.28 (m, 1H), 6.51 (d, 1H, <inline-formula><mml:math id="m269"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>8.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 6.20 (d, 1H, <inline-formula><mml:math id="m270"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>8.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.59 (dd, 1H, <inline-formula><mml:math id="m271"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.6</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m272"><mml:mrow><mml:mn>6.8</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 4.41–4.33 (m, 1H), 3.21 (dd, 1H, <inline-formula><mml:math id="m273"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>3.4</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m274"><mml:mrow><mml:mn>13.7</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.73 (dd, 1H, <inline-formula><mml:math id="m275"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>7.5</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m276"><mml:mrow><mml:mn>12.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.42–2.32 (m, 2H), 2.09 (d, 1H, <inline-formula><mml:math id="m277"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>16.8</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.06–1.86 (m, 4H), 1.83–1.77 (m 2H), 1.74–1.61 (m, 3H), 1.53–1.45 (m, 1H), 1.40–1.33 (m, 5H), 1.13 (s, 3H), 1.09–1.02 (m, 3H), 0.92 (d, 3H, <inline-formula><mml:math id="m278"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.85 (d, 3H, <inline-formula><mml:math id="m279"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.9</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.84 (d, 3H, <inline-formula><mml:math id="m280"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.8</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.67 (s, 3H); <inline-formula><mml:math id="m281"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m282"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m283"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 151.1, 149.8, 141.9, 134.4, 131.6, 129.2, 128.9, 127.9, 126.0, 122.0, 67.3, 66.4, 64.3, 54.9, 47.5, 43.3, 41.5, 40.5, 39.5, 35.9, 35.4, 34.4, 32.8, 29.7, 28.0, 27.6. 25.4, 23.7, 22.9, 22.8, 22.6, 18.6, 12.5.</p>
</sec>
<sec id="s2.6.6">
<title>Synthesis of 3.</title>
<p>Diethyl azodicarboxylate (<inline-formula><mml:math id="m284"><mml:mrow><mml:mn>6.1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m285"><mml:mrow><mml:mn>14</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of the Ac-7-DHC (<inline-formula><mml:math id="m286"><mml:mrow><mml:mn>2.0</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m287"><mml:mrow><mml:mn>4.7</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in benzene (<inline-formula><mml:math id="m288"><mml:mrow><mml:mn>25</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>), then heated to reflux. After overnight period, the reaction mixture was cooled and concentrated. The reaction resulted in a 3:1 mixture of isomers in favor of the desired product. The mixture was purified by column chromatography (hexanes:EtOAc, 4:1) to yield the product as a white powder (<inline-formula><mml:math id="m289"><mml:mrow><mml:mn>2.7</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 96%). The isomers could be partially separated by column chromatography using toluene:EtOAc (4:1).</p>
</sec>
<sec id="s2.6.7">
<title>Synthesis of 8-DHC.</title>
<p><inline-formula><mml:math id="m290"><mml:mrow><mml:msub><mml:mrow><mml:mtext>EtNH</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m291"><mml:mrow><mml:mo>∼</mml:mo><mml:mn>15</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) was condensed into a flask at <inline-formula><mml:math id="m292"><mml:mrow><mml:mo>−</mml:mo><mml:mn>78</mml:mn><mml:mo>°</mml:mo><mml:mi mathvariant="normal">C</mml:mi></mml:mrow></mml:math></inline-formula>. A cooled solution of 3 (<inline-formula><mml:math id="m293"><mml:mrow><mml:mn>2.0</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m294"><mml:mrow><mml:mn>3.3</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in THF (<inline-formula><mml:math id="m295"><mml:mrow><mml:mn>15</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) was added, followed by Li° (<inline-formula><mml:math id="m296"><mml:mrow><mml:mn>0.23</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m297"><mml:mrow><mml:mn>33</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>mmol</mml:mtext></mml:mrow></mml:math></inline-formula>). The reaction mixture turned blue on completion. After 3 h, the reaction was quenched with saturated <inline-formula><mml:math id="m298"><mml:mrow><mml:msub><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow></mml:math></inline-formula> and warmed to room temperature to dissipate the <inline-formula><mml:math id="m299"><mml:mrow><mml:msub><mml:mrow><mml:mtext>EtNH</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. The reaction was diluted with EtOAc and washed with additional saturated <inline-formula><mml:math id="m300"><mml:mrow><mml:msub><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow></mml:math></inline-formula> and brine and dried over <inline-formula><mml:math id="m301"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. The product was purified by column chromatography (hexanes:EtOAc, 4:1) and isolated as a white powder (<inline-formula><mml:math id="m302"><mml:mrow><mml:mn>0.52</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 42%). Product of higher purity was obtained after purification by semipreparative HPLC (C18, <inline-formula><mml:math id="m303"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CH</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mtext>CN</mml:mtext></mml:mrow></mml:math></inline-formula>:MeOH, 70:30). <inline-formula><mml:math id="m304"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m305"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m306"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.41 (br s, 1H), 3.58–3.47 (m, 1H), 2.51 (br s, 2H), 2.32–2.28 (m, 2H), 2.15–2.06 (m, 3H), 2.01–1.94 (m, 1H), 1.91-1.82 (m, 3H), 1.64–1.22 (m, 12H), 1.16 (s, 3H), 1.12–1.09 (m, 4H), 0.91 (d, 3H, <inline-formula><mml:math id="m307"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.5</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.85 (d, 3H, <inline-formula><mml:math id="m308"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.83 (d, 3H, <inline-formula><mml:math id="m309"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.63 (s, 3H); <inline-formula><mml:math id="m310"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m311"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m312"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 138.8, 132.0, 126.4, 119.5, 71.4, 54.7, 51.8, 42.2, 41.9, 39.5, 37.3, 36.8, 36.2, 36.1, 35.6, 31.9, 29.0, 28.8, 28.0, 23.9, 22.9, 22.8, 22.5, 22.2, 18.7, 11.3.</p>
</sec>
<sec id="s2.6.8">
<title>Synthesis of 5,9,14-triene.</title>
<p>PTAD (<inline-formula><mml:math id="m313"><mml:mrow><mml:mn>45</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m314"><mml:mrow><mml:mn>0.26</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of 8-DHC (<inline-formula><mml:math id="m315"><mml:mrow><mml:mn>68</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m316"><mml:mrow><mml:mn>0.18</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in <inline-formula><mml:math id="m317"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CH</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m318"><mml:mrow><mml:mn>1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>). The reaction resulted in a mixture of the desired triene and the 5,7,9-PTAD. After 2 h, the reaction mixture was concentrated and purified by column chromatography (hexanes:EtOAc, 4:1). <inline-formula><mml:math id="m319"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m320"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m321"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.48 (br s, 1H), 5.36 (br s, 1H), 3.55-3.52 (m, 1H), 2.85 (d, 1H, <inline-formula><mml:math id="m322"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>20.2</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>) 2.57 (dd, 1H, <inline-formula><mml:math id="m323"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>2.2</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m324"><mml:mrow><mml:mn>22.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.39–2.16 (m, 5H), 2.10–1.88 (m, 4H), 1.62–1.54 (m, 3H), 1.53–1.48 (m, 2H), 1.45–1.29 (m, 4H), 1.19 (s, 3H), 1.15–1.13 (m, 4H), 0.92 (d, 3H, <inline-formula><mml:math id="m325"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0,86 (s, 3H), 0.84 (s, 3H), 0.83 (s, 3H); <inline-formula><mml:math id="m326"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m327"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m328"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 149.8, 137.7, 137.2, 120.8, 119.2, 118.2, 71.7, 57.2, 45.0, 42.2, 39.4, 37.8, 36.8, 36.0, 35.9, 35.5, 34.0, 31.9, 27.9, 27.1, 23.7, 22.8, 22.7, 22.5, 21.8, 18.8, 15.4.</p>
</sec>
<sec id="s2.6.9">
<title>Synthesis of 5,9,14-MeOH adduct.</title>
<p>PTAD (<inline-formula><mml:math id="m329"><mml:mrow><mml:mn>0.14</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m330"><mml:mrow><mml:mn>0.80</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of the 5,9,14-triene (<inline-formula><mml:math id="m331"><mml:mrow><mml:mn>30</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m332"><mml:mrow><mml:mn>0.078</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in MeOH (<inline-formula><mml:math id="m333"><mml:mrow><mml:mn>30</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) and benzene (<inline-formula><mml:math id="m334"><mml:mrow><mml:mn>1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, for solubility). After 1 h, the reaction was concentrated and purified by semipreparative HPLC (C18, MeOH). <inline-formula><mml:math id="m335"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m336"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m337"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.34 (d, 1H, <inline-formula><mml:math id="m338"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 4.73 (d, 1H, <inline-formula><mml:math id="m339"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>4.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.66–3.61 (m, 1H), 3.20 (s, 3H), 2.88 (br s, 2H), 2.43 (d, 1H, <inline-formula><mml:math id="m340"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>20</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.21–2.13 (m, 2H), 2.10–1.96 (m, 3H), 1.91–1.85 (m, 2H), 1.79–1.72 (m, 2H), 1.51–1.45 (m, 4H), 1.39–1.37 (m, 3H), 1.18–1.08 (m, 6H), 1.05 (s, 3H), 0.96 (d, 3H, <inline-formula><mml:math id="m341"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>4.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.88 (d, 3H, <inline-formula><mml:math id="m342"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.2</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.87 (d, 3H, <inline-formula><mml:math id="m343"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.1</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.84 (s, 3H); <inline-formula><mml:math id="m344"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m345"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m346"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 152.8, 137.7, 129.3, 119.4, 77.5, 70.8, 70.4, 54.6, 52.1, 43.5, 43.4, 41.4, 39.5, 38.9, 37.0, 36.0, 33.7, 31.3, 29.7, 29.2, 28.0, 27.9, 24.3, 24.1, 23.8, 22.8, 22.5, 19.0, 18.0.</p>
</sec>
<sec id="s2.6.10">
<title>Synthesis of 5.</title>
<p>TBDMSCl (<inline-formula><mml:math id="m347"><mml:mrow><mml:mn>2.9</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m348"><mml:mrow><mml:mn>0.019</mml:mn><mml:mtext>  mol</mml:mtext></mml:mrow></mml:math></inline-formula>) and imidazole (<inline-formula><mml:math id="m349"><mml:mrow><mml:mn>1.8</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m350"><mml:mrow><mml:mn>0.026</mml:mn><mml:mtext>  mol</mml:mtext></mml:mrow></mml:math></inline-formula>) were added to a solution of ergosterol (<inline-formula><mml:math id="m351"><mml:mrow><mml:mn>5.2</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m352"><mml:mrow><mml:mn>0.013</mml:mn><mml:mtext>  mol</mml:mtext></mml:mrow></mml:math></inline-formula>) in a mixture of THF:DMF (<inline-formula><mml:math id="m353"><mml:mrow><mml:mn>60</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, 1:1). After the reaction stirred overnight, it was diluted with hexanes:EtOAc (1:1) and washed with <inline-formula><mml:math id="m354"><mml:mrow><mml:msub><mml:mi mathvariant="normal">H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:math></inline-formula> and brine. The organic layer was dried over <inline-formula><mml:math id="m355"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> and concentrated. The product was purified by column chromatography (hexanes:EtOAc, 9:1) and isolated as a white powder (<inline-formula><mml:math id="m356"><mml:mrow><mml:mn>6.1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 91%).</p>
<p><inline-formula><mml:math id="m357"><mml:mrow><mml:mi mathvariant="normal">Pb</mml:mi><mml:msub><mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtext>OAc</mml:mtext></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m358"><mml:mrow><mml:mn>8.0</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m359"><mml:mrow><mml:mn>0.018</mml:mn><mml:mtext>  mol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added in portions to a solution of the TBDMS-protected ergosterol (<inline-formula><mml:math id="m360"><mml:mrow><mml:mn>6.1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m361"><mml:mrow><mml:mn>0.012</mml:mn><mml:mtext>  mol</mml:mtext></mml:mrow></mml:math></inline-formula>) and phthalhydrazide (<inline-formula><mml:math id="m362"><mml:mrow><mml:mn>2.9</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m363"><mml:mrow><mml:mn>0.018</mml:mn><mml:mtext>  mol</mml:mtext></mml:mrow></mml:math></inline-formula>) in <inline-formula><mml:math id="m364"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CH</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m365"><mml:mrow><mml:mn>120</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) and HOAc (<inline-formula><mml:math id="m366"><mml:mrow><mml:mn>12</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>). After 1 h, the reaction mixture was carefully neutralized with saturated <inline-formula><mml:math id="m367"><mml:mrow><mml:msub><mml:mrow><mml:mtext>NaHCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. The organic layer was partitioned, washed with brine, and dried over <inline-formula><mml:math id="m368"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. Column chromatography (hexanes:EtOAc, 9:1) afforded the product (<inline-formula><mml:math id="m369"><mml:mrow><mml:mn>4.3</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 54%) as a yellow foam. <inline-formula><mml:math id="m370"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m371"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m372"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 8.15-8.06 (m, 2H), 7.67–7.64 (m, 2H), 6.62 (d, 1H, <inline-formula><mml:math id="m373"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>9.2</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 6.23 (d, 1H, <inline-formula><mml:math id="m374"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>8.2</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.22–5.08 (m, 2H), 3.94–3.83 (m, 2H), 3.61-3.51 (m, 1H), 2.10–1.93 (m, 4H), 1.86–1.79 (m, 2H), 1.62–1.58 (m, 4H), 1.49–1.24 (m, 8H), 0.99 (app t, 6H, <inline-formula><mml:math id="m375"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>2.9</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.88-0.78 (mult s, 12H), 0.83 (s, 9H), 0.06 (s, 3H), <inline-formula><mml:math id="m376"><mml:mrow><mml:mo>−</mml:mo><mml:mn>0.03</mml:mn></mml:mrow></mml:math></inline-formula> (s, 3H); <inline-formula><mml:math id="m377"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m378"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m379"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 161.8, 159.5, 138.4, 135.3, 132.6, 132.4, 132.0, 130.5, 130.2, 128.6, 126.9, 126.5, 68.4, 67.4, 67.0, 56.5, 50.5, 49.0, 44.1, 42.6, 40.4, 39.8, 39.2, 35.6, 34.7, 33.0, 30.5, 28.1, 25.9, 24.4, 21.8, 20.8, 19.9, 19.6, 18.5, 18.0, 17.4, 13.3, <inline-formula><mml:math id="m380"><mml:mrow><mml:mo>−</mml:mo><mml:mn>4.4</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m381"><mml:mrow><mml:mo>−</mml:mo><mml:mn>5.0</mml:mn></mml:mrow></mml:math></inline-formula>.</p>
</sec>
<sec id="s2.6.11">
<title>Synthesis of aldehyde 6.</title>
<p>Ozone was bubbled through a solution of 5 (<inline-formula><mml:math id="m382"><mml:mrow><mml:mn>4.3</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m383"><mml:mrow><mml:mn>6.3</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in <inline-formula><mml:math id="m384"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CH</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>:MeOH (<inline-formula><mml:math id="m385"><mml:mrow><mml:mn>60</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, 3:1) at 0°C. After 1 h, the ozone was stopped and <inline-formula><mml:math id="m386"><mml:mrow><mml:msub><mml:mrow><mml:mtext>PPh</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m387"><mml:mrow><mml:mn>1.8</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m388"><mml:mrow><mml:mn>6.9</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added. The reaction was allowed to warm to room temperature and concentrated after 1 h. The product was purified by column chromatography (hexanes:EtOAc, 4:1) and isolated as a yellow foam (<inline-formula><mml:math id="m389"><mml:mrow><mml:mn>2.9</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 74%). <inline-formula><mml:math id="m390"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m391"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m392"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 9.52 (d, 1H, <inline-formula><mml:math id="m393"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>3.5</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 8.13–8.06 (m, 2H), 7.68–7.65 (m, 2H), 6.44 (d, 1H, <inline-formula><mml:math id="m394"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>8.2</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 6.20 (d, 1H, <inline-formula><mml:math id="m395"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>8.2</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.98 (dd, 1H, <inline-formula><mml:math id="m396"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>7.4</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m397"><mml:mrow><mml:mn>11.5</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.85 (dd, 1H, <inline-formula><mml:math id="m398"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>4.6</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m399"><mml:mrow><mml:mn>14.1</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.61–3.50 (m, 1H), 2.35–2.27 (m, 1H), 2.10–2.03 (m, 2H), 1.96–1.90 (m, 3H), 1.78–1.70 (m, 2H), 1.63–1.58 (m, 4H), 1.49–1.34 (m, 4H), 1.10 (d, 3H, <inline-formula><mml:math id="m400"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>3.8</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.99 (s, 3H), 0.84 (s, 3H), 0.82 (s, 9H), 0.05 (s, 3H), <inline-formula><mml:math id="m401"><mml:mrow><mml:mo>−</mml:mo><mml:mn>0.04</mml:mn></mml:mrow></mml:math></inline-formula> (s, 3H); <inline-formula><mml:math id="m402"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m403"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m404"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 204.5, 161.8, 159.6, 138.8, 132.7, 132.5, 130.4, 130.1, 128.1, 127.0, 126.5, 68.0, 67.3, 67.0, 51.7, 50.6, 48.9, 48.4, 44.7, 40.4, 39.1, 35.5, 34.6, 30.4, 26.5, 25.9, 24.3, 22.2, 18.5, 18.0, 13.5, 13.4, <inline-formula><mml:math id="m405"><mml:mrow><mml:mo>−</mml:mo><mml:mn>4.4</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m406"><mml:mrow><mml:mo>−</mml:mo><mml:mn>5.0</mml:mn></mml:mrow></mml:math></inline-formula>.</p>
</sec>
<sec id="s2.6.12">
<title>Synthesis of unsaturated ester 7.</title>
<p>Methyl (triphenylphosphoranylidene)acetate (<inline-formula><mml:math id="m407"><mml:mrow><mml:mn>4.4</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m408"><mml:mrow><mml:mn>13</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of 6 (<inline-formula><mml:math id="m409"><mml:mrow><mml:mn>5.3</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m410"><mml:mrow><mml:mn>8.8</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in <inline-formula><mml:math id="m411"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CH</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m412"><mml:mrow><mml:mn>40</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>). After overnight, the reaction mixture was concentrated. Purification by column chromatography (hexanes:EtOAc, 4:1) yielded the product (<inline-formula><mml:math id="m413"><mml:mrow><mml:mn>4.6</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 80%) as a yellow powder. <inline-formula><mml:math id="m414"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m415"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m416"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 8.10–8.02 (m, 2H), 7.64–7.61 (m, 2H), 6.76 (dd, 1H, <inline-formula><mml:math id="m417"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>9.0</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m418"><mml:mrow><mml:mn>15.6</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 6.59 (d, 1H, <inline-formula><mml:math id="m419"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>8.2</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 6.17 (d, 1H, <inline-formula><mml:math id="m420"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>8.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.68 (d, 1H, <inline-formula><mml:math id="m421"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>15.6</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.91 (dd, 1H, <inline-formula><mml:math id="m422"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>7.1</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m423"><mml:mrow><mml:mn>11.7</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.82 (dd, 1H, <inline-formula><mml:math id="m424"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>4.6</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m425"><mml:mrow><mml:mn>14.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.64 (s, 3H), 3.58–3.47 (m, 4H), 1.83–1.73 (m, 1H), 1.61–1.55 (m, 4H), 1.48–1.25 (m, 6H), 1.03 (d, 3H, <inline-formula><mml:math id="m426"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.5</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.95 (s, 3H), 0.81 (s, 9H), 0.79 (s, 3H), 0.02 (s, 3H), <inline-formula><mml:math id="m427"><mml:mrow><mml:mo>−</mml:mo><mml:mn>0.07</mml:mn></mml:mrow></mml:math></inline-formula> (s, 3H); <inline-formula><mml:math id="m428"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m429"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m430"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 167.1, 161.7, 159.5, 154.2, 138.6, 132.6, 132.5, 130.4, 130.1, 128.3, 126.9, 126.4, 118.9, 68.0, 67.3, 67.0, 55.5, 51.3, 50.5, 48.6, 44.4, 40.3, 39.2, 35.5, 34.6, 30.4, 27.6, 25.8, 24.3, 21.8, 19.2, 18.5, 18.1, 14.1, 13.3, <inline-formula><mml:math id="m431"><mml:mrow><mml:mo>−</mml:mo><mml:mn>4.4</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m432"><mml:mrow><mml:mo>−</mml:mo><mml:mn>5.0</mml:mn></mml:mrow></mml:math></inline-formula>.</p>
</sec>
<sec id="s2.6.13">
<title>Synthesis of saturated ester 8.</title>
<p>Raney Ni (<inline-formula><mml:math id="m433"><mml:mrow><mml:mo>∼</mml:mo><mml:mn>1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 20%/wt) was added to a solution of 7 (<inline-formula><mml:math id="m434"><mml:mrow><mml:mn>3.8</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m435"><mml:mrow><mml:mn>5.8</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in THF (<inline-formula><mml:math id="m436"><mml:mrow><mml:mn>60</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>). The reaction mixture was sparged with <inline-formula><mml:math id="m437"><mml:mrow><mml:msub><mml:mi mathvariant="normal">H</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> for 15 min, and then left under a balloon of <inline-formula><mml:math id="m438"><mml:mrow><mml:msub><mml:mi mathvariant="normal">H</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. After 30 min, the reaction was complete as determined by <inline-formula><mml:math id="m439"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR. The reaction mixture was filtered through a pad of Celite® and concentrated. No purification was necessary and the product (<inline-formula><mml:math id="m440"><mml:mrow><mml:mn>3.8</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 98%) was isolated as a yellow foam. <inline-formula><mml:math id="m441"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m442"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m443"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 8.16–8.05 (m, 2H), 7.69–7.62 (m, 2H), 6.61 (d, 1H, <inline-formula><mml:math id="m444"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>8.2</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 6.22 (d, 1H, <inline-formula><mml:math id="m445"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>8.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.93–3.81 (m, 2H), 3.62 (s, 3H), 3.59–3.51 (m, 1H), 2.38–2.28 (m, 1H), 2.25–2.14 (m, 1H), 2.09–1.93 (m, 4H), 1.82–1.72 (m, 2H), 1.61–1.50 (m, 4H), 1.40–1.33 (m, 8H), 0.98 (s, 3H), 0.90 (d, 3H, <inline-formula><mml:math id="m446"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.1</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.82 (s, 9H), 0.79 (s, 3H), 0.05 (s, 3H), <inline-formula><mml:math id="m447"><mml:mrow><mml:mo>−</mml:mo><mml:mn>0.04</mml:mn></mml:mrow></mml:math></inline-formula> (s, 3H); <inline-formula><mml:math id="m448"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m449"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m450"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 174.5, 161.8, 159.5, 138.5, 132.6, 132.5, 130.5, 130.2, 128.5, 126.9, 126.5, 68.3, 67.4, 67.0, 56.2, 5.4, 50.5, 48.8, 44.3, 40.3, 39.3, 35.5, 34.6, 30.7, 30.6, 30.4, 27.4, 25.9, 24.4, 21.8, 18.5, 18.1, 18.0, 13.1, <inline-formula><mml:math id="m451"><mml:mrow><mml:mo>−</mml:mo><mml:mn>4.4</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m452"><mml:mrow><mml:mo>−</mml:mo><mml:mn>5.0</mml:mn></mml:mrow></mml:math></inline-formula>.</p>
</sec>
<sec id="s2.6.14">
<title>Synthesis of 7-dehydrocholenol 9.</title>
<p><inline-formula><mml:math id="m453"><mml:mrow><mml:msub><mml:mrow><mml:mtext>LiAlH</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (1M/THF, <inline-formula><mml:math id="m454"><mml:mrow><mml:mn>75</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m455"><mml:mrow><mml:mn>0.10</mml:mn><mml:mtext>  mol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of 8 (<inline-formula><mml:math id="m456"><mml:mrow><mml:mn>8.7</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m457"><mml:mrow><mml:mn>0.013</mml:mn><mml:mtext>  mol</mml:mtext></mml:mrow></mml:math></inline-formula>) in THF (<inline-formula><mml:math id="m458"><mml:mrow><mml:mn>65</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>), and then heated to reflux. After 30 min, the reaction mixture was cooled and quenched with 10% HCl. The reaction mixture was diluted with EtOAc and washed with <inline-formula><mml:math id="m459"><mml:mrow><mml:msub><mml:mrow><mml:mtext>NaHCO</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> and then with brine, and dried over <inline-formula><mml:math id="m460"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. Purification by column chromatography (hexanes:EtOAc, 4:1) yielded the product as a white powder (<inline-formula><mml:math id="m461"><mml:mrow><mml:mn>4.0</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 65%). <inline-formula><mml:math id="m462"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m463"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m464"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.53 (d, 1H, <inline-formula><mml:math id="m465"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>5.5</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.37–5.34 (m, 1H), 3.61–3.52 (m, 3H), 2.31 (d, 2H, <inline-formula><mml:math id="m466"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>7.6</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.08–2.04 (m, 1H), 1.93–1.80 (m, 4H), 1.72–1.53 (m, 6H), 1.49–1.19 (m, 10H), 0.94 (d, 3H, <inline-formula><mml:math id="m467"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.91 (s, 3H), 0.87 (s, 9H), 0.60 (s, 3H), 0.05 (s, 6H); <inline-formula><mml:math id="m468"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m469"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m470"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 141.0, 140.7, 119.1, 116.3, 71.2, 63.5, 55.7, 54.4, 46.2, 42.9, 41.3, 39.2, 38.5, 37.0, 35.9, 32.4, 31.7, 29.3, 28.1, 25.9, 23.0, 21.1, 18.8, 18.2, 16.3, 11.8, <inline-formula><mml:math id="m471"><mml:mrow><mml:mo>−</mml:mo><mml:mn>4.6</mml:mn></mml:mrow></mml:math></inline-formula>.</p>
</sec>
<sec id="s2.6.15">
<title>Synthesis of mesylate 10.</title>
<p>Methanesulfonyl chloride (<inline-formula><mml:math id="m472"><mml:mrow><mml:mn>0.51</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m473"><mml:mrow><mml:mn>6.6</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of 9 (<inline-formula><mml:math id="m474"><mml:mrow><mml:mn>2.1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m475"><mml:mrow><mml:mn>4.4</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in anhydrous pyridine (<inline-formula><mml:math id="m476"><mml:mrow><mml:mn>20</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) at 0°C. After 30 min, the reaction mixture was concentrated under high vacuum. The residue was dissolved in EtOAc and washed with <inline-formula><mml:math id="m477"><mml:mrow><mml:msub><mml:mi mathvariant="normal">H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:math></inline-formula>, and then with brine, and dried over <inline-formula><mml:math id="m478"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. The product (<inline-formula><mml:math id="m479"><mml:mrow><mml:mn>2.1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 89%) was used in the next reaction without any purification. <inline-formula><mml:math id="m480"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m481"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m482"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.51 (d, 1H, <inline-formula><mml:math id="m483"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.36-5.34 (m, 1H), 4.18 (app dt, 2H, <inline-formula><mml:math id="m484"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.9</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m485"><mml:mrow><mml:mn>6.5</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.61–3.51 (m, 1H), 2.98 (s, 3H), 2.30 (d, 2H, <inline-formula><mml:math id="m486"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>7.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.07–2.02 (m, 1H), 1.93–1.76 (m, 5H), 1.71–1.05 (m, 4H), 0.94 (d, 3H, <inline-formula><mml:math id="m487"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.90 (s, 3H), 0.86 (s, 9H), 0.59 (s, 3H), 0.04 (s, 6H); <inline-formula><mml:math id="m488"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m489"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m490"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 140.8, 140.7, 119.1, 116.4, 71.2, 70.6, 55.5, 54.4, 46.2, 42.9, 41.3, 39.1, 38.5, 37.3, 37.0, 35.6, 32.3, 31.4, 28.0, 25.9, 25.8, 22.9, 21.1, 18.6, 18.2, 16.3, 11.8, <inline-formula><mml:math id="m491"><mml:mrow><mml:mo>−</mml:mo><mml:mn>4.7</mml:mn></mml:mrow></mml:math></inline-formula>.</p>
</sec>
<sec id="s2.6.16">
<title>Synthesis of <inline-formula><mml:math id="m492"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext mathvariant="bold">-</mml:mtext><mml:mn>7</mml:mn><mml:mtext mathvariant="bold">-</mml:mtext><mml:mi>D</mml:mi><mml:mi>H</mml:mi><mml:mi>C</mml:mi></mml:mrow></mml:math></inline-formula>.</title>
<p>A solution of <inline-formula><mml:math id="m493"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>2</mml:mn><mml:mtext>-bromopropane</mml:mtext></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m494"><mml:mrow><mml:mn>1.8</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m495"><mml:mrow><mml:mn>19</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in THF (<inline-formula><mml:math id="m496"><mml:mrow><mml:mn>15</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) was added in portions to Mg° (<inline-formula><mml:math id="m497"><mml:mrow><mml:mn>0.50</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m498"><mml:mrow><mml:mn>21</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in a minimal amount of THF. After 30 min, a solution of <inline-formula><mml:math id="m499"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">Li</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mtext>CuCl</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m500"><mml:mrow><mml:mn>0.1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">M</mml:mi><mml:mo>/</mml:mo><mml:mtext>THF</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m501"><mml:mrow><mml:mn>3.9</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m502"><mml:mrow><mml:mn>0.39</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added, followed by the mesylate 10 (<inline-formula><mml:math id="m503"><mml:mrow><mml:mn>2.1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m504"><mml:mrow><mml:mn>3.9</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>). The <inline-formula><mml:math id="m505"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">Li</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mtext>CuCl</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> was freshly prepared from LiCl (<inline-formula><mml:math id="m506"><mml:mrow><mml:mn>85</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m507"><mml:mrow><mml:mn>2.0</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) and <inline-formula><mml:math id="m508"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CuCl</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m509"><mml:mrow><mml:mn>135</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m510"><mml:mrow><mml:mn>1.0</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in THF (<inline-formula><mml:math id="m511"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>). The reaction mixture turned from gray to dark brown. After 1 h, the reaction was quenched with saturated <inline-formula><mml:math id="m512"><mml:mrow><mml:msub><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow></mml:math></inline-formula> and extracted with EtOAc. The organics were washed with brine and dried over <inline-formula><mml:math id="m513"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. The product was purified by column chromatography (hexanes:EtOAc, 19:1) and isolated as a white powder (<inline-formula><mml:math id="m514"><mml:mrow><mml:mn>1.5</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 77%).</p>
<p>TBAF (1M/THF, <inline-formula><mml:math id="m515"><mml:mrow><mml:mn>4.5</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m516"><mml:mrow><mml:mn>4.5</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of the previous compound (<inline-formula><mml:math id="m517"><mml:mrow><mml:mn>1.5</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m518"><mml:mrow><mml:mn>3.0</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in THF (<inline-formula><mml:math id="m519"><mml:mrow><mml:mn>15</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>). After overnight, the reaction mixture was diluted with EtOAc, washed with brine, and dried over <inline-formula><mml:math id="m520"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. Purification by column chromatography (hexanes:EtOAc, 4:1) yielded the product as a white powder (<inline-formula><mml:math id="m521"><mml:mrow><mml:mn>0.90</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 77%). Higher purity was attained with purification by semipreparative HPLC (C18, MeOH). <inline-formula><mml:math id="m522"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m523"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m524"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.55 (dd, 1H, <inline-formula><mml:math id="m525"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>3.0</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m526"><mml:mrow><mml:mn>6.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 5.38–5.34 (m, 1H), 3.66-3.56 (m, 1H), 2.45 (ddd, 1H, <inline-formula><mml:math id="m527"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>2.5</mml:mn></mml:mrow></mml:math></inline-formula>, 6.3, <inline-formula><mml:math id="m528"><mml:mrow><mml:mn>14.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.26 (t, 1H, <inline-formula><mml:math id="m529"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>13.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.10–2.03 (m, 1H), 1.98-1.85 (m, 4H), 1.72–1.53 (m, 4H), 1.40–1.09 (m, 14H), 0.92 (s, 3H), 0.91 (d, 3H, <inline-formula><mml:math id="m530"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.3</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.59 (s, 3H); <inline-formula><mml:math id="m531"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m532"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m533"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 141.4, 139.7, 119.6, 116.2, 70.4, 55.8, 54.4, 46.2, 42.9, 40.7, 39.1, 38.3, 37.0, 36.1, 31.9, 28.0, 23.8, 23.0, 21.1, 18.8, 16.2, 11.8.</p>
</sec>
<sec id="s2.6.17">
<title>Synthesis of 11.</title>
<p>Diethyl azodicarboxylate (<inline-formula><mml:math id="m534"><mml:mrow><mml:mn>0.90</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m535"><mml:mrow><mml:mn>5.7</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of the 7-dehydrocholenol 9 (<inline-formula><mml:math id="m536"><mml:mrow><mml:mn>0.89</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m537"><mml:mrow><mml:mn>1.9</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in benzene (<inline-formula><mml:math id="m538"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) and then heated to reflux. After 4 h, the reaction mixture was cooled and concentrated. The reaction resulted in a 3:1 mixture of isomers in favor of the desired product. The mixture was purified by column chromatography (hexanes:EtOAc, 1:1) to yield the product as a white powder (<inline-formula><mml:math id="m539"><mml:mrow><mml:mn>0.81</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 66%). The isomers could be partially separated by column chromatography using toluene:EtOAc (1:1).</p>
</sec>
<sec id="s2.6.18">
<title>Synthesis of TBS-8-dehydrocholenol.</title>
<p><inline-formula><mml:math id="m540"><mml:mrow><mml:msub><mml:mrow><mml:mtext>EtNH</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m541"><mml:mrow><mml:mo>∼</mml:mo><mml:mn>4</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) was condensed into a flask at <inline-formula><mml:math id="m542"><mml:mrow><mml:mo>−</mml:mo><mml:mn>78</mml:mn><mml:mo>°</mml:mo><mml:mi mathvariant="normal">C</mml:mi></mml:mrow></mml:math></inline-formula>. A cooled solution of 11 (<inline-formula><mml:math id="m543"><mml:mrow><mml:mn>0.56</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m544"><mml:mrow><mml:mn>0.87</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in THF (<inline-formula><mml:math id="m545"><mml:mrow><mml:mn>4</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) was added, followed by Li° (<inline-formula><mml:math id="m546"><mml:mrow><mml:mn>60</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m547"><mml:mrow><mml:mn>8.6</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>). The reaction mixture turned blue on completion. After 1 h, the reaction was quenched with saturated <inline-formula><mml:math id="m548"><mml:mrow><mml:msub><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow></mml:math></inline-formula> and warmed to room temperature to dissipate the <inline-formula><mml:math id="m549"><mml:mrow><mml:msub><mml:mrow><mml:mtext>EtNH</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. The reaction was diluted with EtOAc and washed with additional saturated <inline-formula><mml:math id="m550"><mml:mrow><mml:msub><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow></mml:math></inline-formula> and then with brine and dried over <inline-formula><mml:math id="m551"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. The product was purified by column chromatography (hexanes:EtOAc, 4:1) and isolated as a white powder (<inline-formula><mml:math id="m552"><mml:mrow><mml:mn>0.25</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 61%). <inline-formula><mml:math id="m553"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m554"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m555"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.38 (br s, 1H), 3.59 (t, 2H, <inline-formula><mml:math id="m556"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.53–3.43 (m, 1H), 2.51 (br s, 2H), 2.32 (t, 1H, <inline-formula><mml:math id="m557"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>13.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.23–21.6 (m, 1H), 2.12–2.09 (m, 2H), 2.02–1.72 (m, 4H), 1.64–1.55 (m, 4H), 1.46–1.23 (m, 10H), 1.15 (s, 3H), 0.93 (d, 3H, <inline-formula><mml:math id="m558"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.5</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.86 (s, 9H), 0.63 (s, 3H), 0.03 (s, 6H); <inline-formula><mml:math id="m559"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m560"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m561"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 139.7, 132.3, 126.2, 119.0, 72.2, 63.5, 54.5, 51.8, 42.7, 42.0, 37.4, 36.8, 36.0, 35.8, 32.4, 31.7, 29.4, 28.9, 28.8, 25.9, 22.9, 22.8, 22.2, 18.6, 18.2, 11.2, <inline-formula><mml:math id="m562"><mml:mrow><mml:mo>−</mml:mo><mml:mn>4.7</mml:mn></mml:mrow></mml:math></inline-formula>.</p>
</sec>
<sec id="s2.6.19">
<title>Synthesis of mesylate 12.</title>
<p>Methanesulfonyl chloride (<inline-formula><mml:math id="m563"><mml:mrow><mml:mn>60</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m564"><mml:mrow><mml:mn>0.78</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of the TBS-8-dehydrocholenol (<inline-formula><mml:math id="m565"><mml:mrow><mml:mn>0.25</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m566"><mml:mrow><mml:mn>0.53</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in anhydrous pyridine (<inline-formula><mml:math id="m567"><mml:mrow><mml:mn>3</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>). After 1 h, the reaction mixture was concentrated under high vacuum. The residue was dissolved in EtOAc and washed with <inline-formula><mml:math id="m568"><mml:mrow><mml:msub><mml:mi mathvariant="normal">H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant="normal">O</mml:mi></mml:mrow></mml:math></inline-formula> and then with brine and then dried over <inline-formula><mml:math id="m569"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. The product (<inline-formula><mml:math id="m570"><mml:mrow><mml:mn>0.32</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 100%) was used without purification in the next reaction. <inline-formula><mml:math id="m571"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m572"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m573"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.36 (br s, 1H), 4.16 (dt, 2H, <inline-formula><mml:math id="m574"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>1.9</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m575"><mml:mrow><mml:mn>6.5</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 3.50–3.42 (m, 1H), 2.96 (s, 3H), 2.49 (br s, 2H), 2.30 (t, 1H, <inline-formula><mml:math id="m576"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>13.0</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 2.20–2.08 (m, 3H), 1.97–1.71 (m, 5H), 1.63–1.21 (m, 12H), 1.13 (s, 3H), 0.92 (d, 3H, <inline-formula><mml:math id="m577"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.4</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.85 (s, 9H), 0.61 (s, 3H), 0.01 (s, 6H); <inline-formula><mml:math id="m578"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m579"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m580"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 139.6, 132.3, 126.1, 119.0, 72.2, 71.8, 70.6, 54.4, 51.7, 42.7, 42.0, 37.4, 37.3, 36.7, 35.7, 35.6, 32.4, 31.4, 28.9, 28.7, 25.9, 25.8, 22.9, 22.8, 22.2, 18.5, 18.2, 11.2, <inline-formula><mml:math id="m581"><mml:mrow><mml:mo>−</mml:mo><mml:mn>4.7</mml:mn></mml:mrow></mml:math></inline-formula>.</p>
</sec>
<sec id="s2.6.20">
<title>Synthesis of <inline-formula><mml:math id="m582"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext mathvariant="bold">-</mml:mtext><mml:mn>8</mml:mn><mml:mtext mathvariant="bold">-</mml:mtext><mml:mi>D</mml:mi><mml:mi>H</mml:mi><mml:mi>C</mml:mi></mml:mrow></mml:math></inline-formula>.</title>
<p>A solution of <inline-formula><mml:math id="m583"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>2</mml:mn><mml:mtext>-bromopropane</mml:mtext></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m584"><mml:mrow><mml:mn>0.30</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m585"><mml:mrow><mml:mn>3.2</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in THF (<inline-formula><mml:math id="m586"><mml:mrow><mml:mn>3</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>) was added in portions to Mg° (<inline-formula><mml:math id="m587"><mml:mrow><mml:mn>80</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m588"><mml:mrow><mml:mn>3.3</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in a minimal amount of THF. After 30 min, a solution of <inline-formula><mml:math id="m589"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">Li</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mtext>CuCl</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m590"><mml:mrow><mml:mn>0.1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">M</mml:mi><mml:mo>/</mml:mo><mml:mtext>THF</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m591"><mml:mrow><mml:mn>0.7</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m592"><mml:mrow><mml:mn>0.070</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added, followed by the mesylate 9 (<inline-formula><mml:math id="m593"><mml:mrow><mml:mn>0.38</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m594"><mml:mrow><mml:mn>0.69</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>). The <inline-formula><mml:math id="m595"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">Li</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mtext>CuCl</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> was freshly prepared from LiCl (<inline-formula><mml:math id="m596"><mml:mrow><mml:mn>85</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m597"><mml:mrow><mml:mn>2.0</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) and <inline-formula><mml:math id="m598"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CuCl</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m599"><mml:mrow><mml:mn>135</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mg</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m600"><mml:mrow><mml:mn>1.0</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in THF (<inline-formula><mml:math id="m601"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>). The reaction mixture turned from gray to dark brown. After 1 h, the reaction was quenched with saturated <inline-formula><mml:math id="m602"><mml:mrow><mml:msub><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow></mml:math></inline-formula> and extracted with EtOAc. The organics were washed with brine and dried over <inline-formula><mml:math id="m603"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. The product was purified by column chromatography (hexanes:EtOAc, 19:1) and isolated as a colorless oil (<inline-formula><mml:math id="m604"><mml:mrow><mml:mn>0.18</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 51%).</p>
<p>TBAF (1M/THF, <inline-formula><mml:math id="m605"><mml:mrow><mml:mn>0.60</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m606"><mml:mrow><mml:mn>0.60</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) was added to a solution of the previous compound (<inline-formula><mml:math id="m607"><mml:mrow><mml:mn>0.18</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m608"><mml:mrow><mml:mn>0.36</mml:mn><mml:mtext>  mmol</mml:mtext></mml:mrow></mml:math></inline-formula>) in THF (<inline-formula><mml:math id="m609"><mml:mrow><mml:mn>2</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mL</mml:mi></mml:mrow></mml:math></inline-formula>). After overnight period, the reaction mixture was diluted with EtOAc, washed with brine, and dried over <inline-formula><mml:math id="m610"><mml:mrow><mml:msub><mml:mrow><mml:mtext>MgSO</mml:mtext></mml:mrow><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. Purification by column chromatography (hexanes:EtOAc, 4:1) yielded the product as a white powder (<inline-formula><mml:math id="m611"><mml:mrow><mml:mn>0.10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">g</mml:mi></mml:mrow></mml:math></inline-formula>, 71%). Higher purity was attained with purification by semipreparative HPLC (C18, <inline-formula><mml:math id="m612"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CH</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub><mml:mtext>CN</mml:mtext></mml:mrow></mml:math></inline-formula>:MeOH, 70:30). <inline-formula><mml:math id="m613"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m614"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m615"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 5.40 (br s, 1H), 3.57–3.46 (m, 1H), 2.51 (br s, 2H), 2.31–2.27 (m, 2H), 2.11–2.05 (m, 3H), 2.01–1.95 (m, 1H), 193–1.81 (m, 3H), 1.62–1.26 (m, 11H), 1.16–1.08 (m, 4H), 1.16 (s, 3H), 0.90 (d, 3H, <inline-formula><mml:math id="m616"><mml:mrow><mml:mi mathvariant="normal">J</mml:mi><mml:mo>=</mml:mo><mml:mn>6.5</mml:mn><mml:mtext>  Hz</mml:mtext></mml:mrow></mml:math></inline-formula>), 0.62 (s, 3H); <inline-formula><mml:math id="m617"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> NMR (<inline-formula><mml:math id="m618"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CDCl</mml:mtext></mml:mrow><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) <inline-formula><mml:math id="m619"><mml:mi mathvariant="normal">δ</mml:mi></mml:math></inline-formula> 138.8, 132.0, 126.4, 119.5, 71.4, 54.7, 51.8, 42.2, 41.9, 39.2, 37.3, 36.8, 36.2, 36.1, 35.6, 31.9, 29.0, 28.8, 23.8, 23.0, 22.8, 22.2, 18.7, 11.3.</p>
</sec>
</sec>
<sec id="s2.7">
<title>Statistics</title>
<p>Statistical analyses were performed with Prism software (V5.01, GraphPad Prism 5) in combination with spreadsheet-based software including Excel® (Microsoft®). In addition, <italic>p</italic>-values <inline-formula><mml:math id="m620"><mml:mrow><mml:mo>&lt;</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></inline-formula> were considered significant, and specific analyses used are indicated with each set of data and experiment. Unless otherwise noted, at least three replicates of all experiments were undertaken.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<sec id="s3.1">
<title>High-Throughput Screen for Environmental Cholesterol Biosynthesis Disruptors</title>
<p>The mouse neuroblastoma cell line, Neuro-2a, was screened against the ToxCast™ Chemical Library for lead-hit identification of environmental cholesterol biosynthesis disruptors. The identities of the 1,851 chemicals tested were blinded throughout the screening process. Known bioactive compounds that affect cholesterol biosynthesis were included on each plate to assess the health and responsiveness of the cells (Figure S2). The results of these positive controls demonstrated that the cells were actively synthesizing cholesterol and that expected metabolic changes could be induced. In alignment with similar screens for cholesterol biosynthesis disruptors using the PTAD-derivatization method, an exposure of a single concentration of <inline-formula><mml:math id="m621"><mml:mrow><mml:mn>1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula> for 24 h was used (<xref ref-type="bibr" rid="c32">Korade 2016</xref>; <xref ref-type="bibr" rid="c28">Kim 2016</xref>; <xref ref-type="bibr" rid="c72">Wages 2018</xref>). Furthermore, <italic>z</italic>-scores (<inline-formula><mml:math id="m622"><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mtext>compound</mml:mtext></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mrow><mml:mtext>vehicle</mml:mtext></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi mathvariant="normal">σ</mml:mi><mml:mrow><mml:mtext>vehicle</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) were calculated for each chemical tested from two independent screens and then averaged (Table S3). For the four sterol metabolites assayed (lanosterol, desmosterol, 7-dehydrocholesterol, and cholesterol), 46 lead-hit chemicals were identified as having a <italic>z</italic>-score greater than three (<xref ref-type="fig" rid="f2">Figure 2</xref>). Of the 1,851 chemicals screened, 4 caused substantial cell loss in both screens, so they were included in lead-hit dose–response verification to determine whether doses at lower concentrations caused changes in sterol biology. Those compounds were colchicine, tributyltin methacrylate, tributyltin chloride, and tributyltin benzoate.</p>
<fig id="f2" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p>Lead-hit determination of ToxCast™ Chemical Library for environmental cholesterol biosynthesis disruptors. (A) Workflow of high-throughput screen from entire library screened to the four selected lead-hit compounds, from bottom left, clockwise: tributyltin chloride, endosulfan sulfate, fenpropimorph, spiroxamine. Lead-hit compounds were identified through the results of two independent screens of the ToxCast™ library using Neuro-2a cells as an in vitro model at a screening exposure of <inline-formula><mml:math id="m623"><mml:mrow><mml:mn>1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula> for 24 h. Of the compounds screened, those determined as lead-hits for elevating 7-dehydrocholesterol (B) and lanosterol (C) are presented with their respective <italic>z</italic>-score values and those prioritized indicated with blue arrows.</p>
</caption>
<alt-text>Figure 2A is comprises a workflow with the following steps taking place one after the other: ToxCast chemical screen (1851 compounds) leads to lead hit validation (46 compounds), which leads to Lan (17 compounds) and 7DHC (21 compounds). Lan leads to endosulafan and tributyltin chloride, and 7DHC leads to frenpropimorph and spiroxamine. Figures 2B and 2C are horizontal bar graphs, plotting 7 dehydrocholesterol and lanosterol (y-axis), respectively, across z score. Those prioritized in elevating 7DHC are spiroxamine and fenpropimorph. Those prioritized in elevating lan are endosulfan sulfate and tributyltin chloride.</alt-text>
<graphic xlink:href="ehp-128-017014-g002"></graphic>
</fig>
<p>All lead-hits were validated in a similar experimental paradigm but with conditioning the cells to an exposure media that was serum-free, and thus cholesterol-free, to reduce confounding sources of cholesterol. Although the three compounds that elevated cholesterol and five compounds that elevated desmosterol in the primary screen were not confirmed in the validation experiment (Table S1), the activity of each of the 21 7-DHC (<xref ref-type="fig" rid="f2">Figure 2B</xref>) and 17 lanosterol (<xref ref-type="fig" rid="f2">Figure 2C</xref>) elevating chemicals were verified at the <inline-formula><mml:math id="m624"><mml:mrow><mml:mn>1</mml:mn><mml:mtext>  uM</mml:mtext></mml:mrow></mml:math></inline-formula> dose. However, an additional five 7-DHC lead-hits and 4 lanosterol lead-hits were deprioritized because they could not reliably induce a dose–response effect in Neuro-2a cells. Additionally, the four compounds that were further tested due to cytotoxicity observed in the screening experiments provided two additional lead-hits (tributyltin methacrylate and tributyltin chloride) as lanosterol elevating chemicals with <italic>z</italic>-scores of 4.4 at <inline-formula><mml:math id="m625"><mml:mrow><mml:mn>100</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula>, each (<xref ref-type="fig" rid="f2">Figure 2C</xref>).</p>
<p>Prioritization of lead-hits for future experimentation was based on two additional factors: <italic>a</italic>) evidence of current commercial use in the environment and <italic>b</italic>) unknown impact on mammalian sterol biosynthesis (Table S1 and Figure S1). Five compounds were deprioritized because of a lack of potential human exposure and because they remain experimental compounds, and 19 compounds were deprioritized because data showing their capacity to inhibit DHCR7 or CYP51 already exist (Table S1). Tributyltin methacrylate was deprioritized due to experimental limitations. The chemicals ultimately selected for continued assessment for their potential impact on human cholesterol biosynthesis were endosulfan sulfate, tributyltin chloride, fenpropimorph, and spiroxamine (<xref ref-type="fig" rid="f2">Figure 2A</xref>).</p>
</sec>
<sec id="s3.2">
<title>Derivatization of 8-Dehydrocholesterol with PTAD</title>
<p>The derivatization of 7-DHC, lanosterol, and desmosterol by PTAD occurs by either a Diels-Alder reaction of the 7-DHC diene (<xref ref-type="bibr" rid="c38">Liu et al. 2014</xref>) or an ene reaction of the lanosterol and desmosterol tail olefin (<xref ref-type="bibr" rid="c32">Korade et al. 2016</xref>). However, the reaction of 8-DHC with PTAD was more complex and involved the formation of multiple products. <xref ref-type="fig" rid="f3">Figure 3</xref> shows the products formed from the reaction of 8-DHC and PTAD. To account for these products, it seems reasonable to suggest that 8-DHC undergoes an ene reaction with PTAD to give an adduct that undergoes elimination to the 5,7,9- and 5,9,14-trienes. The ene product shown in <xref ref-type="fig" rid="f3">Figure 3</xref> is isolable and has been characterized, but there are two other possible ene intermediates (not shown), both of which could eliminate PTAD to generate the same two trienes. The 5,7,9-triene readily undergoes a Diels-Alder reaction with PTAD, and this triene is never isolated in any reaction mixtures. However, the 5,9,14-triene does not undergo a Diels-Alder reaction and instead ultimately results in the MeOH adduct.</p>
<fig id="f3" orientation="portrait" position="float">
<label>Figure 3.</label>
<caption>
<p>Proposed mechanism for the reaction of (A) 7-dehydrocholesterol, (B) desmosterol (or lanosterol), and (C) 8-dehydrocholesterol with PTAD. 7-DHC undergoes a Diels-Alder reaction, whereas Des and Lan undergo an ene reaction on the tail olefin. For 8-DHC, the Diels-Alder and MeOH adducts are the major products formed through a series of ene, elimination, and Diels-Alder reactions.</p>
</caption>
<alt-text>Figures 3A, 3B, and 3C are chemical reactions. In 3A, 7DHC leads to 7DHC-PTAD through PTAD. In 3B, Des leads to Des-PTAD through PTAD. In 3C, 8DHC leads to Ene through PTAD, and Ene leads to 5, 7, 9 triene (which also leads to 5, 7, 9 PTAD) plus 5, 9, 14 triene (which also leads to 5, 9, 14 MeOH adduct).</alt-text>
<graphic xlink:href="ehp-128-017014-g003"></graphic>
</fig>
<p>To confirm the identity of the 8-DHC adducts, as well as provide evidence for the scheme shown in <xref ref-type="fig" rid="f3">Figure 3</xref>, we synthesized and characterized the proposed intermediates as described below. The authentic adducts were analyzed by LC-MS and compared with an 8-DHC-PTAD reaction mixture (<xref ref-type="fig" rid="f4">Figure 4</xref>). The ene intermediate was not observed in the actual sample mixture; it is likely unstable and eliminates to one of the trienes. However, the 5,7,9-PTAD and 5,9,14-MeOH adducts were found in roughly equal amounts. We chose to monitor the Diels-Alder product in sample analyses because it appears to be much more stable than the MeOH adduct and it gives characteristic fragmentation patterns.</p>
<fig id="f4" orientation="portrait" position="float">
<label>Figure 4.</label>
<caption>
<p>LC-MS analysis of (A) isolated and characterized products compared with (B) reaction of 8-dehydrocholesterol with PTAD under conditions used in sample analysis. The products were analyzed on an UPLC C18 column (Acquity UPLC BEH C18, <inline-formula><mml:math id="m626"><mml:mrow><mml:mn>1.7</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">m</mml:mi></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m627"><mml:mrow><mml:mn>2.1</mml:mn><mml:mo>×</mml:mo><mml:mn>50</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">mm</mml:mi></mml:mrow></mml:math></inline-formula>) with 100% MeOH (0.1% v/v acetic acid) mobile phase at a flow rate of <inline-formula><mml:math id="m628"><mml:mrow><mml:mn>500</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">L</mml:mi><mml:mo>/</mml:mo><mml:mtext>min</mml:mtext></mml:mrow></mml:math></inline-formula> and runtime of 1.2 min. The following SRMs were monitored: 5,7,9-PTAD <inline-formula><mml:math id="m629"><mml:mrow><mml:mn>558</mml:mn><mml:mo>→</mml:mo><mml:mn>363</mml:mn></mml:mrow></mml:math></inline-formula>, ene <inline-formula><mml:math id="m630"><mml:mrow><mml:mn>560</mml:mn><mml:mo>→</mml:mo><mml:mn>365</mml:mn></mml:mrow></mml:math></inline-formula>, and 5,9,14-MeOH <inline-formula><mml:math id="m631"><mml:mrow><mml:mn>399</mml:mn><mml:mo>→</mml:mo><mml:mn>363</mml:mn></mml:mrow></mml:math></inline-formula>.</p>
</caption>
<alt-text>Figures 4A and 4B are three graphs each. 4A plots relative abundance (y-axis) for 5, 7, 9 PTAD (0.43), ene (0.42), and 5, 9, 14 MeOH (0.37), respectively, across time (x-axis). 4B plots relative abundance (y-axis) for 5, 7, 9 PTAD (0.43), ene (nill), and 5, 9, 14 MeOH (0.37), respectively, across time (x-axis).</alt-text>
<graphic xlink:href="ehp-128-017014-g004"></graphic>
</fig>
</sec>
<sec id="s3.3">
<title>Independent Synthesis of 8-DHC PTAD Adducts</title>
<p>The intermediate trienes and their PTAD adducts shown in <xref ref-type="fig" rid="f3">Figure 3</xref> were independently synthesized to provide evidence for the mechanism and confirm the identity of the product used in the analysis. The 5,7,9- and 5,9,14-trienes were both synthesized from 7-DHC (<xref ref-type="fig" rid="f5">Figure 5</xref>). Oxidation of the protected 7-DHC with <inline-formula><mml:math id="m632"><mml:mrow><mml:mi mathvariant="normal">Hg</mml:mi><mml:msub><mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtext>OAc</mml:mtext></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> generated the 5,7,9-triene. This triene underwent a Diels-Alder reaction with PTAD to form the 5,7,9-PTAD adduct. The Ac-7-DHC was converted to 8-DHC through an ene reaction with diethyl azodicarboxylate (DEAD) followed by reduction with Li° in <inline-formula><mml:math id="m633"><mml:mrow><mml:msub><mml:mrow><mml:mtext>EtNH</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. When 8-DHC was treated with one equivalent of PTAD in <inline-formula><mml:math id="m634"><mml:mrow><mml:msub><mml:mrow><mml:mtext>CH</mml:mtext></mml:mrow><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="normal">Cl</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, it underwent an ene reaction followed by elimination to generate the 5,9,14-triene. Treatment of this triene with an excess of PTAD in MeOH, mimicking the analysis reaction conditions, resulted in the 5,9,14-MeOH adduct. Characterization of these intermediate trienes and their PTAD adducts by NMR and LC/MS confirmed the proposed products shown in <xref ref-type="fig" rid="f3">Figure 3</xref>.</p>
<fig id="f5" orientation="portrait" position="float">
<label>Figure 5.</label>
<caption>
<p>Synthesis of 5,7,9- and 5,9,14-trienes and their PTAD adducts.</p>
</caption>
<alt-text>Figure 5 comprises the synthesis of chemical compounds. Compound 1 leads to compound 2 through a. Compound 2 leads to 5, 7, 9 triene through b. 5, 7, 9 triene leads to 5, 7, 9 PTAD through c. Compound 1 also leads to compound 3 below. Compound 3 leads to 8DHC through e. 8DHC leads to 5, 9, 14 triene through c. 5, 9, 14 triene leads to 5, 9, 14 MeOH through f. Reagents a, b, c, d, e, and f are Hg open parenthesis OAc close parenthesis sub 2; NaOH, MeOH virgule H sub 2 O; PTAD (1 eq), CH sub 2 CL sub 2; DEAD; Li super o, EtNH sub 2; and PTAD (10 eq), respectively.</alt-text>
<graphic xlink:href="ehp-128-017014-g005"></graphic>
</fig>
</sec>
<sec id="s3.4">
<title>Synthesis of Isotopically Labeled Standards</title>
<p>The syntheses of the <inline-formula><mml:math id="m635"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-labeled</mml:mtext></mml:mrow></mml:math></inline-formula> Des and Lan have been previously reported (<xref ref-type="bibr" rid="c32">Korade et al. 2016</xref>). The <inline-formula><mml:math id="m636"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="m637"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>8</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula> were both synthesized from the 7-dehydrocholenol intermediate 9, which was prepared starting with ergosterol (<xref ref-type="fig" rid="f6">Figure 6</xref>). The alcohol and diene of ergosterol were protected as the silyl ether and Diels-Alder adduct, respectively. The protected ergosterol 5 was ozonized to generate the aldehyde and subsequently underwent a Horner-Wadsworth-Emmons reaction to generate the ester 7. The <inline-formula><mml:math id="m638"><mml:mrow><mml:mi mathvariant="normal">α</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">β</mml:mi><mml:mtext>-unsaturated</mml:mtext></mml:mrow></mml:math></inline-formula> ester was selectively hydrogenated using Raney nickel as the catalyst. The ester and phthalhydrazide protecting group were then reduced to generate the 7-dehydrocholenol 9.</p>
<fig id="f6" orientation="portrait" position="float">
<label>Figure 6.</label>
<caption>
<p>Synthesis of 7-dehydrocholenol intermediate for <inline-formula><mml:math id="m639"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="m640"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>8</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>.</p>
</caption>
<alt-text>Figure 6 comprises the synthesis of chemical compounds. Compound 4 leads to compound 5 through a, b. Compound 5 leads to compound 6 through c. Compound 6 leads to compound 7 through d. Compound 7 leads to compound 8 through e. Compound 8 leads to compound 9 through f. The reagents a, b, c, d, e, and f are TBDMSCL, im; phthalhydrazide, Pb open parenthesis OAc close parenthesis sub 4; O sub 3 and PPH sub 3; methyl (triphenylphosphoranylidene) acetate; H sub 2, Raney Ni; and LiAIH sub 4.</alt-text>
<graphic xlink:href="ehp-128-017014-g006"></graphic>
</fig>
<p>The TBS-7-dehydrocholenol was converted to the mesylate 10. A Grignard reaction with <inline-formula><mml:math id="m641"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>2</mml:mn><mml:mtext>-bromopropane</mml:mtext></mml:mrow></mml:math></inline-formula> followed by deprotection afforded the <inline-formula><mml:math id="m642"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>. TBS-7-dehydrocholenol was converted to TBS-8-dehydrocholenol 11 using the same route as described above for 8-DHC. An ene reaction with DEAD, followed by a Li° reduction generated the desired product. The <inline-formula><mml:math id="m643"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>8</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula> was synthesized following the same Grignard reaction sequence as that used for the <inline-formula><mml:math id="m644"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula> (<xref ref-type="fig" rid="f7">Figure 7</xref>).</p>
<fig id="f7" orientation="portrait" position="float">
<label>Figure 7.</label>
<caption>
<p>Synthesis of <inline-formula><mml:math id="m645"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="m646"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mtext>-</mml:mtext><mml:mn>8</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>.</p>
</caption>
<alt-text>Figure 7 comprises the synthesis of chemical compounds. Compound 9 leads to compound 10 through a. Compound 10 leads to d sub 7 7 DHC. Compound 9 also leads to 11 major through d. 11 major leads to compound 12 through e, a. Compound 12 leads to d sub 7 8 DHC through b, c. The reagents a, b, c, d, and e are MsCl, pyr; d sub 7 2 bromopropane, Mg super o and Li sub 2 CuCl sub 4, and 6 or 9; TBAF; DEAD; and Li sub o, EtNH sub 2.</alt-text>
<graphic xlink:href="ehp-128-017014-g007"></graphic>
</fig>
</sec>
<sec id="s3.5">
<title>Concentration-Dependent Effects of Environmental Cholesterol Biosynthesis Disruptors</title>
<p>The capacity of endosulfan sulfate and tributyltin chloride to elevate lanosterol was assessed by exposing Neuro-2a cells across a range of concentrations (<inline-formula><mml:math id="m647"><mml:mrow><mml:mn>0</mml:mn><mml:mo>–</mml:mo><mml:mn>4</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula>); fenpropimorph and spiroxamine were similarly tested for their impact on 7-DHC levels (<xref ref-type="fig" rid="f8">Figure 8</xref>). <inline-formula><mml:math id="m648"><mml:mrow><mml:msub><mml:mrow><mml:mtext>IC</mml:mtext></mml:mrow><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> values for each compound to inhibit either CYP51 or DHCR7 were determined in Neuro-2a cells: endosulfan sulfate, <inline-formula><mml:math id="m649"><mml:mrow><mml:mn>1.1</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula>; tributyltin chloride, <inline-formula><mml:math id="m650"><mml:mrow><mml:mn>0.79</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula>; fenpropimorph, <inline-formula><mml:math id="m651"><mml:mrow><mml:mn>0.97</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula>; and spiroxamine, <inline-formula><mml:math id="m652"><mml:mrow><mml:mn>0.55</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula>. Concentrations of tributyltin chloride exceeding <inline-formula><mml:math id="m653"><mml:mrow><mml:mn>4</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula> were determined to be cytotoxic via lactate-dehydrogenase release detected in the media. In addition to the monitoring of elevations in lanosterol or 7-DHC, the immediate cholesterol precursor desmosterol was shown to decrease in a concentration-dependent manner for each chemical exposure (<xref ref-type="fig" rid="f8">Figure 8</xref>).</p>
<fig id="f8" orientation="portrait" position="float">
<label>Figure 8.</label>
<caption>
<p>Concentration-dependent response of lead-hit compounds on intracellular levels of lanosterol (A,B; solid squares), 7-dehydrocholesterol (C,D; open squares) and desmosterol (solid triangles) in Neuro-2a cells. Cells were exposed to tributyltin chloride (A), endosulfan sulfate (B), fenpropimorph (C), and spiroxamine (D) at the indicated concentration for 24 h. Data presented as nmol sterol/million cells (<inline-formula><mml:math id="m654"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m655"><mml:mrow><mml:mo>±</mml:mo><mml:mtext>SEM</mml:mtext></mml:mrow></mml:math></inline-formula>). *<inline-formula><mml:math id="m656"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></inline-formula>, **<inline-formula><mml:math id="m657"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math></inline-formula>, ***<inline-formula><mml:math id="m658"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula> as determined by post hoc Dunnett’s test following one-way analysis of variance (ANOVA), using vehicle as the control comparison.</p>
</caption>
<alt-text>Figures 8A, 8B, 8C, and 8D are graphs plotting nanomoles Lan virgule 10 super 6 cells; nanomoles Des virgule 10 super 6 cells; nanomoles 7DHC virgule 10 super 6 cells; and nanomoles Des virgule 10 super 6 cells, respectively, (y-axis) across tributyltin chloride (micromolar); endosulfan sulfate (micromolar); fenpropimorph (micromolar); and spiroxamine (micromolar), respectively, (x-axis).</alt-text>
<graphic xlink:href="ehp-128-017014-g008"></graphic>
</fig>
<p>Human cell lines from three different tissue lineages were identified to more firmly establish the potential effect that the two CYP51 inhibitors and two DHCR7 inhibitors have on human populations. Each cell line was determined to have a distinct sterol profile based on absolute values of metabolites analyzed (<xref ref-type="table" rid="t2">Table 2</xref>). For instance, the liver (Hep-G2) and neural (SK-N-SH) cell lines’ sterol profiles both consisted of less than 2% of the cholesterol precursors analyzed in this study; however, the Hep-G2 cell line had a 1.35-fold higher absolute amount of cholesterol than the neural cell line had. In contrast, the lung cell line (A549) had a substantial contribution of the sterol precursor desmosterol of the sterols analyzed in this study, whereas the other neural cell line tested, IMR-32, had a significant proportion to the total sterol content from 7-DHC.</p>
<table-wrap id="t2" orientation="portrait" position="float">
<label>Table 2</label>
<caption>
<p>Sterols (<inline-formula><mml:math id="m659"><mml:mrow><mml:mtext>nmols</mml:mtext><mml:mo>/</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>6</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m660"><mml:mrow><mml:mtext>cells</mml:mtext><mml:mo>±</mml:mo><mml:mtext>SEM</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m661"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></inline-formula>) in four different cell lines of human lineage.</p>
</caption>
<alt-text>Table 2 has the following six columns: cell lines, cholesterol, dehydrocholesterol, dehydrocholesterol, desmosterol, and lanosterol.</alt-text>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
<col align="left" span="1" valign="top"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" id="t2c1" rowspan="1" scope="col"></th>
<th align="center" colspan="1" id="t2c2" rowspan="1" scope="col">Cholesterol</th>
<th align="center" colspan="1" id="t2c3" rowspan="1" scope="col">7-Dehydrocholesterol</th>
<th align="center" colspan="1" id="t2c4" rowspan="1" scope="col">8-Dehydrocholesterol</th>
<th align="center" colspan="1" id="t2c5" rowspan="1" scope="col">Desmosterol</th>
<th align="center" colspan="1" id="t2c6" rowspan="1" scope="col">Lanosterol</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" headers="t2c1" id="t2c7" rowspan="1" scope="row">SK-N-SH</td>
<td align="char" char="plusmn" colspan="1" headers="t2c2 t2c7" rowspan="1">
<inline-formula>
<mml:math id="m662">
<mml:mrow>
<mml:mn>27.6</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.5</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c3 t2c7" rowspan="1">
<inline-formula>
<mml:math id="m663">
<mml:mrow>
<mml:mn>0.14</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.01</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c4 t2c7" rowspan="1">
<inline-formula>
<mml:math id="m664">
<mml:mrow>
<mml:mn>0.07</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.01</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c5 t2c7" rowspan="1">
<inline-formula>
<mml:math id="m665">
<mml:mrow>
<mml:mn>0.36</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.02</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c6 t2c7" rowspan="1">
<inline-formula>
<mml:math id="m666">
<mml:mrow>
<mml:mn>0.19</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.01</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
</tr>
<tr>
<td align="left" colspan="1" headers="t2c1" id="t2c8" rowspan="1" scope="row">IMR-32</td>
<td align="char" char="plusmn" colspan="1" headers="t2c2 t2c8" rowspan="1">
<inline-formula>
<mml:math id="m667">
<mml:mrow>
<mml:mn>24.8</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.8</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c3 t2c8" rowspan="1">
<inline-formula>
<mml:math id="m668">
<mml:mrow>
<mml:mn>1.47</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.12</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c4 t2c8" rowspan="1">
<inline-formula>
<mml:math id="m669">
<mml:mrow>
<mml:mn>0.21</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.03</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c5 t2c8" rowspan="1">
<inline-formula>
<mml:math id="m670">
<mml:mrow>
<mml:mn>0.23</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.02</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c6 t2c8" rowspan="1">
<inline-formula>
<mml:math id="m671">
<mml:mrow>
<mml:mn>0.25</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.01</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
</tr>
<tr>
<td align="left" colspan="1" headers="t2c1" id="t2c9" rowspan="1" scope="row">A549</td>
<td align="char" char="plusmn" colspan="1" headers="t2c2 t2c9" rowspan="1">
<inline-formula>
<mml:math id="m672">
<mml:mrow>
<mml:mn>17.2</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.8</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c3 t2c9" rowspan="1">
<inline-formula>
<mml:math id="m673">
<mml:mrow>
<mml:mn>0.15</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.02</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c4 t2c9" rowspan="1">
<inline-formula>
<mml:math id="m674">
<mml:mrow>
<mml:mn>0.15</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.01</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c5 t2c9" rowspan="1">
<inline-formula>
<mml:math id="m675">
<mml:mrow>
<mml:mn>1.96</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.05</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c6 t2c9" rowspan="1">
<inline-formula>
<mml:math id="m676">
<mml:mrow>
<mml:mn>0.24</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.02</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
</tr>
<tr>
<td align="left" colspan="1" headers="t2c1" id="t2c10" rowspan="1" scope="row">Hep-G2</td>
<td align="char" char="plusmn" colspan="1" headers="t2c2 t2c10" rowspan="1">
<inline-formula>
<mml:math id="m677">
<mml:mrow>
<mml:mn>37.4</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>2.0</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c3 t2c10" rowspan="1">
<inline-formula>
<mml:math id="m678">
<mml:mrow>
<mml:mn>0.04</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.01</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c4 t2c10" rowspan="1">
<inline-formula>
<mml:math id="m679">
<mml:mrow>
<mml:mn>0.09</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.02</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c5 t2c10" rowspan="1">
<inline-formula>
<mml:math id="m680">
<mml:mrow>
<mml:mn>0.68</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.08</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td align="char" char="plusmn" colspan="1" headers="t2c6 t2c10" rowspan="1">
<inline-formula>
<mml:math id="m681">
<mml:mrow>
<mml:mn>0.18</mml:mn>
<mml:mo>±</mml:mo>
<mml:mn>0.01</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The IMR-32 cell line was particularly sensitive to fenpropimorph and spiroxamine, with concentrations as low as <inline-formula><mml:math id="m682"><mml:mrow><mml:mn>10</mml:mn><mml:mtext>  nM</mml:mtext></mml:mrow></mml:math></inline-formula> inducing significant cytotoxicity as determined by lactate dehydrogenase detected in the media after a 24-h exposure (Figure S3). The three less-sensitive cell lines (SK-N-SH, A549, and Hep-G2) were challenged with three concentrations of fenpropimorph and spiroxamine from <inline-formula><mml:math id="m683"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> to <inline-formula><mml:math id="m684"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> (<xref ref-type="fig" rid="f9">Figure 9</xref>).</p>
<fig id="f9" orientation="portrait" position="float">
<label>Figure 9.</label>
<caption>
<p>Impact of fenpropimorph and spiroxamine on 7-dehydrocholesterol (7-DHC; A,B), 8-dehydrocholesterol (8-DHC; C,D), desmosterol (Des; E,F), and cholesterol levels (Chol; G,H) in three different human-derived cell lines: (from left to right) SK-N-SH, A549, and Hep-G2. Cells were exposed to compound (0, 10, 100, <inline-formula><mml:math id="m685"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula>) for 24 h. Omitted bars reflect significant toxicity as determined by release of lactate dehydrogenase. Data presented as nmol sterol/million cells (<inline-formula><mml:math id="m686"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m687"><mml:mrow><mml:mo>±</mml:mo><mml:mtext>SEM</mml:mtext></mml:mrow></mml:math></inline-formula>). *<inline-formula><mml:math id="m688"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></inline-formula>, **<inline-formula><mml:math id="m689"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math></inline-formula>, ***<inline-formula><mml:math id="m690"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula> as determined by post hoc Dunnett’s test following one-way analysis of variance (ANOVA), using vehicle as the control comparison.</p>
</caption>
<alt-text>Figures 9A and 9B plot 7DHC nanomoles virgule 10 super 6 cells (y-axis) across fenpropimorph (SK N SH, A549, and Hep G2) (ranging from 0 nanomolar, 10 nanomolar, 100 nanomolar, and 1000 nanomolar) and spiroxamine (SK N SH, A549, and Hep G2) (ranging from 0 nanomolar, 10 nanomolar, 100 nanomolar, and 1000 nanomolar), respectively, (x-axis). Figures 9C and 9D plot 8DHC nanomoles virgule 10 super 6 cells (y-axis) across fenpropimorph (SK N SH, A549, and Hep G2) (ranging from 0 nanomolar, 10 nanomolar, 100 nanomolar, and 1000 nanomolar) and spiroxamine (SK N SH, A549, and Hep G2) (ranging from 0 nanomolar, 10 nanomolar, 100 nanomolar, and 1000 nanomolar), respectively, (x-axis). Figures 9E and 9F plot Des nanomoles virgule 10 super 6 cells (y-axis) across fenpropimorph (SK N SH, A549, and Hep G2) (ranging from 0 nanomolar, 10 nanomolar, 100 nanomolar, and 1000 nanomolar) and spiroxamine (SK N SH, A549, and Hep G2) (ranging from 0 nanomolar, 10 nanomolar, 100 nanomolar, and 1000 nanomolar), respectively, (x-axis). Figures 9G and 9H plot Chol nanomoles virgule 10 super 6 cells (y-axis) across fenpropimorph (SK N SH, A549, and Hep G2) (ranging from 0 nanomolar, 10 nanomolar, 100 nanomolar, and 1000 nanomolar) and spiroxamine (SK N SH, A549, and Hep G2) (ranging from 0 nanomolar, 10 nanomolar, 100 nanomolar, and 1000 nanomolar), respectively, (x-axis).</alt-text>
<graphic xlink:href="ehp-128-017014-g009"></graphic>
</fig>
<p>No increase in lanosterol was observed for exposures to tributyltin chloride or endosulfan sulfate in any of the four human cell lines across the concentrations tested in this study, with the one exception that tributyltin chloride at the <inline-formula><mml:math id="m691"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> exposure in A549 cells elevated lanosterol levels 2.5-fold (Figure S4A). Positive control inhibition of CYP51 using econazole at <inline-formula><mml:math id="m692"><mml:mrow><mml:mn>100</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> for all four cell lines did show significant elevation of lanosterol levels as determined by Student’s <italic>t</italic>-test (<inline-formula><mml:math id="m693"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula>, Figure S5). Both tributyltin chloride and endosulfan sulfate were deprioritized as compounds of interest due to the observation that neither could reliably inhibit CYP51 in human cells. In contrast to the CYP51 lead-hit compounds, 7-DHC levels were elevated in response to exposure to both fenpropimorph and spiroxamine in the three human cell lines for at least one of the concentrations tested (<xref ref-type="fig" rid="f9">Figure 9A,B</xref>). It is noteworthy that the <inline-formula><mml:math id="m694"><mml:mrow><mml:mn>1,000</mml:mn><mml:mtext>-nM</mml:mtext></mml:mrow></mml:math></inline-formula> exposure of spiroxamine in the Hep-G2 cells was cytotoxic. In most cases, 7-DHC levels and desmosterol levels were inversely altered after the chemical exposures (<xref ref-type="fig" rid="f9">Figure 9E,F</xref>). Unlike spiroxamine (<xref ref-type="fig" rid="f9">Figure 9H</xref>), fenpropimorph did lower absolute cholesterol levels measured in all cell lines tested but showed a reliable concentration-dependent effect only with the Hep-G2 cell line (<xref ref-type="fig" rid="f9">Figure 9G</xref>).</p>
<p>Further experimentation with fenpropimorph and spiroxamine was undertaken to evaluate levels of other 7-DHC relevant metabolites. In addition to 7-DHC serving as a precursor to both cholesterol and vitamin D, this sterol is also isomerized biosynthetically to 8-dehydrocholesterol (8-DHC) by the enzyme Emopamil Binding Protein (EBP, <inline-formula><mml:math id="m695"><mml:mrow><mml:mn>3</mml:mn><mml:mtext>-</mml:mtext><mml:mi mathvariant="normal">β</mml:mi><mml:mtext>-hydroxysteroid -</mml:mtext><mml:mi mathvariant="normal">Δ</mml:mi><mml:mn>8</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m696"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mn>7</mml:mn><mml:mtext>-isomerase</mml:mtext></mml:mrow></mml:math></inline-formula>) (<xref ref-type="fig" rid="f1">Figure 1</xref>). Thus, if DHCR7 is selectively inhibited, and EBP is unaffected by a compound, then 8-DHC would be elevated concomitantly with 7-DHC. Using the newly developed method to assay 8-DHC via PTAD-derivatization, the absolute levels of 8-DHC were determined for the four cells lines tested (<xref ref-type="table" rid="t2">Table 2</xref>). All concentrations tested in the neural SK-N-SH cells for both fenpropimorph (<xref ref-type="fig" rid="f10">Figure 10B</xref>) and spiroxamine (<xref ref-type="fig" rid="f10">Figure 10C</xref>) demonstrated a significant elevation of 8-DHC levels. Because a concomitant increase in 7-DHC and 8-DHC levels along with decreases in the DHCR7 metabolites desmosterol and cholesterol is observed following exposure to fenpropimorph and spiroxamine, it leads to the conclusion that these two pesticides inhibit DHCR7.</p>
<fig id="f10" orientation="portrait" position="float">
<label>Figure 10.</label>
<caption>
<p>Biological synthesis of 8-dehydrocholesterol via isomerization of 7-dehydrocholesterol by the enzyme EBP is shown (A). SK-N-SH cells were exposed to fenpropimorph (B) and spiroxamine (C) at indicated concentrations for 24 h. Data presented as nmol 8-dehydrocholesterol/million cells (<inline-formula><mml:math id="m697"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m698"><mml:mrow><mml:mo>±</mml:mo><mml:mtext>SEM</mml:mtext></mml:mrow></mml:math></inline-formula>). *<inline-formula><mml:math id="m699"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></inline-formula>, ***<inline-formula><mml:math id="m700"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula> as determined by post hoc Dunnett’s test following one-way analysis of variance (ANOVA), using vehicle as the control comparison.</p>
</caption>
<alt-text>Figure 10A comprises synthesis of chemical compounds, where 7dehydrocholesterol leads to cholesterol through DHCR7 and also to 8dehydrocholesterol through EBP. 8dehydrocholesterol also leads to 7dehydrocholesterol through EBP. Figures 10B and 10C plot 8DHC nanomoles virgule 10 super 6 cells (y-axis) across fenpropimorph (nanomolar) and spiroxamine (nanomolar), respectively, (x-axis).</alt-text>
<graphic xlink:href="ehp-128-017014-g010"></graphic>
</fig>
</sec>
<sec id="s3.6">
<title>Temporal Changes in Neuroprogenitor Sterol Levels Exposed to 7-DHC Elevating Pesticides</title>
<p>The accumulated observations for the effect of the two pesticides, fenpropimorph and spiroxamine, suggested that both compounds inhibit human DHCR7. To model the cell type most likely affected by a developmental neurotoxicant such as a DHCR7 inhibitor, hiPSCs were differentiated into neuroprogenitors of the cortical glutamatergic lineage and then exposed to chemicals (<xref ref-type="fig" rid="f11">Figure 11A</xref>). To account for differentiation-induced changes in cholesterol biosynthesis, each de-identified donor cell line was used to produce three separate sets of hiPSC-derived neuroprogenitors for experiments, and the results were then averaged derived from three distinct differentiations (Figure S6). In addition to fenpropimorph and spiroxamine, the most potent 7-DHC elevating lead-hit from the original screen and validation, haloperidol, was used as a reference positive control. Haloperidol at 10 and <inline-formula><mml:math id="m701"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> concentration significantly elevated 7-DHC levels from <inline-formula><mml:math id="m702"><mml:mrow><mml:mn>0.81</mml:mn><mml:mo>±</mml:mo><mml:mn>0.17</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nmol</mml:mtext><mml:mo>/</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>6</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> cells to <inline-formula><mml:math id="m703"><mml:mrow><mml:mn>1.66</mml:mn><mml:mo>±</mml:mo><mml:mn>0.19</mml:mn></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="m704"><mml:mrow><mml:mn>2.2</mml:mn><mml:mo>±</mml:mo><mml:mn>0.30</mml:mn></mml:mrow></mml:math></inline-formula> nmol <inline-formula><mml:math id="m705"><mml:mrow><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext><mml:mo>/</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>6</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> cells, respectively, after 8 h of exposure in hiPSC neuroprogenitors. The maximum effect of haloperidol was observed with a <inline-formula><mml:math id="m706"><mml:mrow><mml:mn>1,000</mml:mn><mml:mtext>-nM</mml:mtext></mml:mrow></mml:math></inline-formula>, 24-h exposure, plateauing at <inline-formula><mml:math id="m707"><mml:mrow><mml:mn>5.37</mml:mn><mml:mo>±</mml:mo><mml:mn>0.28</mml:mn></mml:mrow></mml:math></inline-formula> nmol <inline-formula><mml:math id="m708"><mml:mrow><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext><mml:mo>/</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>6</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> cells.</p>
<fig id="f11" orientation="portrait" position="float">
<label>Figure 11.</label>
<caption>
<p>Human induced pluripotent stem cells (hiPSCs) were differentiated towards a neuroectoderm lineage as shown (A). These hiPSC-derived neuroprogenitor cells were exposed on day 10 of differentiation to fenpropimorph (B,C) or spiroxamine (D,E) at <inline-formula><mml:math id="m709"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> (red triangle) for 4, 8, 12, and 24 h. Neuroprogenitor cells were then analyzed for 7-dehydrocholesterol (B,D) or desmosterol (C,E) and compared with vehicle control (black circle; 0.01% DMSO). Three distinct differentiations were conducted for each donor and averaged; shown is the average of the three donors <inline-formula><mml:math id="m710"><mml:mrow><mml:mo>±</mml:mo><mml:mtext>SEM</mml:mtext></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m711"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></inline-formula>). *<inline-formula><mml:math id="m712"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></inline-formula>, **<inline-formula><mml:math id="m713"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math></inline-formula>, ***<inline-formula><mml:math id="m714"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula> as determined by Bonferroni posttests following two-way analysis of variance (ANOVA).</p>
</caption>
<alt-text>Figure 11A is a differentiation of human induced pluripotent stem cells through a span of 10 days, where differentiated factors are LDN virgule SB431542 and media components are knockout serum and N2. The 8th day reveals replated NPs, and the 10th day reveals exposures. 11B and 11C plot nanomoles 7DHC virgule 10 super 6 cells and nanomoles Des virgule 10 super 6 cells, respectively, (y-axis) across time (hours) for fenpropimorph (ranging from 0 to 1000 nanomolar). 11D and 11D plot nanomoles 7DHC virgule 10 super 6 cells and nanomoles Des virgule 10 super 6 cells, respectively, (y-axis) across time (hours) for spiroxamine (ranging from 0 to 1000 nanomolar).</alt-text>
<graphic xlink:href="ehp-128-017014-g011"></graphic>
</fig>
<p>Fenpropimorph and spiroxamine at <inline-formula><mml:math id="m715"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> led to elevated 7-DHC levels (<xref ref-type="fig" rid="f11">Figure 11B,D</xref>) and reduced desmosterol levels in the hiPSC-derived neuroprogenitors (<xref ref-type="fig" rid="f11">Figure 11C,E</xref>) in comparison with their time-matched vehicle control. Exposure to chemicals at <inline-formula><mml:math id="m716"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> did not significantly change sterol levels in the cells. However, beginning at 4 h, exposure to both pesticides at <inline-formula><mml:math id="m717"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> altered hiPSC sterol profiles as indicated by an increase in 7-DHC levels and decrease in desmosterol levels with spiroxamine (<xref ref-type="fig" rid="f11">Figure 11D,E</xref>) and a decrease in desmosterol levels with fenpropimorph (<xref ref-type="fig" rid="f11">Figure 11C</xref>). After 24 h, similar absolute levels of 7-DHC were observed (fenpropimorph, <inline-formula><mml:math id="m718"><mml:mrow><mml:mn>1.50</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nmol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m719"><mml:mrow><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext><mml:mo>/</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>6</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> cells; spiroxamine, <inline-formula><mml:math id="m720"><mml:mrow><mml:mn>1.54</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nmol</mml:mtext></mml:mrow></mml:math></inline-formula>
<inline-formula><mml:math id="m721"><mml:mrow><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext><mml:mo>/</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mn>6</mml:mn></mml:msup></mml:mrow></mml:math></inline-formula> cells), but fenpropimorph reached peak elevation of 7-DHC 8 h after exposure (<xref ref-type="fig" rid="f11">Figure 11B</xref>).</p>
</sec>
<sec id="s3.7">
<title><italic>De Novo</italic> Cholesterol Synthesis in hiPSC Cells Treated with Fenpropimorph and Spiroxamine</title>
<p>An isotopically labeled sterol precursor provides a highly sensitive means to track the enzymatic turnover of post-lanosterol metabolites during a chemical exposure. Thus, hiPSCs were incubated with a synthetic lanosterol labeled with three <inline-formula><mml:math id="m722"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts></mml:mrow></mml:math></inline-formula> atoms (see <xref ref-type="fig" rid="f12">Figure 12</xref>), and the isotopically labeled sterol products of this precursor—7-DHC, 8-DHC, desmosterol, and cholesterol—were analyzed by LC-MS/MS. A gradual increase in <inline-formula><mml:math id="m723"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-cholesterol</mml:mtext></mml:mrow></mml:math></inline-formula> levels was observed in the neuroprogenitor cells with a doubling of the absolute amount occurring between 12 and 24 h (<xref ref-type="fig" rid="f12">Figure 12</xref>). Between those same time points, a significant decrease of <inline-formula><mml:math id="m724"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula> and an increase in <inline-formula><mml:math id="m725"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-desmosterol</mml:mtext></mml:mrow></mml:math></inline-formula> were also observed (<xref ref-type="fig" rid="f13">Figure 13</xref>). The dynamic change in the profile of isotopically labeled sterols at 24 h provided a useful time point to interrogate the effect of the pesticides on <italic>de novo</italic> cholesterol synthesis.</p>
<fig id="f12" orientation="portrait" position="float">
<label>Figure 12.</label>
<caption>
<p><italic>De novo</italic> synthesis of cholesterol and sterol precursors was accomplished by incubating hiPSC-derived neuroprogenitor cells with <inline-formula><mml:math id="m726"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-lanosterol</mml:mtext></mml:mrow></mml:math></inline-formula> for 24 h and monitoring for <inline-formula><mml:math id="m727"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-sterols</mml:mtext></mml:mrow></mml:math></inline-formula> including <inline-formula><mml:math id="m728"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-dehydrocholesterol</mml:mtext></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="m729"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-cholesterol</mml:mtext></mml:mrow></mml:math></inline-formula> (A). Simplified cholesterol biosynthetic pathway is shown (B). Neuroprogenitor cells were exposed to fenpropimorph (C–F) or spiroxamine (G–J) at <inline-formula><mml:math id="m730"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="m731"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> for the same duration as the <inline-formula><mml:math id="m732"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-lanosterol</mml:mtext></mml:mrow></mml:math></inline-formula> incubation. Absolute values of <inline-formula><mml:math id="m733"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-</mml:mtext><mml:mn>8</mml:mn><mml:mtext>-dehydrocholesterol</mml:mtext></mml:mrow></mml:math></inline-formula> (C,G), <inline-formula><mml:math id="m734"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-desmosterol</mml:mtext></mml:mrow></mml:math></inline-formula> (D,H), <inline-formula><mml:math id="m735"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-dehydrocholesterol</mml:mtext></mml:mrow></mml:math></inline-formula> (E,I), and <inline-formula><mml:math id="m736"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-cholesterol</mml:mtext></mml:mrow></mml:math></inline-formula> (F,J) were detected, quantified and normalized to cell number. Three distinct differentiations were conducted for each donor and averaged; shown is the average of the three donors <inline-formula><mml:math id="m737"><mml:mrow><mml:mo>±</mml:mo><mml:mtext>SEM</mml:mtext></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m738"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></inline-formula>). *<inline-formula><mml:math id="m739"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></inline-formula>, **<inline-formula><mml:math id="m740"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math></inline-formula>, ***<inline-formula><mml:math id="m741"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula> as determined by post hoc Dunnett’s test following one-way analysis of variance (ANOVA).</p>
</caption>
<alt-text>Figure 12A comprises synthesis of chemical compounds, where super 13 C sub 3 Lan leads to a combination of super 13 C sub 3 7DHC and super 13 C sub 3 Chol; 13 C sub 3 7DHC leads to super 13 C sub 3 Chol. Figure 12B is a grid with four cells. The cells in the clock-wise direction are labeled as follows: (1)8DHC, (2)desmosterol, (3)cholesterol, and (4)7DHC. 1 through EBP leads to 4 and 4 through EBP leads to 1. 2 through DCHR24 leads to 3. 4 through DHCR7 also leads to 3. Figures 12C, 12D, 12E, and 12F are graphs plotting 8DHC (picomoles virgule 10 super 6 cells), Des (picomoles virgule 10 super 6 cells), 7DHC (picomoles virgule 10 super 6 cells), and Chol (picomoles virgule 10 super 6 cells), respectively, (y-axis) across fenpropimorph, ranging from 0 to 1000 nanomolar. Figures 12G, 12H, 12I, and 12J are graphs plotting 8DHC (picomoles virgule 10 super 6 cells), Des (picomoles virgule 10 super 6 cells), 7DHC (picomoles virgule 10 super 6 cells), and Chol (picomoles virgule 10 super 6 cells), respectively, (y-axis) across spiroxamine, ranging from 0 to 1000 nanomolar.</alt-text>
<graphic xlink:href="ehp-128-017014-g012"></graphic>
</fig>
<fig id="f13" orientation="portrait" position="float">
<label>Figure 13.</label>
<caption>
<p><italic>De novo</italic> synthesis of cholesterol and sterol precursors was accomplished by incubating hiPSC-derived neuroprogenitor cells with <inline-formula><mml:math id="m742"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-lanosterol</mml:mtext></mml:mrow></mml:math></inline-formula> for 24 h and monitoring for <inline-formula><mml:math id="m743"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-sterols</mml:mtext></mml:mrow></mml:math></inline-formula> at indicated time points. Isotopically labeled sterols analyzed are lanosterol (solid line), desmosterol (solid square, dashed line), 8-DHC (open triangle, solid line), 7-DHC (solid circle, solid line), and cholesterol (open circle, dashed line). Three distinct differentiations were conducted for each donor and averaged; shown is the average of the three donors <inline-formula><mml:math id="m744"><mml:mrow><mml:mo>±</mml:mo><mml:mtext>SEM</mml:mtext></mml:mrow></mml:math></inline-formula> (<inline-formula><mml:math id="m745"><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:math></inline-formula>). *<inline-formula><mml:math id="m746"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.05</mml:mn></mml:mrow></mml:math></inline-formula>, **<inline-formula><mml:math id="m747"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math></inline-formula>, ***<inline-formula><mml:math id="m748"><mml:mrow><mml:mi>p</mml:mi><mml:mo>&lt;</mml:mo><mml:mn>0.001</mml:mn></mml:mrow></mml:math></inline-formula> as determined by repeated measures one-way analysis of variance (ANOVA).</p>
</caption>
<alt-text>Figure 13 is a graph plotting nanomoles super 13 C sub 3 sterol virgule 10 super 6 cells (y-axis) for Lan, Des, 8DHC, 7DHC, and cholesterol across time (hours) (x-axis).</alt-text>
<graphic xlink:href="ehp-128-017014-g013"></graphic>
</fig>
<p>Fenpropimorph and spiroxamine affected <italic>de novo</italic> cholesterol biosynthesis similarly. Exposures of either compound at <inline-formula><mml:math id="m749"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> for 24 h increased <inline-formula><mml:math id="m750"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula> levels (<xref ref-type="fig" rid="f12">Figure 12E,I</xref>) and at a higher dose of <inline-formula><mml:math id="m751"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m752"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-</mml:mtext><mml:mn>8</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula> levels were also significantly elevated (<xref ref-type="fig" rid="f12">Figure 12C,G</xref>). Of importance is that both products of the enzyme DHCR7, <inline-formula><mml:math id="m753"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-desmosterol</mml:mtext></mml:mrow></mml:math></inline-formula> (<xref ref-type="fig" rid="f12">Figure 12D,H</xref>) and <inline-formula><mml:math id="m754"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-cholesterol</mml:mtext></mml:mrow></mml:math></inline-formula> (<xref ref-type="fig" rid="f12">Figure 12F,J</xref>), were significantly decreased in all exposures tested. The enzymatic capacity of DHCR7 to convert 7-DHC to cholesterol can be assessed by the ratio of [<inline-formula><mml:math id="m755"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Chol</mml:mtext></mml:mrow></mml:math></inline-formula>]:[<inline-formula><mml:math id="m756"><mml:mrow><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-Chol</mml:mtext><mml:mo>+</mml:mo><mml:mmultiscripts><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mprescripts></mml:mprescripts><mml:none></mml:none><mml:mrow><mml:mn>13</mml:mn></mml:mrow></mml:mmultiscripts><mml:mtext>-</mml:mtext><mml:mn>7</mml:mn><mml:mtext>-DHC</mml:mtext></mml:mrow></mml:math></inline-formula>], also known as the RCS. Ideally, the RCS is a value of 1 in normal, functional tissues (<xref ref-type="bibr" rid="c17">Genaro-Mattos et al. 2018</xref>; <xref ref-type="bibr" rid="c22">Honda et al. 1995</xref>; <xref ref-type="bibr" rid="c74">Wassif et al. 2005</xref>). The hiPSC-derived neuroprogenitors exposed to the vehicle control (0.01% DMSO) provided an RCS value of <inline-formula><mml:math id="m757"><mml:mrow><mml:mn>0.96</mml:mn><mml:mo>±</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:math></inline-formula>, whereas our reference positive control of haloperidol at <inline-formula><mml:math id="m758"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="m759"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> for 24 h led to an RCS of <inline-formula><mml:math id="m760"><mml:mrow><mml:mn>0.50</mml:mn><mml:mo>±</mml:mo><mml:mn>0.10</mml:mn></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="m761"><mml:mrow><mml:mn>0.28</mml:mn><mml:mo>±</mml:mo><mml:mn>0.14</mml:mn></mml:mrow></mml:math></inline-formula>, respectively. Fenpropimorph compromised the RCS significantly, as determined by one-way analysis of variance (ANOVA), with the <inline-formula><mml:math id="m762"><mml:mrow><mml:mn>10</mml:mn><mml:mtext>-nM</mml:mtext></mml:mrow></mml:math></inline-formula> exposure causing an RCS of <inline-formula><mml:math id="m763"><mml:mrow><mml:mn>0.59</mml:mn><mml:mo>±</mml:mo><mml:mn>0.13</mml:mn></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="m764"><mml:mrow><mml:mn>1,000</mml:mn><mml:mtext>-nM</mml:mtext></mml:mrow></mml:math></inline-formula> exposure causing an RCS of <inline-formula><mml:math id="m765"><mml:mrow><mml:mn>0.38</mml:mn><mml:mo>±</mml:mo><mml:mn>0.07</mml:mn></mml:mrow></mml:math></inline-formula>. Spiroxamine also reduced DHCR7 activity at <inline-formula><mml:math id="m766"><mml:mrow><mml:mn>1,000</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> with an observed RCS of <inline-formula><mml:math id="m767"><mml:mrow><mml:mn>0.50</mml:mn><mml:mo>±</mml:mo><mml:mn>0.10</mml:mn></mml:mrow></mml:math></inline-formula>.</p>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>This study expanded the chemical space known to inhibit human cholesterol biosynthesis by screening the ToxCast™ Chemical Library and demonstrated that two agricultural pesticides, fenpropimorph and spiroxamine, induced an <italic>in vitro</italic> metabolic phenotype similar to the genetic recessive disorder SLOS. The ToxCast™ library is a carefully constructed chemical toolset composed of environmentally relevant compounds maintained by the ToxCast™ program at the U.S. Environmental Protection Agency (<xref ref-type="bibr" rid="c52">Richard et al. 2016</xref>). A constraint of our findings is the requirement that all compounds in the screening library must be suitable for high-throughput screening (<xref ref-type="bibr" rid="c52">Richard et al. 2016</xref>). In this regard, many relevant environmental agents are highly reactive, gaseous, volatile, or DMSO-insoluble and are therefore not included in the ToxCast™ library. Ozone, for example, is a priority chemical for environmental health scientists and governmental regulatory bodies, and there is ample precedent for this highly reactive environmental pollutant to affect human health via oxidation of cholesterol (<xref ref-type="bibr" rid="c50">Pryor et al. 1992</xref>; <xref ref-type="bibr" rid="c51">Pulfer and Murphy 2004</xref>; <xref ref-type="bibr" rid="c61">Speen et al. 2016</xref>).</p>
<p>In comparison with other methods available to quantify sterols, the LC/MS/MS method used in this study has the advantage that it is specific for the important post-lanosterol sterols 7-DHC, 8-DHC, desmosterol, and cholesterol, and it is well-suited for a screen of a library of modest size. Although the method reliably provides quantification of these four sterols and lanosterol in a one-minute run time, we recognize the need to develop rapid high-throughput methods to decrease analysis times further and to expand screening studies to other sterols. Those efforts are underway and will be reported in due course.</p>
<p>Of the compounds screened against the Neuro-2a cell line, 46 were found to affect sterol levels of lanosterol, desmosterol, 7-DHC, or cholesterol. Over half of the 13 validated lead-hits that elevated lanosterol in our screen are of the azole fungicide class. These azole fungicides were designed to inhibit the CYP51 homolog in fungi and, not surprisingly, have affinity toward mammalian CYP51 as well (<xref ref-type="bibr" rid="c56">Rozman et al. 1996</xref>; <xref ref-type="bibr" rid="c73">Warrilow et al. 2013</xref>). In fact, only 3 of the 13 validated lanosterol-elevating lead-hits identified had no previous history of an effect on sterol metabolism: endosulfan sulfate, tributyltin chloride, and tributyltin methacrylate. The majority of the 16 validated lead-hit compounds that elevated 7-DHC are pharmaceuticals or experimental drugs; seven lead-hits are antiseptics of the benzalkonium chlorides, and two are pesticides. Many of the pharmaceuticals (<xref ref-type="bibr" rid="c33">Korade et al. 2017b</xref>) and antiseptics (<xref ref-type="bibr" rid="c21">Herron et al. 2016</xref>) that may be relevant to human health today had been identified previously as DHCR7 inhibitors, corroborating our screening results. The impact of pharmaceuticals and other health products found in the environment on public health is a growing concern (<xref ref-type="bibr" rid="c5">Boxall 2004</xref>), and it is particularly noteworthy that a number of antipsychotics, including some of the most potent DHCR7 inhibitors identified in this study, such as haloperidol, can be detected in drinking water sources as a consequence of improper medical waste disposal (<xref ref-type="bibr" rid="c39">Logarinho et al. 2016</xref>; <xref ref-type="bibr" rid="c59">Silveira et al. 2013</xref>; <xref ref-type="bibr" rid="c68">Van De Steene et al. 2010</xref>).</p>
<p>In contrast to the exposures resulting from improper medical waste disposal, the two potent commercial pesticides fenpropimorph and spiroxamine are unique in ToxCast™ because they pose a more direct primary exposure threat because few studies had yet to explore the potential impact of compounds intended for the environment on human cholesterol biosynthesis. Both fenpropimorph and spiroxamine are used in the prevention of rust disease in viticulture as well as in cereal crops such as wheat and barley. Although no current study exists identifying a relevant human exposure dose for either pesticide, assuming complete absorption, the exposures levels used in this study are in the range of the indicated acute reference dose of daily dietary intake of fenpropimorph (<inline-formula><mml:math id="m768"><mml:mrow><mml:mn>10.5</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula>) and spiroxamine (<inline-formula><mml:math id="m769"><mml:mrow><mml:mn>0.336</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mi mathvariant="normal">μ</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:math></inline-formula>), as established by the U.S. EPA (<xref ref-type="bibr" rid="c66">2004</xref>, <xref ref-type="bibr" rid="c67">2005</xref>). As is the case with most fungicides, the most common route of human exposure is through diet, with concentrated areas of exposure where cereal crops are most produced, available, and inexpensive. For instance, exposure studies of European populations near these crops reveal that metabolites of fenpropimorph can be detected in the blood of nonworker individuals, including pregnant women (<xref ref-type="bibr" rid="c6">Buerge et al. 2016</xref>; <xref ref-type="bibr" rid="c24">Jamin et al. 2014</xref>). Less is known about human exposures to spiroxamine, but evidence exists that applications of spiroxamine to Israeli orchards led to measurable concentrations of the pesticide in the surrounding air (<xref ref-type="bibr" rid="c78">Zivan et al. 2017</xref>), as well as evidence of seasonal elevations near German wastewater discharge sites (<xref ref-type="bibr" rid="c3">Beckers et al. 2018</xref>). Further, these fungicides have been suggested to have no health effects in the majority of the human population (<xref ref-type="bibr" rid="c44">Muri et al. 2009</xref>); therefore, the compounds have a broad global footprint. In fact, due to the current safety profile for morpholine-like pesticides such as fenpropimorph, research is being undertaken to enhance their fungicidal effectiveness by incorporating silicon moieties into their structure, which would extend the half-life of the compounds in mammalian species (<xref ref-type="bibr" rid="c23">Jachak et al. 2015</xref>). These efforts suggest that human exposure to fenpropimorph occurs and that exposure scenarios to spiroxamine are likely. Due to the need to cultivate and maintain cereal crops to sustain world populations, vulnerable and underrepresented groups are also more likely exposed to these pesticides than in the past.</p>
<p>Fenpropimorph and spiroxamine are known to affect fungal sterol biosynthesis by inhibiting either <inline-formula><mml:math id="m770"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mn>14</mml:mn></mml:mrow></mml:math></inline-formula> reductase and <inline-formula><mml:math id="m771"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mn>7</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m772"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mn>8</mml:mn></mml:mrow></mml:math></inline-formula> isomerase or both (<xref ref-type="bibr" rid="c10">Debieu et al. 2000</xref>); however, our data suggest that these compounds have a higher affinity to inhibit DHCR7 in human cells. If indeed fenpropimorph or spiroxamine inhibited the human homologs to <inline-formula><mml:math id="m773"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mn>14</mml:mn></mml:mrow></mml:math></inline-formula> reductase or <inline-formula><mml:math id="m774"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mn>7</mml:mn></mml:mrow></mml:math></inline-formula>, <inline-formula><mml:math id="m775"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mn>8</mml:mn></mml:mrow></mml:math></inline-formula> isomerase, we would expect decreases in 7-DHC and 8-DHC, not increases. One other study to date reported that fenpropimorph did indeed affect mammalian cholesterol biosynthesis, albeit in a mouse cell line (<xref ref-type="bibr" rid="c8">Corio-Costet et al. 1988</xref>). The CYP51 inhibitors, tributyltin chloride and endosulfan sulfate, increased lanosterol levels only in mouse cells. Even though cholesterol biosynthesis is highly conserved across the animal kingdom as determined by gene similarity of all cholesterol biosynthetic enzymes, recent studies have demonstrated that for CYP51, the difference between mouse and human expression is significant with regard to intron regulation and the existence of different isoforms of the gene (<xref ref-type="bibr" rid="c46">Nelson et al. 2004</xref>; <xref ref-type="bibr" rid="c56">Rozman et al. 1996</xref>). These interspecies differences likely explain the discordance with the deprioritization of tributyltin chloride and endosulfan sulfate. Because we were able to show that human CYP51 could still be inhibited with econazole, our results suggest that tributyltin chloride and endosulfan sulfate inhibit CYP51 via an unknown mechanism that is likely not relevant in human cells.</p>
<p>The primary screen data presented in <xref ref-type="fig" rid="f2">Figure 2</xref> were obtained in a murine neuroblastoma cell line (Neuro-2a), and verification of the effect in human cell lines derived from different tissues was explored. The cells examined in this study—SK-N-SH, IMR-32, A549, and Hep-G2<italic>—</italic>have distinct sterol profiles and differential responses to small molecule modifiers of cholesterol biosynthesis (<xref ref-type="bibr" rid="c13">Fon Tacer et al. 2010</xref>; <xref ref-type="bibr" rid="c43">Mitsche et al. 2015</xref>). In fact, the sterol metabolisms of each cell line and their tissue lineages are of some interest. Unlike most tissues that have high turnover rates of cholesterol, the central nervous system is effective at sequestering and storing cholesterol (<xref ref-type="bibr" rid="c11">Dietschy 2009</xref>). Thus, the lack of significant change in cholesterol in the human neuroblastoma SK-N-SH cell line in response to fenpropimorph or spiroxamine could be due to a biological adaptation of these cells to store cholesterol during acute exposure to small molecule inhibitors of cholesterol biosynthesis. These distinct sterolomic profiles across cell lines that match closely with their tissues of origin have the potential to provide additional insights. Even though our <italic>in vitro</italic> data suggested that the lead-hits were most potent in neural cells, the results also demonstrated that the lead-hits could impair cholesterol biosynthesis in other tissues as well. When extrapolating this study’s findings to an actual human, it would be important to consider the impact of the exposure beyond the brain, because liver and lung sterol profiles will likely be disrupted as well.</p>
<p>The cell lines used in this study are derived from oncogenic tissue and for this reason may be criticized as models for developmental toxicity studies. However, hiPSCs are a better model to examine developmental toxicity because they are not transformed cells, and they have the ability to differentiate into any cell type, including neuroprogenitors (<xref ref-type="bibr" rid="c14">Fritsche et al. 2018a</xref>, <xref ref-type="bibr" rid="c15">2018b</xref>; <xref ref-type="bibr" rid="c34">Kumar et al. 2012</xref>). This period of differentiation allows for modeling exposure conditions with the most vulnerable human tissues to better understand neurotoxicant toxicity. Most stem cell–based developmental toxicity testing has been performed using mouse embryonic stem cells (mESCs) due to ethical concerns with human ESCs; but determining toxicity in the analogous hiPSC-based <italic>in vitro</italic> human system has advantages because toxicokinetics and toxicodynamics likely differ in a species-dependent manner, human genetic and environmental factors contributing to disease are not always conserved in mouse or other species, and hiPSCs have fewer ethical concerns relative to human ESCs given their postnatal origin (<xref ref-type="bibr" rid="c14">Fritsche et al. 2018a</xref>, <xref ref-type="bibr" rid="c15">2018b</xref>; <xref ref-type="bibr" rid="c40">Luz and Tokar 2018</xref>). Indeed, of the dozens of assays carried out under different exposure conditions and in different cell types, the most sensitive system found in our study was the <italic>de novo</italic> assay of biosynthesis in neuroprogenitors using an isotopically labeled sterol precursor (see <xref ref-type="fig" rid="f12">Figure 12</xref>). Although increases in 7- and 8-DHC are observed in these assays under most conditions, the decreases observed for desmosterol and cholesterol are particularly telling. Inhibition of DHCR7 should decrease <italic>de novo</italic> biosynthesis of both desmosterol and cholesterol (see <xref ref-type="fig" rid="f1">Figure 1</xref>), and the decrease observed for these sterols at concentrations as low as <inline-formula><mml:math id="m776"><mml:mrow><mml:mn>10</mml:mn><mml:mspace width="0.3em"></mml:mspace><mml:mtext>nM</mml:mtext></mml:mrow></mml:math></inline-formula> seems particularly important.</p>
<p>In conclusion, the results of this study show that about one percent of the ToxCast™ library of environmental agents affected DHCR7, the enzyme that promotes the last critical step in cholesterol biosynthesis, in select mouse and human cell lines. Many of these ToxCast™ hits are found in medical waste, but fenpropimorph and spiroxamine are used extensively in cereal crops and may represent a novel human exposure threat. These two fungicides increased levels of 7- and 8-DHC and reduced levels of desmosterol and cholesterol in several human cell lines and in developing human neural tissue. Even though this work is founded solely on <italic>in vitro</italic> experiments, this research does suggest that these compounds may be developmental neurotoxicants like numerous other pesticides (<xref ref-type="bibr" rid="c20">Gunier et al. 2017</xref>; <xref ref-type="bibr" rid="c54">Roncati et al. 2017</xref>; <xref ref-type="bibr" rid="c69">van Wendel de Joode et al. 2016</xref>). Additionally, adverse-outcome pathway analyses may benefit from the inclusion of cholesterol biosynthesis as a possible key event or even molecular initiating event for frameworks describing environmental neurodevelopmental toxicity (<xref ref-type="bibr" rid="c60">Sorhus et al. 2017</xref>).</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data">
<media xlink:href="ehp-128-017014-s003.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data">
<media xlink:href="ehp-128-017014-s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data">
<media xlink:href="ehp-128-017014-s002.zip">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work was supported in part by the National Institute of Environmental Health Sciences Grants ES024133 (NAP, PAW), ES000267 (PAW, ABB), and ES016931 (ABB). The authors thank A. Richard and K. Houck [U.S. EPA, National Center for Computational Toxicology (NCCT)] for assistance in obtaining the ToxCast™ Chemical Library. We thank K. Ess (Vanderbilt University Medical Center) for the CX-3 line and human dermal fibroblasts. The ToxCast™ Chemical Library was distributed by the Vanderbilt High-Throughput Screening Core Facility with assistance from P. Vinson and C. Whitwell. The Vanderbilt High-throughput Screening Core Facility receives support from the Vanderbilt Institute of Chemical Biology and The Vanderbilt Ingram Cancer Center.</p>
</ack>
<fn-group>
<fn fn-type="other" specific-use="pdf-only">
<p>Supplemental Material is available online (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1289/EHP5053">https://doi.org/10.1289/EHP5053</ext-link>).</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The authors declare they have no actual or potential competing financial interests.</p>
</fn>
<fn fn-type="other" specific-use="pdf-only">
<p><bold>Note to readers with disabilities:</bold>
<italic>EHP</italic> strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in <italic>EHP</italic> articles may not conform to <ext-link ext-link-type="uri" xlink:href="http://ehp.niehs.nih.gov/accessibility/">508 standards</ext-link> due to the complexity of the information being presented. If you need assistance accessing journal content, please contact <email>ehponline@niehs.nih.gov</email>. Our staff will work with you to assess and meet your accessibility needs within 3 working days.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="c1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armstrong</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Westlake</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Snow</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Cawthon</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Armour</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bowman</surname><given-names>AB</given-names></name>, <etal>et al.</etal></person-group>
<year>2017</year>. <article-title>Heterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming</article-title>. <source/>Hum Mol Genet
<volume>26</volume>(<issue>23</issue>):<fpage>4629</fpage>–<lpage>4641</lpage>, PMID: 28973543, <pub-id pub-id-type="doi">10.1093/hmg/ddx345</pub-id>.<pub-id pub-id-type="pmid">28973543</pub-id></mixed-citation>
</ref>
<ref id="c2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bal-Price</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Hogberg</surname><given-names>HT</given-names></name>, <name name-style="western"><surname>Buzanska</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lenas</surname><given-names>P</given-names></name>, <name name-style="western"><surname>van Vliet</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hartung</surname><given-names>T</given-names></name></person-group>
<year>2010</year>. <article-title>In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints</article-title>. <source/>Neurotoxicology
<volume>31</volume>(<issue>5</issue>):<fpage>545</fpage>–<lpage>554</lpage>, PMID: 19969020, <pub-id pub-id-type="doi">10.1016/j.neuro.2009.11.006</pub-id>.<pub-id pub-id-type="pmid">19969020</pub-id></mixed-citation>
</ref>
<ref id="c3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beckers</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Busch</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Krauss</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Schulze</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Brack</surname><given-names>W</given-names></name></person-group>
<year>2018</year>. <article-title>Characterization and risk assessment of seasonal and weather dynamics in organic pollutant mixtures from discharge of a separate sewer system</article-title>. <source/>Water Res
<volume>135</volume>:<fpage>122</fpage>–<lpage>133</lpage>, PMID: 29466716, <pub-id pub-id-type="doi">10.1016/j.watres.2018.02.002</pub-id>.<pub-id pub-id-type="pmid">29466716</pub-id></mixed-citation>
</ref>
<ref id="c4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Björkhem</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Meaney</surname><given-names>S</given-names></name></person-group>
<year>2004</year>. <article-title>Brain cholesterol: long secret life behind a barrier</article-title>. <source/>Arterioscler Thromb Vasc Biol
<volume>24</volume>(<issue>5</issue>):<fpage>806</fpage>–<lpage>815</lpage>, PMID: 14764421, <pub-id pub-id-type="doi">10.1161/01.ATV.0000120374.59826.1b</pub-id>.<pub-id pub-id-type="pmid">14764421</pub-id></mixed-citation>
</ref>
<ref id="c5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boxall</surname><given-names>AB</given-names></name></person-group>
<year>2004</year>. <article-title>The environmental side effects of medication</article-title>. <source/>EMBO Rep
<volume>5</volume>(<issue>12</issue>):<fpage>1110</fpage>–<lpage>1116</lpage>, PMID: 15577922, <pub-id pub-id-type="doi">10.1038/sj.embor.7400307</pub-id>.<pub-id pub-id-type="pmid">15577922</pub-id></mixed-citation>
</ref>
<ref id="c6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buerge</surname><given-names>IJ</given-names></name>, <name name-style="western"><surname>Krauss</surname><given-names>J</given-names></name>, <name name-style="western"><surname>López-Cabeza</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Siegfried</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Stüssi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wettstein</surname><given-names>FE</given-names></name>, <etal>et al.</etal></person-group>
<year>2016</year>. <article-title>Stereoselective metabolism of the sterol biosynthesis inhibitor fungicides fenpropidin, fenpropimorph, and spiroxamine in grapes, sugar beets, and wheat</article-title>. <source/>J Agric Food Chem
<volume>64</volume>(<issue>26</issue>):<fpage>5301</fpage>–<lpage>5309</lpage>, PMID: 27248479, <pub-id pub-id-type="doi">10.1021/acs.jafc.6b00919</pub-id>.<pub-id pub-id-type="pmid">27248479</pub-id></mixed-citation>
</ref>
<ref id="c7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chambers</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Fasano</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Papapetrou</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Tomishima</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sadelain</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Studer</surname><given-names>L</given-names></name></person-group>
<year>2009</year>. <article-title>Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling</article-title>. <source/>Nat Biotechnol
<volume>27</volume>(<issue>3</issue>):<fpage>275</fpage>–<lpage>280</lpage>, PMID: 19252484, <pub-id pub-id-type="doi">10.1038/nbt.1529</pub-id>.<pub-id pub-id-type="pmid">19252484</pub-id></mixed-citation>
</ref>
<ref id="c8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corio-Costet</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Gerst</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Benveniste</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Schuber</surname><given-names>F</given-names></name></person-group>
<year>1988</year>. <article-title>Inhibition by the fungicide fenpropimorph of cholesterol biosynthesis in 3T3 fibroblasts</article-title>. <source/>Biochem J
<volume>256</volume>(<issue>3</issue>):<fpage>829</fpage>–<lpage>834</lpage>, PMID: 3223956, <pub-id pub-id-type="doi">10.1042/bj2560829</pub-id>.<pub-id pub-id-type="pmid">3223956</pub-id></mixed-citation>
</ref>
<ref id="c9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costa</surname><given-names>LG</given-names></name>, <name name-style="western"><surname>Cole</surname><given-names>TB</given-names></name>, <name name-style="western"><surname>Coburn</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Dao</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Roque</surname><given-names>P</given-names></name></person-group>
<year>2014</year>. <article-title>Neurotoxicants are in the air: convergence of human, animal, and in vitro studies on the effects of air pollution on the brain</article-title>. <source/>BioMed Res Int
<volume>2014</volume>:<elocation-id>736385</elocation-id>, PMID: 24524086, <pub-id pub-id-type="doi">10.1155/2014/736385</pub-id>.<pub-id pub-id-type="pmid">24524086</pub-id></mixed-citation>
</ref>
<ref id="c10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Debieu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Bach</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Arnold</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Brousset</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gredt</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Taton</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<year>2000</year>
<article-title>Inhibition of ergosterol biosynthesis by morpholine, piperidine, and spiroketalamine fungicides in <italic>Microdochium nivale</italic>: effect on sterol composition and sterol Δ8→Δ7-isomerase activity</article-title>. <source/>Pestic Biochem Physiol
<volume>67</volume>(<issue>2</issue>):<fpage>85</fpage>–<lpage>94</lpage>, <pub-id pub-id-type="doi">10.1006/pest.2000.2485</pub-id>.</mixed-citation>
</ref>
<ref id="c11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dietschy</surname><given-names>JM</given-names></name></person-group>
<year>2009</year>. <article-title>Central nervous system: cholesterol turnover, brain development and neurodegeneration</article-title>. <source/>Biol Chem
<volume>390</volume>(<issue>4</issue>):<fpage>287</fpage>–<lpage>293</lpage>, PMID: 19166320, <pub-id pub-id-type="doi">10.1515/BC.2009.035</pub-id>.<pub-id pub-id-type="pmid">19166320</pub-id></mixed-citation>
</ref>
<ref id="c12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dvornik</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>P</given-names></name></person-group>
<year>1968</year>. <article-title>Effect of long-term administration of AY-9944, an inhibitor of 7-dehydrocholesterol delta 7-reductase, on serum and tissue lipids in the rat</article-title>. <source/>J Lipid Res
<volume>9</volume>(<issue>5</issue>):<fpage>587</fpage>–<lpage>595</lpage>, PMID: 5726317.<pub-id pub-id-type="pmid">5726317</pub-id></mixed-citation>
</ref>
<ref id="c13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fon Tacer</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Pompon</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Rozman</surname><given-names>D</given-names></name></person-group>
<year>2010</year>. <article-title>Adaptation of cholesterol synthesis to fasting and TNF-alpha: profiling cholesterol intermediates in the liver, brain, and testis</article-title>. <source/>J Steroid Biochem Mol Biol
<volume>121</volume>(<issue>3–5</issue>):<fpage>619</fpage>–<lpage>625</lpage>, PMID: 20206258, <pub-id pub-id-type="doi">10.1016/j.jsbmb.2010.02.026</pub-id>.<pub-id pub-id-type="pmid">20206258</pub-id></mixed-citation>
</ref>
<ref id="c14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fritsche</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Barenys</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Klose</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Masjosthusmann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nimtz</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Schmuck</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<year>2018a</year>. <article-title>Development of the concept for stem cell-based developmental neurotoxicity (DNT) evaluation</article-title>. <source/>Toxicol Sci
<volume>165</volume>(<issue>1</issue>):<fpage>14</fpage>–<lpage>20</lpage>, PMID: 29982725, <pub-id pub-id-type="doi">10.1093/toxsci/kfy175</pub-id>.<pub-id pub-id-type="pmid">29982725</pub-id></mixed-citation>
</ref>
<ref id="c15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fritsche</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Barenys</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Klose</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Masjosthusmann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nimtz</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Schmuck</surname><given-names>M</given-names></name>, <etal>et al.</etal></person-group>
<year>2018b</year>. <article-title>Current availability of stem cell-based in vitro methods for developmental neurotoxicity (DNT) testing</article-title>. <source/>Toxicol Sci
<volume>165</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>30</lpage>, PMID: 29982830, <pub-id pub-id-type="doi">10.1093/toxsci/kfy178</pub-id>.<pub-id pub-id-type="pmid">29982830</pub-id></mixed-citation>
</ref>
<ref id="c16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Genaro-Mattos</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tallman</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Porter</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Korade</surname><given-names>Z</given-names></name>, <etal>et al.</etal></person-group>
<year>2019</year>. <article-title>Maternal aripiprazole exposure interacts with 7-dehydrocholesterol reductase mutations and alters embryonic neurodevelopment</article-title>. <source/>Mol Psychiatry
<volume>24</volume>(<issue>4</issue>):<fpage>491</fpage>–<lpage>500</lpage>, PMID: 30742019, <pub-id pub-id-type="doi">10.1038/s41380-019-0368-6</pub-id>.<pub-id pub-id-type="pmid">30742019</pub-id></mixed-citation>
</ref>
<ref id="c17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Genaro-Mattos</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Tallman</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mirnics</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Korade</surname><given-names>Z</given-names></name>, <etal>et al.</etal></person-group>
<year>2018</year>. <article-title>Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis</article-title>. <source/>Toxicol Appl Pharmacol
<volume>349</volume>:<fpage>21</fpage>–<lpage>28</lpage>, PMID: 29698737, <pub-id pub-id-type="doi">10.1016/j.taap.2018.04.029</pub-id>.<pub-id pub-id-type="pmid">29698737</pub-id></mixed-citation>
</ref>
<ref id="c18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grandjean</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Landrigan</surname><given-names>PJ</given-names></name></person-group>
<year>2006</year>. <article-title>Developmental neurotoxicity of industrial chemicals</article-title>. <source/>Lancet
<volume>368</volume>(<issue>9553</issue>):<fpage>2167</fpage>–<lpage>2178</lpage>, PMID: 17174709, <pub-id pub-id-type="doi">10.1016/S0140-6736(06)69665-7</pub-id>.<pub-id pub-id-type="pmid">17174709</pub-id></mixed-citation>
</ref>
<ref id="c19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grandjean</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Landrigan</surname><given-names>PJ</given-names></name></person-group>
<year>2014</year>. <article-title>Neurobehavioural effects of developmental toxicity</article-title>. <source/>Lancet Neurol
<volume>13</volume>(<issue>3</issue>):<fpage>330</fpage>–<lpage>338</lpage>, PMID: 24556010, <pub-id pub-id-type="doi">10.1016/S1474-4422(13)70278-3</pub-id>.<pub-id pub-id-type="pmid">24556010</pub-id></mixed-citation>
</ref>
<ref id="c20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gunier</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Bradman</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Harley</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Kogut</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Eskenazi</surname><given-names>B</given-names></name></person-group>
<year>2017</year>. <article-title>Prenatal residential proximity to agricultural pesticide use and IQ in 7-year-old children</article-title>. <source/>Environ Health Perspect
<volume>125</volume>(<issue>5</issue>):<elocation-id>057002</elocation-id>, PMID: 28557711, <pub-id pub-id-type="doi">10.1289/EHP504</pub-id>.<pub-id pub-id-type="pmid">28557711</pub-id></mixed-citation>
</ref>
<ref id="c21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herron</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Reese</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Tallman</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Narayanaswamy</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Porter</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>L</given-names></name></person-group>
<year>2016</year>. <article-title>Identification of environmental quaternary ammonium compounds as direct inhibitors of cholesterol biosynthesis</article-title>. <source/>Toxicol Sci
<volume>151</volume>(<issue>2</issue>):<fpage>261</fpage>–<lpage>270</lpage>, PMID: 26919959, <pub-id pub-id-type="doi">10.1093/toxsci/kfw041</pub-id>.<pub-id pub-id-type="pmid">26919959</pub-id></mixed-citation>
</ref>
<ref id="c22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Honda</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tint</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Salen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Batta</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Shefer</surname><given-names>S</given-names></name></person-group>
<year>1995</year>. <article-title>Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes</article-title>. <source/>J Lipid Res
<volume>36</volume>(<issue>7</issue>):<fpage>1595</fpage>–<lpage>1601</lpage>, PMID: 7595082.<pub-id pub-id-type="pmid">7595082</pub-id></mixed-citation>
</ref>
<ref id="c23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jachak</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Ramesh</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Sant</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Jorwekar</surname><given-names>SU</given-names></name>, <name name-style="western"><surname>Jadhav</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Tupe</surname><given-names>SG</given-names></name>, <etal>et al.</etal></person-group>
<year>2015</year>. <article-title>Silicon incorporated morpholine antifungals: design, synthesis, and biological evaluation</article-title>. <source/>ACS Med Chem Lett
<volume>6</volume>(<issue>11</issue>):<fpage>1111</fpage>–<lpage>1116</lpage>, PMID: 26617963, <pub-id pub-id-type="doi">10.1021/acsmedchemlett.5b00245</pub-id>.<pub-id pub-id-type="pmid">26617963</pub-id></mixed-citation>
</ref>
<ref id="c24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamin</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Bonvallot</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Tremblay-Franco</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cravedi</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Chevrier</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cordier</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group>
<year>2014</year>. <article-title>Untargeted profiling of pesticide metabolites by LC-HRMS: an exposomics tool for human exposure evaluation</article-title>. <source/>Anal Bioanal Chem
<volume>406</volume>(<issue>4</issue>):<fpage>1149</fpage>–<lpage>1161</lpage>, PMID: 23892877, <pub-id pub-id-type="doi">10.1007/s00216-013-7136-2</pub-id>.<pub-id pub-id-type="pmid">23892877</pub-id></mixed-citation>
</ref>
<ref id="c25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jung</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Seo</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group>
<year>2013</year>. <article-title>Social deficits in the AY-9944 mouse model of atypical absence epilepsy</article-title>. <source/>Behav Brain Res
<volume>236</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>29</lpage>, PMID: 22944514, <pub-id pub-id-type="doi">10.1016/j.bbr.2012.08.029</pub-id>.<pub-id pub-id-type="pmid">22944514</pub-id></mixed-citation>
</ref>
<ref id="c26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelley</surname><given-names>RI</given-names></name>, <name name-style="western"><surname>Hennekam</surname><given-names>RC</given-names></name></person-group>
<year>2000</year>. <article-title>The Smith-Lemli-Opitz syndrome</article-title>. <source/>J Med Genet
<volume>37</volume>(<issue>5</issue>):<fpage>321</fpage>–<lpage>335</lpage>, PMID: 10807690, <pub-id pub-id-type="doi">10.1136/jmg.37.5.321</pub-id>.<pub-id pub-id-type="pmid">10807690</pub-id></mixed-citation>
</ref>
<ref id="c27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karalis</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Clifton</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wild</surname><given-names>RA</given-names></name></person-group>
<year>2016</year>. <article-title>The risks of statin use in pregnancy: a systematic review</article-title>. <source/>J Clin Lipidol
<volume>10</volume>(<issue>5</issue>):<fpage>1081</fpage>–<lpage>1090</lpage>, PMID: 27678424, <pub-id pub-id-type="doi">10.1016/j.jacl.2016.07.002</pub-id>.<pub-id pub-id-type="pmid">27678424</pub-id></mixed-citation>
</ref>
<ref id="c28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Korade</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Tallman</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Weaver</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Mirnics</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group>
<year>2016</year>. <article-title>Inhibitors of 7-dehydrocholesterol reductase: screening of a collection of pharmacologically active compounds in Neuro2a cells</article-title>. <source/>Chem Res Toxicol
<volume>29</volume>(<issue>5</issue>):<fpage>892</fpage>–<lpage>900</lpage>, PMID: 27097157, <pub-id pub-id-type="doi">10.1021/acs.chemrestox.6b00054</pub-id>.<pub-id pub-id-type="pmid">27097157</pub-id></mixed-citation>
</ref>
<ref id="c29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kleinstreuer</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>West</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Conard</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Fontaine</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Weir-Hauptman</surname><given-names>AM</given-names></name>, <etal>et al.</etal></person-group>
<year>2011</year>. <article-title>Identifying developmental toxicity pathways for a subset of ToxCast chemicals using human embryonic stem cells and metabolomics</article-title>. <source/>Toxicol Appl Pharmacol
<volume>257</volume>(<issue>1</issue>):<fpage>111</fpage>–<lpage>121</lpage>, PMID: 21925528, <pub-id pub-id-type="doi">10.1016/j.taap.2011.08.025</pub-id>.<pub-id pub-id-type="pmid">21925528</pub-id></mixed-citation>
</ref>
<ref id="c30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolf-Clauw</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chevy</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Siliart</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Citadelle</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>C</given-names></name></person-group>
<year>1996</year>. <article-title>Inhibition of 7-dehydrocholesterol reductase by the teratogen AY-9944: a rat model for Smith-Lemli-Opitz syndrome</article-title>. <source/>Teratology
<volume>54</volume>(<issue>3</issue>):<fpage>115</fpage>–<lpage>125</lpage>, PMID: 8987154, <pub-id pub-id-type="doi">10.1002/(SICI)1096-9926(199609)54:3&lt;115::AID-TERA1&gt;3.0.CO;2-2</pub-id>.<pub-id pub-id-type="pmid">8987154</pub-id></mixed-citation>
</ref>
<ref id="c31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korade</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Genaro-Mattos</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Tallman</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Garbett</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Koczok</surname><given-names>K</given-names></name>, <etal>et al.</etal></person-group>
<year>2017a</year>. <article-title>Vulnerability of <italic>DHCR7</italic><sup>+/−</sup> mutation carriers to aripiprazole and trazodone exposure</article-title>. <source/>J Lipid Res
<volume>58</volume>(<issue>11</issue>):<fpage>2139</fpage>–<lpage>2146</lpage>, PMID: 28972118, <pub-id pub-id-type="doi">10.1194/jlr.M079475</pub-id>.<pub-id pub-id-type="pmid">28972118</pub-id></mixed-citation>
</ref>
<ref id="c32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korade</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Tallman</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Koczok</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Balogh</surname><given-names>I</given-names></name>, <etal>et al.</etal></person-group>
<year>2016</year>. <article-title>The effect of small molecules on sterol homeostasis: Measuring 7-dehydrocholesterol in dhcr7-deficient neuro2a cells and human fibroblasts</article-title>. <source/>J Med Chem
<volume>59</volume>(<issue>3</issue>):<fpage>1102</fpage>–<lpage>1115</lpage>, PMID: 26789657, <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01696</pub-id>.<pub-id pub-id-type="pmid">26789657</pub-id></mixed-citation>
</ref>
<ref id="c33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korade</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Warren</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Armstrong</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Porter</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Konradi</surname><given-names>C</given-names></name></person-group>
<year>2017b</year>. <article-title>Effect of psychotropic drug treatment on sterol metabolism</article-title>. <source/>Schizophr Res
<volume>187</volume>:<fpage>74</fpage>, PMID: 28202290, <pub-id pub-id-type="doi">10.1016/j.schres.2017.02.001</pub-id>.<pub-id pub-id-type="pmid">28202290</pub-id></mixed-citation>
</ref>
<ref id="c34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Aboud</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Bowman</surname><given-names>AB</given-names></name></person-group>
<year>2012</year>. <article-title>The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk</article-title>. <source/>Neurotoxicology
<volume>33</volume>(<issue>3</issue>):<fpage>518</fpage>–<lpage>529</lpage>, PMID: 22330734, <pub-id pub-id-type="doi">10.1016/j.neuro.2012.02.005</pub-id>.<pub-id pub-id-type="pmid">22330734</pub-id></mixed-citation>
</ref>
<ref id="c35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Tierney</surname><given-names>E</given-names></name></person-group>
<year>2011</year>. <article-title>Hypothesis: the role of sterols in autism spectrum disorder</article-title>. <source/>Autism Res Treat
<volume>2011</volume>:<elocation-id>653570</elocation-id>, PMID: 22937253, <pub-id pub-id-type="doi">10.1155/2011/653570</pub-id>.<pub-id pub-id-type="pmid">22937253</pub-id></mixed-citation>
</ref>
<ref id="c36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leoni</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Caccia</surname><given-names>C</given-names></name></person-group>
<year>2014</year>. <article-title>Study of cholesterol in Huntington’s disease</article-title>. <source/>Biochem Biophys Res Commun
<volume>446</volume>(<issue>3</issue>):<fpage>697</fpage>–<lpage>701</lpage>, PMID: 24525128, <pub-id pub-id-type="doi">10.1016/j.bbrc.2014.01.188</pub-id>.<pub-id pub-id-type="pmid">24525128</pub-id></mixed-citation>
</ref>
<ref id="c37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lepesheva</surname><given-names>GI</given-names></name>, <name name-style="western"><surname>Hargrove</surname><given-names>TY</given-names></name>, <name name-style="western"><surname>Kleshchenko</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nes</surname><given-names>WD</given-names></name>, <name name-style="western"><surname>Villalta</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Waterman</surname><given-names>MR</given-names></name></person-group>
<year>2008</year>. <article-title>CYP51: a major drug target in the cytochrome P450 superfamily</article-title>. <source/>Lipids
<volume>43</volume>(<issue>12</issue>):<fpage>1117</fpage>–<lpage>1125</lpage>, PMID: 18769951, <pub-id pub-id-type="doi">10.1007/s11745-008-3225-y</pub-id>.<pub-id pub-id-type="pmid">18769951</pub-id></mixed-citation>
</ref>
<ref id="c38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lamberson</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Haas</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Korade</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Porter</surname><given-names>NA</given-names></name></person-group>
<year>2014</year>. <article-title>A highly sensitive method for analysis of 7-dehydrocholesterol for the study of Smith-Lemli-Opitz syndrome</article-title>. <source/>J Lipid Res
<volume>55</volume>(<issue>2</issue>):<fpage>329</fpage>–<lpage>337</lpage>, PMID: 24259532, <pub-id pub-id-type="doi">10.1194/jlr.D043877</pub-id>.<pub-id pub-id-type="pmid">24259532</pub-id></mixed-citation>
</ref>
<ref id="c39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Logarinho</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Rosado</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lourenço</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Barroso</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Araujo</surname><given-names>ARTS</given-names></name>, <name name-style="western"><surname>Gallardo</surname><given-names>E</given-names></name>, <etal>et al.</etal></person-group>
<year>2016</year>. <article-title>Determination of antipsychotic drugs in hospital and wastewater treatment plant samples by gas chromatography/tandem mass spectrometry</article-title>. <source/>J Chromatogr B Analyt Technol Biomed Life Sci
<volume>1038</volume>:<fpage>127</fpage>, PMID: 28029546, <pub-id pub-id-type="doi">10.1016/j.jchromb.2016.10.031</pub-id>.<pub-id pub-id-type="pmid">28029546</pub-id></mixed-citation>
</ref>
<ref id="c40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luz</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Tokar</surname><given-names>EJ</given-names></name></person-group>
<year>2018</year>. <article-title>Pluripotent stem cells in developmental toxicity testing: a review of methodological advances</article-title>. <source/>Toxicol Sci
<volume>165</volume>(<issue>1</issue>):<fpage>31</fpage>–<lpage>39</lpage>, PMID: 30169765, <pub-id pub-id-type="doi">10.1093/toxsci/kfy174</pub-id>.<pub-id pub-id-type="pmid">30169765</pub-id></mixed-citation>
</ref>
<ref id="c41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martín</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pfrieger</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Dotti</surname><given-names>C</given-names></name></person-group>
<year>2014</year>. <article-title>Cholesterol in brain disease: sometimes determinant and frequently implicated</article-title>. <source/>EMBO Rep
<volume>15</volume>(<issue>10</issue>):<fpage>1036</fpage>–<lpage>1052</lpage>, PMID: 25223281, <pub-id pub-id-type="doi">10.15252/embr.201439225</pub-id>.<pub-id pub-id-type="pmid">25223281</pub-id></mixed-citation>
</ref>
<ref id="c42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGrogan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Snowball</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Charlton</surname><given-names>RA</given-names></name></person-group>
<year>2017</year>. <article-title>Statins during pregnancy: a cohort study using the General Practice Research Database to investigate pregnancy loss</article-title>. <source/>Pharmacoepidemiol Drug Saf
<volume>26</volume>(<issue>7</issue>):<fpage>843</fpage>–<lpage>852</lpage>, PMID: 28176447, <pub-id pub-id-type="doi">10.1002/pds.4176</pub-id>.<pub-id pub-id-type="pmid">28176447</pub-id></mixed-citation>
</ref>
<ref id="c43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitsche</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>McDonald</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Hobbs</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Cohen</surname><given-names>JC</given-names></name></person-group>
<year>2015</year>. <article-title>Flux analysis of cholesterol biosynthesis in vivo reveals multiple tissue and cell-type specific pathways</article-title>. <source/>eLife
<volume>4</volume>:<elocation-id>e07999</elocation-id>, PMID: 26114596, <pub-id pub-id-type="doi">10.7554/eLife.07999</pub-id>.<pub-id pub-id-type="pmid">26114596</pub-id></mixed-citation>
</ref>
<ref id="c44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muri</surname><given-names>SD</given-names></name>, <name name-style="western"><surname>van der Voet</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Boon</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>van Klaveren</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Brüschweiler</surname><given-names>BJ</given-names></name></person-group>
<year>2009</year>. <article-title>Comparison of human health risks resulting from exposure to fungicides and mycotoxins via food</article-title>. <source/>Food Chem Toxicol
<volume>47</volume>(<issue>12</issue>):<fpage>2963</fpage>–<lpage>2974</lpage>, PMID: 19345717, <pub-id pub-id-type="doi">10.1016/j.fct.2009.03.035</pub-id>.<pub-id pub-id-type="pmid">19345717</pub-id></mixed-citation>
</ref>
<ref id="c45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neely</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Litt</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Tidball</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>GG</given-names></name>, <name name-style="western"><surname>Aboud</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Hopkins</surname><given-names>CR</given-names></name>, <etal>et al.</etal></person-group>
<year>2012</year>. <article-title>DMH1, a highly selective small molecule BMP inhibitor promotes neurogenesis of hiPSCs: comparison of PAX6 and SOX1 expression during neural induction</article-title>. <source/>ACS Chem Neurosci
<volume>3</volume>(<issue>6</issue>):<fpage>482</fpage>–<lpage>491</lpage>, PMID: 22860217, <pub-id pub-id-type="doi">10.1021/cn300029t</pub-id>.<pub-id pub-id-type="pmid">22860217</pub-id></mixed-citation>
</ref>
<ref id="c46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nelson</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Zeldin</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Hoffman</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Maltais</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Wain</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Nebert</surname><given-names>DW</given-names></name></person-group>
<year>2004</year>. <article-title>Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants</article-title>. <source/>Pharmacogenetics
<volume>14</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>18</lpage>, PMID: 15128046, <pub-id pub-id-type="doi">10.1097/00008571-200401000-00001</pub-id>.<pub-id pub-id-type="pmid">15128046</pub-id></mixed-citation>
</ref>
<ref id="c47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okita</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Matsumura</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Okada</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Morizane</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Okamoto</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group>
<year>2011</year>. <article-title>A more efficient method to generate integration-free human iPS cells</article-title>. <source/>Nat Methods
<volume>8</volume>(<issue>5</issue>):<fpage>409</fpage>–<lpage>412</lpage>, PMID: 21460823, <pub-id pub-id-type="doi">10.1038/nmeth.1591</pub-id>.<pub-id pub-id-type="pmid">21460823</pub-id></mixed-citation>
</ref>
<ref id="c48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porter</surname><given-names>FD</given-names></name></person-group>
<year>2008</year>. <article-title>Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management</article-title>. <source/>Eur J Hum Genet
<volume>16</volume>(<issue>5</issue>):<fpage>535</fpage>–<lpage>541</lpage>, PMID: 18285838, <pub-id pub-id-type="doi">10.1038/ejhg.2008.10</pub-id>.<pub-id pub-id-type="pmid">18285838</pub-id></mixed-citation>
</ref>
<ref id="c49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Porter</surname><given-names>FD</given-names></name>, <name name-style="western"><surname>Herman</surname><given-names>GE</given-names></name></person-group>
<year>2011</year>. <article-title>Malformation syndromes caused by disorders of cholesterol synthesis</article-title>. <source/>J Lipid Res
<volume>52</volume>(<issue>1</issue>):<fpage>6</fpage>–<lpage>34</lpage>, PMID: 20929975, <pub-id pub-id-type="doi">10.1194/jlr.R009548</pub-id>.<pub-id pub-id-type="pmid">20929975</pub-id></mixed-citation>
</ref>
<ref id="c50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pryor</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bermúdez</surname><given-names>E</given-names></name></person-group>
<year>1992</year>. <article-title>Cholesterol ozonation products as biomarkers for ozone exposure in rats</article-title>. <source/>Biochem Biophys Res Commun
<volume>188</volume>(<issue>2</issue>):<fpage>618</fpage>–<lpage>623</lpage>, PMID: 1445306, <pub-id pub-id-type="doi">10.1016/0006-291x(92)91101-u</pub-id>.<pub-id pub-id-type="pmid">1445306</pub-id></mixed-citation>
</ref>
<ref id="c51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pulfer</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>RC</given-names></name></person-group>
<year>2004</year>. <article-title>Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant</article-title>. <source/>J Biol Chem
<volume>279</volume>(<issue>25</issue>):<fpage>26331</fpage>–<lpage>26338</lpage>, PMID: 15096493, <pub-id pub-id-type="doi">10.1074/jbc.M403581200</pub-id>.<pub-id pub-id-type="pmid">15096493</pub-id></mixed-citation>
</ref>
<ref id="c52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richard</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Judson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Houck</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Grulke</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Volarath</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Thillainadarajah</surname><given-names>I</given-names></name>, <etal>et al.</etal></person-group>
<year>2016</year>. <article-title>ToxCast chemical landscape: paving the road to 21st century toxicology</article-title>. <source/>Chem Res Toxicol
<volume>29</volume>(<issue>8</issue>):<fpage>1225</fpage>–<lpage>1251</lpage>, PMID: 27367298, <pub-id pub-id-type="doi">10.1021/acs.chemrestox.6b00135</pub-id>.<pub-id pub-id-type="pmid">27367298</pub-id></mixed-citation>
</ref>
<ref id="c53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roelofs</surname><given-names>MJE</given-names></name>, <name name-style="western"><surname>Temming</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Piersma</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>van den Berg</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van Duursen</surname><given-names>MBM</given-names></name></person-group>
<year>2014</year>. <article-title>Conazole fungicides inhibit Leydig cell testosterone secretion and androgen receptor activation <italic>in vitro</italic></article-title>. <source/>Toxicol Rep
<volume>1</volume>:<fpage>271</fpage>–<lpage>283</lpage>, PMID: 5598417, <pub-id pub-id-type="doi">10.1016/j.toxrep.2014.05.006</pub-id>.<pub-id pub-id-type="pmid">28962244</pub-id></mixed-citation>
</ref>
<ref id="c54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roncati</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Pusiol</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Piscioli</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Lavezzi</surname><given-names>AM</given-names></name></person-group>
<year>2017</year>. <article-title>Neurodevelopmental disorders and pesticide exposure: the northeastern Italian experience</article-title>. <source/>Arch Toxicol
<volume>91</volume>(<issue>2</issue>):<fpage>603</fpage>–<lpage>604</lpage>, PMID: 28032145, <pub-id pub-id-type="doi">10.1007/s00204-016-1920-7</pub-id>.<pub-id pub-id-type="pmid">28032145</pub-id></mixed-citation>
</ref>
<ref id="c55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roux</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mulliez</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Gaoua</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Cormier</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Chevy</surname><given-names>F</given-names></name>, <etal>et al.</etal></person-group>
<year>2000</year>. <article-title>Role of cholesterol in embryonic development</article-title>. <source/>Am J Clin Nutr
<volume>71</volume>(<issue>suppl 5</issue>):<fpage>1270s</fpage>–<lpage>1279s</lpage>, PMID: 10799401, <pub-id pub-id-type="doi">10.1093/ajcn/71.5.1270s</pub-id>.<pub-id pub-id-type="pmid">10799401</pub-id></mixed-citation>
</ref>
<ref id="c56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rozman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Strömstedt</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tsui</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Scherer</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Waterman</surname><given-names>MR</given-names></name></person-group>
<year>1996</year>. <article-title>Structure and mapping of the human lanosterol 14alpha-demethylase gene (CYP51) encoding the cytochrome P450 involved in cholesterol biosynthesis; comparison of exon/intron organization with other mammalian and fungal CYP genes</article-title>. <source/>Genomics
<volume>38</volume>(<issue>3</issue>):<fpage>371</fpage>–<lpage>381</lpage>, PMID: 8975714, <pub-id pub-id-type="doi">10.1006/geno.1996.0640</pub-id>.<pub-id pub-id-type="pmid">8975714</pub-id></mixed-citation>
</ref>
<ref id="c57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schroepfer</surname><given-names>G</given-names></name></person-group>
<year>2000</year>. <article-title>Oxysterols: modulators of cholesterol metabolism and other processes</article-title>. <source/>Physiol Rev
<volume>80</volume>(<issue>1</issue>):<fpage>361</fpage>–<lpage>554</lpage>, PMID: 10617772, <pub-id pub-id-type="doi">10.1152/physrev.2000.80.1.361</pub-id>.<pub-id pub-id-type="pmid">10617772</pub-id></mixed-citation>
</ref>
<ref id="c58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sikora</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Pettit-Kekel</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Penfield</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Merkens</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Steiner</surname><given-names>RD</given-names></name></person-group>
<year>2006</year>. <article-title>The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome</article-title>. <source/>Am J Med Genet A
<volume>140</volume>(<issue>14</issue>):<fpage>1511</fpage>–<lpage>1518</lpage>, PMID: 16761297, <pub-id pub-id-type="doi">10.1002/ajmg.a.31294</pub-id>.<pub-id pub-id-type="pmid">16761297</pub-id></mixed-citation>
</ref>
<ref id="c59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silveira</surname><given-names>MAK</given-names></name>, <name name-style="western"><surname>Caldas</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Guilherme</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>FP</given-names></name>, <name name-style="western"><surname>BdS</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cerqueira</surname><given-names>MBR</given-names></name>, <etal>et al.</etal></person-group>
<year>2013</year>
<article-title>Quantification of pharmaceuticals and personal care product residues in surface and drinking water samples by SPE and LC-ESI-MS/MS</article-title>. <source/>J Brazilian Chem Soc
<volume>24</volume>:<fpage>1385</fpage>–<lpage>1395</lpage>, <pub-id pub-id-type="doi">10.5935/0103-5053.20130176</pub-id>.</mixed-citation>
</ref>
<ref id="c60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorhus</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Incardona</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Furmanek</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Goetz</surname><given-names>GW</given-names></name>, <name name-style="western"><surname>Scholz</surname><given-names>NL</given-names></name>, <name name-style="western"><surname>Meier</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group>
<year>2017</year>. <article-title>Novel adverse outcome pathways revealed by chemical genetics in a developing marine fish</article-title>. <source/>eLife
<volume>6</volume>: <elocation-id>e20707</elocation-id>, PMID: 28117666, <pub-id pub-id-type="doi">10.7554/eLife.20707</pub-id>.<pub-id pub-id-type="pmid">28117666</pub-id></mixed-citation>
</ref>
<ref id="c61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Speen</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Bauer</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Meyer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gowdy</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Fessler</surname><given-names>MB</given-names></name>, <etal>et al.</etal></person-group>
<year>2016</year>. <article-title>Ozone-derived oxysterols affect liver x receptor (LXR) signaling: a potential role for lipid-protein adducts</article-title>. <source/>J Biol Chem
<volume>291</volume>(<issue>48</issue>):<fpage>25192</fpage>–<lpage>25206</lpage>, PMID: 27703007, <pub-id pub-id-type="doi">10.1074/jbc.M116.732362</pub-id>.<pub-id pub-id-type="pmid">27703007</pub-id></mixed-citation>
</ref>
<ref id="c62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thurm</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tierney</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Farmer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Albert</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Joseph</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Swedo</surname><given-names>S</given-names></name>, <etal>et al.</etal></person-group>
<year>2016</year>. <article-title>Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update</article-title>. <source/>J Neurodev Disord
<volume>8</volume>:<fpage>12</fpage>, PMID: 27053961, <pub-id pub-id-type="doi">10.1186/s11689-016-9145-x</pub-id>.<pub-id pub-id-type="pmid">27053961</pub-id></mixed-citation>
</ref>
<ref id="c63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tidball</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Bryan</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Uhouse</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Aboud</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Feist</surname><given-names>JE</given-names></name>, <etal>et al.</etal></person-group>
<year>2015</year>. <article-title>A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington‘s disease</article-title>. <source/>Hum Mol Genet
<volume>24</volume>(<issue>7</issue>):<fpage>1929</fpage>–<lpage>1944</lpage>, PMID: 25489053, <pub-id pub-id-type="doi">10.1093/hmg/ddu609</pub-id>.<pub-id pub-id-type="pmid">25489053</pub-id></mixed-citation>
</ref>
<ref id="c64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tidball</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Neely</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Chamberlin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Aboud</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Kuma</surname><given-names>KK</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>B</given-names></name>, <etal>et al.</etal></person-group>
<year>2016</year>. <article-title>Genomic instability associated with p53 knockdown in the generation of Huntington’s disease human induced pluripotent stem cells</article-title>. <source/>PLoS One
<volume>11</volume>(<issue>3</issue>):<elocation-id>e0150372</elocation-id>, PMID: 26982737, <pub-id pub-id-type="doi">10.1371/journal.pone.0150372</pub-id>.<pub-id pub-id-type="pmid">26982737</pub-id></mixed-citation>
</ref>
<ref id="c65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tierney</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bukelis</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Ahmed</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Aneja</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kratz</surname><given-names>L</given-names></name>, <etal>et al.</etal></person-group>
<year>2006</year>
<article-title>Abnormalities of cholesterol metabolism in autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet</article-title>
<volume>141B</volume>(<issue>6</issue>):<fpage>666</fpage>–<lpage>668</lpage>, <pub-id pub-id-type="doi">10.1002/ajmg.b.30368</pub-id>.</mixed-citation>
</ref>
<ref id="c66">
<mixed-citation publication-type="book"><collab>U.S. EPA (U.S. Environmental Protection Agency)</collab>. <year>2004</year>
<article-title>Health risk assessment for spiroxamine use in/on grapes, hops, and imported bananas</article-title>. <ext-link ext-link-type="uri" xlink:href="https://www3.epa.gov/pesticides/chem_search/hhbp/R100183.pdf">https://www3.epa.gov/pesticides/chem_search/hhbp/R100183.pdf</ext-link> [accessed <date-in-citation content-type="access-date">17 June 2018</date-in-citation>].</mixed-citation>
</ref>
<ref id="c67">
<mixed-citation publication-type="book"><collab>U.S. EPA</collab>. <year>2005</year>
<article-title>Fenpropimorph hed human health risk assessment to support tolerance on imported bananas</article-title>. <ext-link ext-link-type="uri" xlink:href="https://www3.epa.gov/pesticides/chem_search/hhbp/R116369.pdf">https://www3.epa.gov/pesticides/chem_search/hhbp/R116369.pdf</ext-link> [accessed <date-in-citation content-type="access-date">17 June 2018</date-in-citation>].</mixed-citation>
</ref>
<ref id="c68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van De Steene</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Stove</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Lambert</surname><given-names>WE</given-names></name></person-group>
<year>2010</year>. <article-title>A field study on 8 pharmaceuticals and 1 pesticide in Belgium: removal rates in waste water treatment plants and occurrence in surface water</article-title>. <source/>Sci Total Environ
<volume>408</volume>(<issue>16</issue>):<fpage>3448</fpage>–<lpage>3453</lpage>, PMID: 20471061, <pub-id pub-id-type="doi">10.1016/j.scitotenv.2010.04.037</pub-id>.<pub-id pub-id-type="pmid">20471061</pub-id></mixed-citation>
</ref>
<ref id="c69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Wendel de Joode</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Mora</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Lindh</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Hernández-Bonilla</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Córdoba</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Wesseling</surname><given-names>C</given-names></name>, <etal>et al.</etal></person-group>
<year>2016</year>. <article-title>Pesticide exposure and neurodevelopment in children aged 6-9 years from Talamanca, Costa Rica</article-title>. <source/>Cortex
<volume>85</volume>:<fpage>137</fpage>–<lpage>150</lpage>, PMID: 27773359, <pub-id pub-id-type="doi">10.1016/j.cortex.2016.09.003</pub-id>.<pub-id pub-id-type="pmid">27773359</pub-id></mixed-citation>
</ref>
<ref id="c70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vance</surname><given-names>J</given-names></name></person-group>
<year>2012</year>. <article-title>Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases</article-title>. <source/>Dis Model Mech
<volume>5</volume>(<issue>6</issue>):<fpage>746</fpage>–<lpage>755</lpage>, PMID: 23065638, <pub-id pub-id-type="doi">10.1242/dmm.010124</pub-id>.<pub-id pub-id-type="pmid">23065638</pub-id></mixed-citation>
</ref>
<ref id="c71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vrijheid</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Slama</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Chatzi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Coen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van den Hazel</surname><given-names>P</given-names></name>, <etal>et al.</etal></person-group>
<year>2014</year>. <article-title>The human early-life exposome (HELIX): project rationale and design</article-title>. <source/>Environ Health Perspect
<volume>122</volume>(<issue>6</issue>):<fpage>535</fpage>–<lpage>544</lpage>, PMID: 24610234, <pub-id pub-id-type="doi">10.1289/ehp.1307204</pub-id>.<pub-id pub-id-type="pmid">24610234</pub-id></mixed-citation>
</ref>
<ref id="c72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wages</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Korade</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Porter</surname><given-names>NA</given-names></name></person-group>
<year>2018</year>. <article-title>Identification and characterization of prescription drugs that change levels of the cholesterol precursors 7-dehydrocholesterol and desmosterol</article-title>. <source/>J Lipid Res
<volume>59</volume>(<issue>10</issue>):<fpage>1916</fpage>, PMID: 30087204, <pub-id pub-id-type="doi">10.1194/jlr.M086991</pub-id>.<pub-id pub-id-type="pmid">30087204</pub-id></mixed-citation>
</ref>
<ref id="c73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warrilow</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Parker</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>SL</given-names></name></person-group>
<year>2013</year>. <article-title>Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens</article-title>. <source/>Antimicrob Agents Chemother
<volume>57</volume>(<issue>3</issue>):<fpage>1352</fpage>–<lpage>1360</lpage>, PMID: 23274672, <pub-id pub-id-type="doi">10.1128/AAC.02067-12</pub-id>.<pub-id pub-id-type="pmid">23274672</pub-id></mixed-citation>
</ref>
<ref id="c74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wassif</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Krakowiak</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Gewandter</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Sterner</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Javitt</surname><given-names>N</given-names></name>, <etal>et al.</etal></person-group>
<year>2005</year>. <article-title>Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts</article-title>. <source/>Mol Genet Metab
<volume>85</volume>(<issue>2</issue>):<fpage>96</fpage>–<lpage>107</lpage>, PMID: 15896653, <pub-id pub-id-type="doi">10.1016/j.ymgme.2004.12.009</pub-id>.<pub-id pub-id-type="pmid">15896653</pub-id></mixed-citation>
</ref>
<ref id="c75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wier</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Guerriero</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>RF</given-names></name></person-group>
<year>1989</year>. <article-title>Implementation of a primary screen for developmental neurotoxicity</article-title>. <source/>Toxicol Sci
<volume>13</volume>(<issue>1</issue>):<fpage>118</fpage>–<lpage>136</lpage>, PMID: 2767352, <pub-id pub-id-type="doi">10.1093/toxsci/13.1.118</pub-id>.<pub-id pub-id-type="pmid">2767352</pub-id></mixed-citation>
</ref>
<ref id="c76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Oldenburg</surname><given-names>KR</given-names></name></person-group>
<year>1999</year>. <article-title>A simple statistical parameter for use in evaluation and validation of high throughput screening assays</article-title>. <source/>J Biomol Screen
<volume>4</volume>(<issue>2</issue>):<fpage>67</fpage>–<lpage>73</lpage>, PMID: 10838414, <pub-id pub-id-type="doi">10.1177/108705719900400206</pub-id>.<pub-id pub-id-type="pmid">10838414</pub-id></mixed-citation>
</ref>
<ref id="c77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Qiang</surname><given-names>L</given-names></name></person-group>
<year>2015</year>. <article-title>Cholesterol metabolism and homeostasis in the brain</article-title>. <source/>Protein Cell
<volume>6</volume>(<issue>4</issue>):<fpage>254</fpage>–<lpage>264</lpage>, PMID: 25682154, <pub-id pub-id-type="doi">10.1007/s13238-014-0131-3</pub-id>.<pub-id pub-id-type="pmid">25682154</pub-id></mixed-citation>
</ref>
<ref id="c78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zivan</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Bohbot-Raviv</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Dubowski</surname><given-names>Y</given-names></name></person-group>
<year>2017</year>. <article-title>Primary and secondary pesticide drift profiles from a peach orchard</article-title>. <source/>Chemosphere
<volume>177</volume>:<fpage>303</fpage>–<lpage>310</lpage>, PMID: 28314235, <pub-id pub-id-type="doi">10.1016/j.chemosphere.2017.03.014</pub-id>.<pub-id pub-id-type="pmid">28314235</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>